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5      Foreword   
Originally founded as the Royal Prussian Institute of  Infectious 
Diseases  on  July  1st  1891  with  Robert  Koch  as  its  director, 
the  institute  has  since  experienced  dramatic  changes  to 
achieve  its  present  standing  as  the  German  National  Public 
Health Institute. Officially named after Robert Koch in 1912 – 























–  together  with  the  2001  release  of  the  Protection  against 
Infection  Act  further  fostered  the   Robert  Koch  Institute’s 
 leading role in collaborations within the Federal States.
The  new  millennium  saw  further  expansion  with  the 
formation  of  the  Centre  for  Biological  Threats  and  Special 
Pathogens  in  2002.  This  centre  closes  an  earlier  gap  in 






The German Parliament  agreed upon a budget  to  allow  the 
necessary  expansion  of  staff  at  the  RKI,  making  it  possible 
to  better  tackle,  for  example,  the  new  challenges  in  health 
protection  and  prevention  of  infection  posed  by  our  ageing 
society.  A  key  element  of  this  agenda  was  the  construction 
of  a  high  containment  BSL-4  laboratory  facility,  which  was 
inaugurated in 2015. Second, our institute has been mandated 
since  2008  to  continuously  perform  representative  surveys 
of the population’s health. The data generated by such health 
monitoring, which is available to the public and public health 
scientists  in  Germany,  forms  the  basis  for  developing  and 
evaluating intervention strategies at the national level. 
It  is  important  to  acknowledge  that  the  history  of  the 
 Robert Koch Institute is not without its dark periods, and in 
this context  it needs  to be mentioned  that  the  institute  took 
critical  responsibility  for  its  historic  burden  by  launching  a 









Control  (ECDC),  the  European  Commission  and  the  World 
Health Organization (WHO). The institute also has a constant 
exchange of views with some hundred public health institutes 
globally  as  part  of  the  International  Association  of  National 
Public Health Institutes (IANPHI). 
The institute is run by the efforts of its more than 1,100 
dedicated  employees  who,  with  their  over  ninety  different 
professions, transform the institute’s vision to protect health 
and explore risks into reality, an excellent basis for providing 
sound  recommendations  to  political  decision  makers.  The 




of  the  institute and  the expertise of  its  staff. We will always 
strive to keep pace with scientific and social developments in 
order to fulfil our duties in the best possible way. 
This  booklet  gives  you  an  insight  into  the  Robert  Koch 
Institute as it stands 125 years after its foundation. Enjoy the tour!
Best regards
Prof. Dr. Lothar H. Wieler
President of the robert Koch Institute
125 Years Robert Koch Institute –The Public Health Institute
The Locations of the Robert Koch Institute
the rKI has its headquarters and 
two additional locations in berlin  
as well as a branch in Wernigerode. 
after completion of building  
works, two sites will remain in berlin,  
nord ufer and seestraße, both  
in the direct vicinity of the charité 
university hospital and other research 
facilities. the historic site at  nord ufer 
(up) houses the institute’s hIV  
and bioinformatics units, its man-
agement and a small museum 
displaying memorabilia from the  
life and work of the institute’s 
founder, robert Koch. In addition, 
the mausoleum containing robert 
Koch’s remains can be visited
In the 12th century town of 
Wernigerode, the rKI is housed  
in modern laboratories and in  
one of the oldest of its many  half-
timbered  buildings. the main areas 
of activities are bacterial infections 
and anti biotic resistance
at seestraße, you find the  
majority of research laboratories 
including a biosaftey level 4  
laboratory as well as central facilities 
such as the It unit
General-Pape-straße contains  
the Department of epidemiology 
and health Monitoring and  
the institute’s printery
8 9      The Public Health Institute      The Public Health Institute      




disease,  prolonging  life  and  promoting  health  through  the 
organized  efforts  of  society.”  (Acheson  1988,  WHO  2011). 
 Central elements are the twin characteristics of public health 
as  a  science  and  practical  discipline,  as  well  as  the  goal  of 
achieving population health.
Other  definitions  incorporate  additional  perspectives. 





















 Ω Multi-  and  interdisciplinary:  In  line  with  this  compre-
hensive approach, public health relies on a  large number 
of disciplines and applies a wide variety of methods. Impor-







Objectives, tasks and fields of action for public health 
According  to  the  WHO  definition,  the  objectives  of  public 
health are to prevent diseases, prolong life and promote health 
(WHO  2011).  With  the  Essential  Public  Health  Operations 
(EPHO),  the  WHO  Regional  Committee  for  Europe  formu-













9.  Information,  communication and social mobilization  for 
health





Historical development and new challenges
Early  forms  of  public  health  services  existed  in  the  towns 
and cities of northern Italy as early as the late 13th/early 14th 
 centuries  and,  from  there,  spread  to  German  trading   cities. 
Another important step in the development of public health 
was the “medizinische Polizey” (medical police) in the emerg-
ing  territorial  states:  health  assurance  by  means  of  public 
surveillance  and  health  administration.  The  first  modern 
health  sciences began  to evolve  in  the  19th  century. Worthy 
of note  for Germany  in  this context are  the subject areas of 
“social medicine” (Salomon Neumann and Rudolf Virchow), 















health  and  disease  (e.g.  urban  living,  the  risk  of   epidemics, 
industrial  labour)  and  the  prevailing  social  and  politi-




by  challenges  such  as  emerging  (MERS  and  Ebola)  as  well 
as  re-emerging  infectious  diseases  (e.g.  HIV,  malaria  and 
tuberculosis)  and  increasing  developments  of  resistance. 
Among the non-communicable diseases, cardiovascular disor-
ders, cancer, diabetes and mental disorders are of particular 




change,  so  too  must  methods  and  strategies  be  assessed, 





The Public Health Institute
robert Koch Institute, main entrance. completed in 1900, this building 
with its wealth of history stands at nordufer in berlin-Wedding
Measles viruses photographed 
with an electron microscope  
and coloured. the elimination  
of measles is an important public 
health target set by the Who  
for europe and already attained  
in the americas
Unterkapitel      Kapitel   10 11
Tasks of the Robert Koch Institute as national  
Public Health Institute 





This  process  starts  with  the  early  recognition  of  devel-






Independent  evaluation  of  developments  and  trends 
allows the identification of health hazards and priority health 
problems as well  as  the development of  suitable prevention 
strategies. Prognoses and estimations of the burden of  disease 










The programme RKI 2010




diseases,  HIV  and  other  sexually  transmitted  diseases, 
neglected pathogens; antibiotic resistance; vaccinations.
 Ω Coping with new biological threats: SARS, influenza pan-
demics,  bio-terrorism,  crisis  management;  establishment 
of high-security laboratories.
 Ω Combating  non-communicable  diseases:  cancer,  cardio-




activities,  qualification  of  specialized  personnel,  national 





















Franziska Prütz, Thomas Ziese
   The Public Health Institute      
the well-established system of rKI 
monitoring studies covers a broad 
spec trum of questions on health 
status, health behaviour, risk factors, 
prevention and care 
   Kapitel      Unterkapitel Unterkapitel      Kapitel   12 13
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Press, Public Relations, Library
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Regulatory Authority for the 









Prof. Dr. A. Flieger
FG 12
Measles, Mumps, Rubella, and 
Viruses Affecting 
Immunocompromised Patients
Prof. Dr. A. Mankertz
FG 13
Nosocomial Pathogens and 
Antibiotic Resistances
PD Dr. G. Werner
FG 14
Hospital Hygiene, Infection 
Prevention and Control




 Prof. Dr. C.-Th. Bock
FG 16




Influenza and Other Respiratory 
Viruses
PD Dr. T. Wolff
FG 18
HIV and Other Retroviruses
Prof. Dr. N. Bannert
Department 2




German Centre for Cancer 
Registry Data 
Dr. K. Kraywinkel 
FG 21





PD Dr. M. Schlaud
FG 23























PD Dr. O. Wichmann
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Gastrointestinal Infections, Zoonoses 
and Tropical Infections
Prof. Dr. K. Stark
FG 36
Respiratory Infections
Prof. Dr. W. Haas
ZBS
Centre for Biological Threats and 
Special Pathogens
PD Dr. L. Schaade
IBBS
Federal Information Centre for Biological 
Threats and Special Pathogens
Dr. C. Herzog
ZBS 1
Highly Pathogenic Viruses   
PD Dr. A. Nitsche
ZBS 2
Highly Pathogenic Microorganisms














Prof. Dr. R. Kroczek
P 2
Acinetobacter baumanni -  
Biology of a Nosocomial 
Pathogen
PD Dr. G. Wilharm
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PD Dr. B. Renard
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Epidemiological Modelling of 
Infectious Diseases
Prof. Dr. D. Brockmann
GBS














Social Determinants of Health
PD Dr. T. Lampert
Organisation Chart
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Epidemiology  and  Health  Monitoring,  Infectious  Disease 
Epidemiology,  Centre  for  Biological  Threats  and  Special 
Pathogens), the Central Administration as well as the Project 
Groups and the Junior Research Groups report directly to the 
President. Directly assigned to  the President  is  the Manage-
ment Staff (with three departments: Fundamental and Legal 
Issues,  Genetic  Engineering  and  the  Centre  for  Stem  Cell 
Research  Authorization),  the  three  staff  positions  Research 
Coordination, Press and Public Relations as well as Strength-
ening Global Health and Biosecurity. The offices of the Central 














Gröhe  and  Dr.  Barbara  Hendricks.  The  new  structure  also 
includes a laboratory of the highest biosafety level BSL-4. 
Raising the research profile and infectious diseases prepared-
ness of  the  institute  is an  important concern of  the head of 
the institute. The tasks of the Robert Koch Institute in health 
protection  and  in  advising  politics  can  only  be  provided  by 
scientific  distinction.  The  establishment  of  an  internal 
committee  to  ensure  the  scientific  quality  was  achieved  by 
implementing the Research Council in the late nineties. The 
Scientific  Advisory  Board  is  an  external  advisory  committee 
that ultimately promotes scientific excellence; it usually makes 




 intensified  these  activities  by  establishing  Junior  Research 
Groups.  Here  young  scientists  are  offered  the  possibility  to 











































In  order  to  answer  these  questions,  strategic  processes  are 
taking  place  during  which  we  ask  ourselves  whether  the 












Institute  therefore  adopts  responsibility  as  an  integral  part 
in well-functioning international networks. 
In the end we must be measured by the extent to which 
our  recommendations  are  heard,  understood  and  success-
fully put  into practice  in  the world beyond  the Robert Koch 
Institute.  Only  then  will  our  impact  on  society  be  mani-
fested   comprehensively  when  our  knowledge  and  expertise 
will  be  applied.  Success  in  addressing  challenging  health 
priorities  guarantees  the   Robert  Koch  Institute  to  offer  the 
most exciting jobs in the health sciences, a cornerstone to live 
up to the institute’s public health mission.  www.rki.de/wieler-en
heaD of InstItute ~ Prof. Dr. Lothar h. Wieler (President) ~ PD Dr. Lars schaade (Vice President)
secretarY ~ sabine tesfayohannes ~ annegret eisele ~ Jennifer schmitt ~ Jennifer hunziger (from left to right)
 “Our science-based  
mission is the improvement  
 of public health.”
 Prof. Dr. Lothar H. Wieler
   Head of the Institute      
16    Infectious Diseases      
Infections are the result of exposition and disposition of the 
host  and  the pathogenicity of  the  infective agent.  In contin-











 Ω to  investigate  changes  in  key  features  of  pathogens  like 












Enteroviruses,  and  Influenza)  and  5 Consultant Laboratories 
(Norovirus, Rotavirus, Listeria, RSV, hMPV, PIV, Cryptococcus/ 
















1. Deutscher bundestag. 2014. bericht der bundesregierung über 
nosokomiale Infektionen und erreger mit speziellen resistenzen 
und Multiresistenzen. Drucksache 18/3600 (erstellt durch das 
robert Koch-Institut, aG nosokomiale Infektionen).
2. Mielke M. 2010 Prevention and control of nosocomial infections 
and resistance to antibiotics in europe. Primum non nocere:  
elements of successful prevention and control of healthcare-
associated infections. Int J Med Microbiol 300: 346–350.
3. ruscher c, Pfeifer Y, Layer f, schaumann r, Levin K, Mielke M. 
2014. Inguinal skin colonization with multidrug-resistant bacteria 
among residents of elderly care facilities: frequency, persistence 
and molecular analysis. Int J Med Microbiol. 2014 aug 18. pii: 
s1438-4221(14)00105-2.
4. Mitglieder der Leitlinienkommission. 2015. s2k-guideline  
gastro intestinal infectious diseases and Whipple’s disease.  
Z Gastroenterol. 2015 May; 53(5): 418–459.
5. Jacob J, finke a, Mielke M. 2012 the mgla gene and its flanking 
regions in brucella: the role of mgla in tolerance to hostile  
environments, fe-metabolism and in vivo persistence.  
Int J. Med Microbiology 302 (3), pp. 148–154.
Department 1: Infectious Diseases 
heaD of DePartMent ~ Prof. Dr. Martin Mielke
aDMInIstratIVe staff ~ Jacqueline ahrens
heaDs of unIts ~ Prof. Dr. antje flieger ~ Prof. Dr. annette Mankertz (Deputy of the Head of Department) ~ PD Dr. Guido Werner
Prof. Dr. Mardjan arvand ~ Prof. Dr. claus-thomas bock ~ Dr. anton aebischer ~ PD Dr. thorsten Wolff ~ Prof. Dr. norbert bannert
In  addition,  the  inactivation  of  infective  agents  by   chemical 
and  physical  methods  is  investigated  and  certified  in  the 
unit  for  Hospital  Hygiene,  Infection  Prevention  and  Con-
trol which also hosts  the Commission for Hospital Hygiene 
and   Infection  Prevention.  The  respective  recommendations 
describe the national best practice standards for the prevention 
of  nosocomial infections.





(WHO  and  ECDC)  and  the  support  of  the  national  regional 
networks established  for  the  implementation of measures  to 
defend the distribution of antimicrobial resistant bacteria.
www.rki.de/abt1-en
“The most basic approach  
to reduce antimicrobial resistance  
is to understand microbial  
evo lution and to prevent infections.”  






Chronic/ persistent infection 
Successful defense/ Immunity 
the macrophage has  
a most decisive role in the 
defense against invading 
microorganisms. Interac-
tion of macrophages with 
facultative intracellular 





Chronic/ r i tent infection 




Chro ic/ persistent infection 
Successful defense/ I unity 
Bacterial burden 
Time
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such  as  Salmonella enterica, Escherichia coli,  Campylobacter 
spp.,  Yersinia enterocolitica, Shigella  spp.,  Listeria monocy-
togenes  and  the  lung  pathogen  Legionella  pneumophila. 
Expertise  in  diagnostics,  taxonomy  and  epidemiology  of 
Enterobacteriaceae is flanked by research into the  epidemiology, 
pathogenicity,  and  persistance  of  Salmonella,  intestinal 




laboratory  based  epidemiology  including  outbreak  detection 
and  investigation of  food borne bacterial pathogens  such as 
Salmonella, Shigella,  Shiga  toxin  producing/enterohaemor-
rhagic E. coli, Y. enterocolitica, C. jejuni and C. coli. Moreover, 
within the scope of the German-Austrian Binational Consiliary 
Laboratory for Listeria, the unit as the German partner together 





by  the  pathogens  under  investigation,  the  applied  research 
and reference work done at the unit are of great public health 
importance.  Immediate  value  for pathogen surveillance and 
outbreak  investigation  appears  from  the  cooperation  with 
the  epidemiologists  at  the  unit  “Gastrointestinal  Infections, 
Zoonoses  and  Tropical  Infections”  at  the  Robert  Koch 
 Institute,  public  health  authorities  of  the  federal  states,  and 
with the respective foodstuff control and veterinary authorities 
in case of outbreak investigations. 
Methodologically,  the  basic  approach  in  laboratory-based 
 epidemiology  is  strain  typing.  At  the  unit  “Enteropathogenic 
Bacteria  and  Legionella”  phenotypically  oriented  conven-
tional  subtyping  methods  such  as  serotyping,  phage  typing 
or  antibiotic  susceptibility  testing  as  well  as  modern  molec-
ular  DNA-based  techniques  such  as  PCR,  macrorestriction/
PFGE,  MLST  or  MLVA  are  applied  in  order  to  discriminate 
taxonomically and epidemiologically unrelated bacterial strains 
or  to  identify  clonal  relationships  between  independent  iso-
lates.  Currently,  whole  genome  sequencing  is  established  in 
the unit to adapt and develop methods for subtyping routines 
and  for  the  prediction  of  virulence  and  antibiotic  resistance. 
A detailed characterization of pathogen isolates based on their 
genome sequences allows the identification of clonal relation-
ships  between  independent  isolates  more  precisely.  Reliable 
information about the epidemiological relatedness of  pathogen 




the  risk  potential  for  particular  clones  among  the  pathogen 
species  investigated.  Beyond  this  main  business  of  the  unit 
“Enteropathogenic Bacteria and Legionella” that is related to 
Publications
1. Pees M, rabsch W, Plenz b, fruth a, Prager r, simon s, schmidt V, 
Munch s, braun P. (2013). evidence for the transmission of salmo-
nella from reptiles to children in Germany, July 2010 to october 2011. 
euro surveill. 2013 nov 14;18(46). pii: 20634.
2. tietze e, Dabrowski PW, Prager r, radonic a, fruth a, auraß P, 
nitsche a, Mielke M, flieger a. (2015). comparative genomic 
analysis of two novel sporadic shiga toxin-producing escherichia 
coli o104: h4 strains isolated 2011 in Germany. PLos one 10(4): 
e0122074.
3. aurass P, Gerlach t, becher D, Voigt b, Karste s, bernhardt J, 
riedel K, hecker M, flieger a. (2016). Life stage-specific Proteomes 
of Legionella pneumophila reveal a highly Differential abundance 
of Virulence-associated Dot/Icm effectors. Mol cell Proteomics. 
2016 Jan 15.
4. Kuhle K, Krausze J, curth u, rössle M, heuner K, Lang c, flieger 
a. (2014). oligomerization inhibits Legionella pneumophila Plab 
phospholipase a activity. J biol chem. 289(27): 18657–18666. doi: 
10.1074/jbc.M114.573196. epub 2014 May 8. 
5. rismondo, J., cleverley, r. M., Lane, h. V., Großhennig, s., steglich, 
a., Möller, L., Mannala, G. K., hain, t., Lewis, r. J., halbedel, s. 
(2016). structure of the bacterial cell division determinant Gpsb 


















protein  secretion  contribute  to  invasion  and  intracellular 
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in unit  12. These viruses predominantly  infect  children and 
young adults. Since infection can lead to severe complications 
and cause large outbreaks, it is fortunate that safe and effective 
vaccines  are  available  against  measles,  mumps,  rubella  and 
chickenpox. The main focus of our work is (I) to detect these 
viruses  and  determine  their  prevalence  within  the  German 
population, and (II) to analyze their transmission,  molecular 
evolution,  basis  of  pathogenicity  and  interaction  with  the 
immune  system.  Besides  collaborating  with  the   German 
Public  Health  System,  we  also  conduct  research  and  teach 
 university students. 
Measles and rubella may be  finally eradicated by global 





diagnose  cases  in  outbreak  settings  and  are  involved  in  the 
development of ring trials as an external quality assessment. 
Molecular surveillance includes genotyping of measles viruses 
from  outbreaks  to  uncover  the  origin  of  the  virus,  track  its 
spread and determine the length of virus transmission chains 
(Figure).  We  provide  evidence  that  the  vaccines  still  protect 
against  contemporary  viruses  by  monitoring  antigenic  vari-
ation  and  suspected  vaccination  failures.  We  participate  in 
seroprevalence studies conducted by our colleagues in Depart-
ment 2 assessing the German population’s immunity against 
measles,  mumps,  rubella,  chickenpox  and  cytomegalovirus. 
These  results  contribute  to  Germany’s  progress  towards  the 
elimination of measles and rubella scheduled for 2020. Since 


















To  search  for  new  animal  viruses  that  could  become 
a health hazard for humans, we study the evolution of adeno-, 
herpes-,  and  polyomaviruses  in  collaboration  with  RKI  unit 
P3. We focus on viruses detected  in apes, rodents, domestic 
animals  and  pet  animals,  i.e.  species  with  a  similar  genetic 
background to humans or with an environmental proximity, 
in  order  to  assess  their  potential  transmission  to  humans. 
A plethora of viruses have been identified and the evaluation 
of  their  potential  impact  on  human  health  using  molecular 
 methods is an ongoing task.
Furthermore,  we  are  interested  in  characterizing 
adeno-  and  cytomegalovirus  infections  frequently  affecting 
immunosuppressed  children  after  hematopoietic  stem  cell 
transplantation.  Cytomegalovirus  also  can  result  in  major 
Publications
1. Mankertz a, beutel u, schmidt fJ, borgmann s, Wenzel Je, Ziegler P, 
Weißbrich b, santibanez s. Laboratory-based investigation of sus-
pected mumps cases submitted to the German national reference 
centre for measles, mumps, and rubella, 2008 to 2013.  
Int J Med Microbiol. 2015 oct;305(7): 619–626.
2. Geyer h, bauer M, neumann J, Lüdde a, rennert P, friedrich n, 
claus c, Perelygina L, Mankertz a. Gene expression profiling  
of rubella virus infected primary endothelial cells of fetal and adult 
origin. Virology Journal, in press. 
3. hoppe, e., Pauly, M., Gillespie, t. r., akoua-Koffi, c., hohmann, 
G., fruth, b., ... & todd, a. (2015). Multiple cross-species transmission 
events of human adenoviruses (hadV) during hominine evolution. 
Molecular biology and evolution, msv090. 
4. siedler, a., Dettmann, M., tolksdorf, K., Polte, c., Walter, c.,  
& ehlers, b. (2015). Laboratory investigations of vaccinated patients 
with varicella. Vaccine, 33(16), 1968–1973. 
5. Voigt s, schaffrath rosario a, Mankertz a. cytomegalovirus  
seroprevalence among children and adolescents in Germany:  
Data from the German health Interview and examination survey 
for children and adolescents, 2003 – 2006. open forum Infect  
Dis 2016; in press.
birth  defects  including  hearing  loss.  We  are  interested  in 
mechanisms  used  by  these  viruses  to  circumvent  the  host 
immune  response,  involving  molecules  that  were  captured 
from  the host  itself during evolution. These  viral  analogues 




egies  that  lead  to  better  virus  control  in  case  of  viremia  in 
immunosuppressed individuals. Since the strong side effects 
of  antiviral  therapy  frequently  lead  to  treatment  discontin-
uation,  other  treatment  options  like  adoptive  transfer  of 
virus-specific T lymphocytes are needed. 
The  unit  for  Animal  Experiments  is  also  affiliated 
with  unit  12  and  serves  RKI  scientists  conducting  animal 
 experiments  that  study  infection  and  immunisation.  These 
are mainly  trials with a variety of different viruses, bacteria, 
and parasites, and are carried out by qualified animal keepers 
and  handlers.  Mice,  rats,  hamsters,  guinea  pigs  and  rabbits 
are  kept  under  conditions  that  meet  the  requirements  of 
 animal protection law and the relevant regulations. The unit’s 
animal keepers are trained every year.            www.rki.de/fg12-en
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Genotyping	   Molecular	  Surveillance	  
Measles	  virus	  D4-­‐Hamburg:	  	  
25,000	  cases	  in	  13	  countries	  
Molecul r	  surveillance	  enables	  us	  to	  follow	  th 	  tra smission	  of	  measles	  virus	  closely.	  	  
Here	  a	  variant	  was	  tracked	  from	  Germany	  to	  Bulgaria	  and	  finally	  throughout	  Europe.	  
Molecular surveillance enables us to  
follow the transmission of measles virus 
closely. here a variant was tracked  
from Germany to bulgaria and finally 
throughout europe
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Unit 13: Nosocomial Pathogens  
and Antibiotic Resistances
Unit 13 addresses nosocomial bacterial pathogens with a high 









Molecular  typing  and  analysis  of  the  population  struc-
ture of the above-mentioned nosocomial pathogens as well as 
detection and molecular analysis of virulence and resistance 
genes are  in  the centre of  the work  in unit  13 and  the NRC 







strengths  and  antibiotic  resistances;  (b)  molecular  analysis 
and  typing  of  nosocomial  Staphylococcus, Enterococcus  and 
enterobacterial  isolates  (ESBL-,  AmpC-  and/or  Carbapene-








As  an  inherent  and  important  part  of  our  work  we  support 
public  health  officials,  diagnostic  laboratories  and  hospital 
hygiene  specialists  with  state-of-the-art  molecular  analysis 
and  strain  characterizations  in  order  to  elucidate  possible 
outbreak   scenarios.  In  this  regard,  we  regularly  cooperate 
with  colleagues  from  the  Department  of  Infectious  Disease 
 Epidemiology, unit 37. 
The NRC Staphylococci and Enterococci promotes an intense 
exchange  with  European  reference  laboratories  and  with 
European and international agencies (ECDC, WHO). Within 
Germany, we build our work on the basis of a productive and 
successful  network  of  diagnostic  and  reference   laboratories 
sending  in  strains  for  further  characterisation.  We  have 
established  strong  collaborations  with  the  NRC  for  Gram- 




research  projects  (see  below).  Our  group  hosts  the   network 
of reference laboratories on antimicrobial resistance.








Society),  as  editors  and  reviewers  for  many  scientific  jour-
nals, as referees of funding agencies (European Commission, 
BMBF) and as representatives for European and international 
working  groups,  for  instance  at  the  European  Centre  for 
Disease Prevention and Control (ECDC). 
Part of our work is dedicated to national and international 






in  cooperation  with  groups/laboratories  from  the  BfR,  FLI, 
 several German universities); (c) elucidating novel mechanisms 
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“Against every antibiotic men  
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plasmids. J antimicrob. chemother (2015) 70(6): 1630–1638.
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enterococcus faecalis MLst st40. bMc Genomics (2015) 16(1): 175. 
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Left: network of collaborating 
laboratories sending Mrsa/
staphylococci for analysis to  
the national reference centre 
right: co-resistances in Mrsa 
from German hospital patients 
2008 – 2015 (data of the nrc) 
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A  second  area  of  research  is  stimulated  by  the  similarity  of 
substances  used  for  disinfection  with  those  involved  in  the 
inactivation of certain pathogens (e.g. intracellular pathogens) 








in  changes  in  growth  kinetics  (small  colony  variants),  toler-
ance to oxidative stress (H2O2), and persistence in activated 
macrophages.
In  summary,  unit  14  is  a  unit  that  takes  a  multi-faceted 
approach  to  achieving  one  goal:  minimizing  the  risk  of  HAI 
in hospitals and other healthcare facilities.   www.rki.de/fg14-en
Unit 14: Hospital Hygiene,  
Infection Prevention and Control
The unit for Hospital Hygiene, Infection Prevention and Control 
in Department  1  is most directly  engaged  in  the  transfer  of 
knowledge in the field of prevention and control of infectious 
diseases, the development and validation of methods to inac-
tivate  medically  important  pathogens,  and  research  into  the 
mechanisms by which pathogens tolerate stress. These areas 
of expertise are supported by three columns: 
Prevention and control of healthcare-associated infections
More than 18 million hospitalisations are reported in Germany 












best  practice  recommendations,  and  investigates  and  sup-
ports their implementation. Further information  concerning 
KRINKO can be found on page 115.




This structure  is  invaluable  for gaining deeper  insights  into 
the prevalence and risks of HAI  in  long-term care  facilities. 




and  answers  to  questions  from  healthcare  professionals, 
the  media,  and  governmental  institutions  concerning  the 
interpretation and implementation of the recommendations. 
Furthermore,  we  are  involved  in  many  reviews  aimed 
at evaluating and improving the safety of patients and health- 
care workers. 
Inactivation of Pathogenic Microorganisms
It was Robert Koch himself  who, more  than  100 years  ago, 
established methods to assess the efficacy of disinfection and 
sterilisation  procedures  in  the  laboratory.  His  fundamental 






























1. ruscher c, Kraus-haas M, nassauer a, Mielke M (2015)  
healthcare-associated infections and antimicrobial use in long 
term care facilities (haLt-2): German results of the second  
european prevalence survey. bundesgesundheitsbl – Gesundheits-
forsch – Gesundheitsschutz 58(4–5): 436–451.
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(2015) [Guideline of the German association for the control of Viral 
Diseases (DVV) eV and the robert Koch Institute (rKI) for testing 
chemical disinfectants for effectiveness against viruses in human 
medicine. Version of 1 December, 2014]. bundesgesundheitsbl – 
Gesundheitsforsch – Gesundheitsschutz. 58(4–5): 493–504. German.
3. rabenau hf, steinmann J, rapp I, schwebke I, eggers M (2014)
evaluation of a virucidal quantitative carrier test for surface  
disinfectants. PLos one 9 (1): e86128. epub Jan 27. doi: 10.1371/
journal.pone.0086128.
4. ruscher c, Pfeifer Y, Layer f, schaumann r, Levin K, Mielke M (2014) 
Inguinal skin colonization with multidrug-resistant bacteria among 
residents of elderly care facilities: frequency, persistence, molecular 
analysis and clinical impact. Int J Med Microbiol 304(8): 1123–1134.
5. thomzig a, Wagenführ K, Daus ML, Joncic M, schulz-schaeffer WJ, 
thanheiser M, Mielke M, beekes M (2014). Decontamination of  
medical devices from pathological amyloid-beta-, tau- and alpha- 
synuclein aggregates. acta neuropathol commun Vol 2: 151.
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clostridium difficile: vegetative cells and spores
“The art of healing can alleviate much  
suffering, but better is the art of  
preventing a disease before it appears.”
Max von Pettenkofer (1818  –  1901)
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Unit 15: Gastroenteritis and Hepatitis Viruses, 
Enteroviruses
The  unit  for  Viral  Gastroenteritis  and  Hepatitis  Viruses, 
Enteroviruses  in  the  Department  1  is  engaged  in  primarily 
fecal-orally  transmitted  human  pathogens  of  viral  gastroen-




circulation  using  modern  molecular  epidemiological  meth-
ods. A  recent  report by Balabanova et  al.  (PLOS ONE  2011) 
listed these viruses as high and highest prioritized pathogens 
in accordance with their importance for national surveillance 
and  epidemiological  research.  The  unit  hosts  the  National 
Reference  Centre  for  Poliomyelitis  and  Enteroviruses  (NRC 
PE) which is also a Regional Reference Laboratory of WHO/
Europe  for  Poliomyelitis,  and  since  2010  the  Office  of  the 





surveillance  of  circulating  viruses  and  population  dynam-
ics,  special  diagnostics  (e.g.  fine-typing),  quality  assurance 
(e.g. preparation of external quality assessments), maintain-
ing of virus strain collections, as well as analyses of outbreaks 
(in  cooperation  with  the  Department  for  Infectious  Disease 
Epidemiology at the RKI). Our laboratories carry out consult-
ing and scientific studies within the framework of their remit. 
The  special  task  of  the  NRC  PE  is  the  monitoring  of 
the polio-free status of Germany. Therefore,  the enterovirus 
surveillance  based  on  investigation  of  patients  with   aseptic 
meningitis/encephalitis  and  acute  flaccid  paralyses  was 















The  investigations  are  performed  in  close  cooperation 
with national and international networks, e.g. NoroNet, Euro-
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In  order  to  gain  new  insights  into  the  pathogenesis  and 















The  findings  of  the  research  projects  are  translated 














1	   3	   5	   7	   9	   11	   1	   3	   5	   7	   9	   11	   1	   3	   5	   7	   9	   11	   1	   3	   5	   7	   9	   11	   1	   3	   5	   7	   9	   11	   1	   3	   5	   7	   9	   11	   1	   3	   5	   7	   9	   11	   1	   3	   5	   7	   9	   11	   1	   3	   5	   7	   9	   11	  










Month/Year	  of	  tes9ng	  
EV-­‐PCR	  pos.	  
EV-­‐PCR	  neg.	  




1. 	  asep$c	  meningi$s/encephali$s	  
2. 	  acute	  flaccid	  paralysis	  
Laboratory	  Network	  for	  Enterovirus	  Diagnos$c	  	  	  
(LaNED:	  14	  cer$fied	  network	  labs)	   Robert	  Koch	  Ins$tute	  Hospital	  
Office	  of	  Na$onal	  Cer$fica$on	  
CommiNee	  (NCC)	  	  
lab	  report	  
pseudonym.	  data	  
WHO	  report	  weekly	  report	  stool/CSF	  sample	  
free	  EV-­‐diagnos$c	  
“To identify the  
smallest is the challenge  
 of the big picture.”
 Prof. Dr. C.-Thomas Bock
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Unit 16: Mycotic and Parasitic Agents  
and Mycobacteria
The  unit  is  concerned  with  consultancy  on,  training  in  and 
research  into  infections  by  eukaryotic  pathogens  and  myco-
bacteria  (mainly  non-tuberculous  mycobacteria)  in  the 
context of Public Health. Our research addresses these aspects 
by  focusing  on  relevant  endemic  parasitoses,  on  systemic 
mycoses  and  on  infections  with  mycobacteria,  i.e.  NTM. 
The microorganisms studied are widespread  in  the environ-
ment, some considered zoonotic and they can cause difficult 
to  treat  infections  in  vulnerable  groups,  including  children 
and  immunocompromised  hosts.  Neglect  at   various   levels 
is  a  common  denominator  that  characterizes  the   societal 
response  to  the  health  threat  inflicted  by  these  pathogens 
especially  in  developed  countries.  However,  with  an   ageing 
population  and  significant  changes  in  globalization  and 
climate  we  are  well  advised  to  remain  alert.  Our  activities 
aim at:  1.)  advancing pathogen  identification and diagnostic 
 methods; 2.) contributing to a better molecular understanding 
of virulence, pathogenicity and drug resistance mechanisms 
of  these  pathogens;  3.)  exploiting  the  knowledge  gained 









identification  methods,  and  by  improvement  of  serological 
assays the spectrum of tools available to this laboratory suited 
both for single case analysis and for molecular  epidemiological 
surveillance  is  continuously  expanded.  In  many  infections 
due  to  ubiquitous  environmental  organisms,  such  as  NTM, 
distinguishing disease from mere colonization is a challenge. 





Nowadays,  genome  information  is  often  instrumental 
to forge novel diagnostic strategies to detect rare, non-model 
pathogens. We adopted this approach to improve  diagnostics 
for  rare  amoebiases.  These  can  cause  severe  encephalitis 
with  no  proven  therapeutic  options  and  a  near  100%  fatal-




1. hahn, J., et al., high sensitivity of Giardia duodenalis to tetrahy-
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apiospermum and Pseudallescheria boydii isolates from cystic 
fibrosis patients. J cyst fibros, 2013. 12(6): p. 592–598.
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for  instance,  the  protozoan  parasite  causing  the  abovemen-







characterization  for  the  clinically  relevant  discrimination 
of  these  agents.  For  Cryptococcus  spp.  and  NTM  we  pur-
sue  similar  goals.  In  cooperation  with  clinical  institutions, 
we focus on fungal and NTM isolates of patients with cystic 
 fibrosis. These patients are a relevant proxy for the large group 
of  vulnerable  patients  suffering  from  chronic  obstructive 
pulmonary diseases  (COPD). The unit  is also  investing  into 
numerous  readout  systems  to  evaluate  pathogenicity.  This 
activity ranges from establishing human intestinal organoids 
for  analysis  of  human-specific  gastrointestinal  pathogens  to 
wax moths as a  cost-efficient  fast  in vivo model  to  compare 
 virulence of e.g. Cryptococci or, generally, microbial pathogens 
with a broad host range.
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Figure 1: Main objectives and focal pathogens of unit 16 
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Figure 2: Prevalence of Toxoplasma gondii based on a represenative cross section of the population in 
Germany.  
Fig. 1: Main objectives and focal pathogens of unit 16
Main objectives are: i) Improving identification  
and diagnostic methods; ii) better molecular 
understanding of virulence, pathogenicity and  
drug resistance; iii) expand the tool box of molec - 
ular epidemiology and improving rational risk  
analysis. the work relies on specific expert teams 
concerned with the indicated pathogens
fig. 2: Prevalence of toxoplasma gondii based on a 
represenative cross section of the population in Germany 











 “We do care about  
neglected infections!”
 Dr. Anton Aebischer
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Unit 17: Influenza Viruses and Other  
Respiratory Viruses













WHO  coordinates  a  worldwide  surveillance  network  in 
more  than  hundred  states  that  closely  monitors  circulating 
influenza viruses and allows adjustment and formulation of 




is  to conduct virological  surveillance at  the national  level by 
cooperating  with  sentinel  physicians  all  over  Germany  and 
investigating  respiratory  tract  samples  from  patients  with 
influenza-like  illness  in  the  context of  the nationwide  senti-








viruses  as  well  as  characterization  data  are  timely  shared 
with  the  Influenza  WHO  Collaborating  Centre  in  London. 
Surveillance  findings  are  reported  continuously  during  the 
influenza season at global, European and national level.
In  an  effort  to  determine  the  roles  of  other  pathogens 
in  causing  influenza-like  illness  we  also  investigate  other 
circulating respiratory tract viruses including respiratory syncy-
tial viruses (RSV), adenoviruses, human metapneumoviruses 
(HMPV),  rhinoviruses,  coronaviruses  and  parainfluenza 
viruses  (PIV).  In  fact,  the  status  of  a  consultant  laboratory 
dedicated to respiratory syncytial virus, human metapneumo-
virus and parainfluenza virus, headed by Dr.  Janine Reiche, 
has  been  assigned  to  the  unit  in  2015.  Further  research 
fields  include  the  development  of  laboratory  diagnostics, 
genetic  variability  and  evolution  of  influenza  viruses,  inter- 
and  intrasubtype  reassortment,  antiviral  resistance  as  well 
as serological  studies  to  investigate  the efficacy of  influenza 
vaccination in specific risk groups. 
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number  of  documented  zoonotic  trans-species  infections, 
some of which are accompanied by an unusually high case- 
fatality of patients  such as seen  for H7N9 or H5N1 subtype 
viruses.  Although  these  transmissions  have  not  resulted  in 
sustained spread among humans and did not occur in Europe, 
it  is  part  of  the  NIC  routine  to  develop  and  have  dedicated 
 diagnostic tests for the detection of zoonotic influenza viruses 
in patients ready to use. 
Apart  from  the  activities  immediately  contributing  to 
protect  people  from  circulating  influenza  viruses  the  unit 
pursues  additional  research  to  gain  a  better  understanding 








Respiratory  tract  viruses  remain a  formidable challenge 
for public health as some of them lay considerable socio-eco-
nomic  burden  on  societies  by  causing  regular  epidemics 
affecting  millions  each  year,  whereas  others  emerge  from 




the  properties  of  epidemic  strains,  but  also  to  help  with  an 
 assessment of the pathobiology of novel virus strains.
www.rki.de/fg17-en
“Expect the unexpected  
working with  
 influenza viruses.”
 PD Dr. Thorsten Wolff
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figure 1 (top): transmission electron microscopy 
shows budding of human influenza a virus (h3n2) 
from a type II pneumocyte in human alveolar lung 
tissue infected ex vivo. released virus particles were 
colorized in red distinguishing them from microvilli 
on the surface of the infected cell
figure 2 (right): Detection and positivity rate of  
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Unit 18: HIV and Other Retroviruses 




HIV  is  the  most  prominent  member  of  the  family  of 
retroviruses. These viruses are able to integrate their genome 






To  allow  the  HIV-variants  currently  circulating  in 
 Germany to be analysed, we recently established a  monitoring 
scheme  based  on  new  HIV  diagnoses  that  are  reported  to 
the Robert Koch Institute as a statutory duty for anonymous 
notification.  Approximately  60%  of  the  notifications  are 
accompanied with dried serum spot  (DSS) samples  that are 
examined  serologically  to  discriminate  between  recent  and 
long-standing  infections.  Using  these  and  other  results,  the 
Department of Infectious Disease Epidemiology is then able to 
estimate the incidence rates for HIV infection. The DSS also 
provide a source of viral RNA that  is used  to determine  the 
HIV subtype and identify transmitted drug resistance (TDR). 
TDR is of particular clinical relevance as it is associated with 
increasing  rates  of  antiretroviral  therapy  failure.  Knowledge 
of  the  different  HIV  subtypes  currently  circulating  within 





is  used  to  identify  and  explore  HIV  transmission  networks, 
 helping to better develop suitable prevention strategies.
Various clinical implications of HIV infection are   inves - 
tigated  in  the  HIV-1  seroconverter  study.  These  include  the 
impact of TDR and its persistence on treatment success and 
the roles played by co-infections and host genetic  factors on 
 disease  progression  and  virus  evolution.  This   longitudinal 
study was initiated in 1997 in collaboration with unit 34 and 
currently involves a cohort of about 3,400 patients with known 
dates  of  infection.  Results  and  HIV  sequences  from  this 




Within  unit  18,  HIV  diagnostics  are  conducted  in  a 
DIN EN ISO 15189 and DIN ISO/IEC 17025 accredited lab-
oratory  using  modern  molecular  technologies  such  as  next 
generation  sequencing.  Tests  for  HTLV  and  for  a  panel  of 
non-human  retroviruses are also routinely performed within 
the  framework  of  cross-sectional  epidemiological  studies 
and confirmatory diagnostics that are regularly requested by 






optimise  the  sensitivity  and  specificity  of  tests  for  detecting 
and quantifying retroviruses. For example, refined  diagnostic 
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and	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Figure	  1:	  Major	  fields	  of	  surveillance	  and	  research	  in	  Unit	  18	  
Major fields of surveillance and research in unit 18
Molecular surveillance of recently acquired hIV-1 infections 2013–2014.  
(a) transmitted drug resistance. (b) hIV-1 subtype distribution
Figure	  2:	  Molecular	  surveillance	  of	  recently	  acquired	  HIV-­‐1	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  HIV-­‐1	  subtype	  distribu<on.	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Figure	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  acquired	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“It is time to change the course of HIV 
epidemic in Germany and effec tively 
reduce the number of new cases  
and transmitted resistances. A reinforced 
monitoring and molecular analysis  
of circulating HIV genotypes supports 
these efforts.”
  Prof. Dr. Norbert Bannert exogenous  and  endogenous  retroviruses  and  into  potential 
options  for  therapeutic  intervention.  We  are  also  studying 
host  cell  mechanisms  that  prevent  the  excessive  expression 
and proliferation of endogenous retroviruses. In addition, the 






CD4  T  cells  are  being  examined  and  highly  sensitive  diag-
nostic methods  for  the quantification of proviruses  in  these 
cells developed.
We  are  confident  that  the  molecular  surveillance  and 
research in unit 18 will continue to make valuable contributions 
to  our  understanding  of  retroviruses  and  to  national  efforts 
aimed at changing the course of HIV epidemic in Germany.
www.rki.de/fg18-en
   Infectious Diseases      
34
The main topics handled in this department are the  significant 
health  challenges  and  burdens  placed  on  the  population 
in  general  and  the  healthcare  system  in  particular.  These 
 challenges are characterised by rapidly changing working and 












The  department  carries  out  nationwide  health  monitoring 
for  this  purpose.  The  data  collected  in  the  regularly  recur-
ring representative health surveys are included in the health 








The  department  works  in  a  close  network  of  cooper-














Child and youth health 
In  view  of  the  particular  significance  of  the  childhood  and 
 adolescence  stage,  a  Child  and  Youth  Health  steering  com-
mittee  is  part  of  the  department’s  management.  In  this 
committee, proposals are developed for the strategic objectives 








External quality assurance project
Due to its experience in conducting epidemiological prospec-
tive  studies,  the  department  was  awarded  the  contract  for 
an  external  quality  assurance  project  within  the  prospective 
 “German National Cohort” study. In this context, a working 
group  refines  the  submitted  quality  assurance  concept  con-
tinuously.  Amongst  others  they  conduct  routinely  on-site 
monitoring  in all  18  study  centres, develop quantitative  and 
qualitative   methods  such  as  statistical  procedures  for  data 
 quality or analyses of study documents.







The staff of the central department administration 
The staff of the central department administration conduct day-
to-day  administrative  and  secretarial  tasks,  such  as  electronic 





(for example  in  the preparation of publications by   conducting 
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Department 2: working group “German national cohort”
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Cancer is a disease that places a high burden on individuals 
and  society.  It  is  responsible  for  one  out  of  four  deaths  in 
developed countries, where surveys have found that  it  is  the 
most  feared among  life-threatening diseases,  also  called  the 
“emperor of  all maladies”. However,  cancer has become,  in 
many cases, a treatable or even curable condition. Recent data 
suggest  that more than half of all cancer patients either can 
be cured or die with  rather  than  from  their cancer. Not only 
our biological and clinical, but also our epidemiological knowl-
edge  about  cancer  is  constantly  growing.  This  has  spurred 















 Ω Studying  the  effects  of  screening  programmes,  such  as 
 mammography screening, on population health 
 Ω Evaluating  the  effects  of  primary  prevention  measures, 
such as HPV vaccination programmes 
 Ω Monitoring progress  in  cancer  treatment using mortality 
and survival data
 Ω Identifying  the  need  for  future  research  in  cancer  epide-
miology
 Ω Supporting  scientific  research  on  cancer,  e.g.  providing 
baseline data, enabling data alignment with cohort studies 
or patient recruitment for case-control studies
As  cancer  registries  in  Germany  are  run  by  the  individual 






the  state  registries  to  improve  and  standardize  methods  of 
registration, coding, data processing and analysis. It regularly 




1. cancer in Germany 2011/2012. 10th edition. robert Koch Institute 
(ed.) and the association of Population-based cancer registries  
in Germany (ed.). berlin, 2016.
2. buttmann-schweiger n, Klug s, Luyten a. holleczek b, heitz f,  
Du bois a, Kraywinkel K. Incidence patterns and temporal trends 
of invasive nonmelanotic vulvar tumors in Germany 1999–2011.  
a population-based cancer registry analysis.  
PLos one. 2015 May 28;10(5).
3. Wienecke a, barnes b, neuhauser h, Kraywinkel K: Incident cancers 
attributable to alcohol consumption in Germany, 2010. cancer 
causes and control 2015 Jun;26(6): 903–911.
4. Wienecke a, barnes b, Lampert t, Kraywinkel K. changes in cancer 
incidence attributable to tobacco smoking in Germany, 1999 to 2008. 
Int J cancer. 2014 feb 1;134(3): 682–691.
5. haberland J, bertz J, Wolf u, Ziese t, Kurth b-M. German cancer 
statistics 2004. bMc cancer. 2010;10: 52.
The main mission of the ZfKD is to provide national incidence, 
prevalence,  survival,  and  mortality  statistics  for  malignant 
diseases. Other indicators, such as the distribution of tumor 








the  ZfKD  and  the  Association  of  Population-based  Cancer 






The  ZfKD  has  an  active  presence  on  the  internet.  On 
www.krebsdaten.de, we publish short articles on current  topics 









(including  non-melanoma  skin  cancer  and  some  pre-malig-
nant conditions), this dataset is especially valuable for analysis 
of rare cancers and clinically relevant cancer subtypes.
“Our mission is to provide infor mation 
on cancer risks in the population,  
for scientists and decision makers as  
well as for the general public.”
Dr. Klaus Kraywinkel
The  team  of  the  ZfKD  is  committed  to  providing  accu-
rate,  understandable  information  on  cancer  epidemiology. 
We answer a growing number of enquiries from politicians, 
health  administrations,  scientists,  healthcare  professionals, 
media, and also from the general public.
The  ZfKD  is  involved  in  national  and  international 
 committees  for  cancer  registration,  cancer  screening  and 
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Unit 21: Epidemiological Data Centre / 
Research Data Centre 
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ously  checked  for  possible  examiner  or  equipment  effects. 
In addition, the second recording of a portion of the collected 












The  statistics  working  group  for  the  entire  department 
is also part of this unit.                   www.rki.de/fg21-en
Main Data Workflow
Delivery of Public Use Files
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Unit 22: Epidemiological Laboratory
Results from laboratory tests of blood and urine samples can 
provide valuable  information on  risk  factors or health prob-






The  unit  “Epidemiological  Laboratory”  is  responsible  for 
the  processing  of  blood  and  urine  samples  taken  from  par-
ticipants  in  the  nation-wide  health  examination  surveys  of 
the  Robert  Koch  Institute.  This  task  includes  contributions 
to the planning of new studies (what biospecimens should be 
taken  in  what  way,  what  biomarkers  should  be  analyzed  by 
what method), the processing and laboratory testing of blood 




The  unit  “Epidemiological  Laboratory”  is  structured 
into  two  sub-units:  The  laboratory  sub-unit  is  responsible 















 Ω Continuous  adaptation  to  standard  requirements  (inter na- 
tional and national standards and guidelines; e.g., Rili-BÄK – 
Guidelines  of  the  German  Medical  Board  for  Quality 
 Assurance of Quantitative Medical Laboratory Tests)
 Ω Creation of age-dependent, method-specific reference ranges
 Ω Identification  of  current  trends  in  laboratory  diagnosis, 




 Ω Planning  and  conceptual  design  of  sero-epidemiological 
parts of population-based studies,  including  the selection 
of  measured  values  and  determination  of  their  relevance 
to public health
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administration  and  evaluates  survey  methods  and  process 
related data continuously.
Based on the health studies DEGS (German Health Inter-
view  and  Examination  Survey  for  Adults),  GEDA  (German 




different  projection  of  the  studies  enables  cross-sectional, 
trend  and  longitudinal  comparisons.  The  thus  established 
nationally  representative  data  base  is  used  in  public  health 
research  and  allows  the  RKI  to  give  evidence  based  health 














 Ω Random  sampling,  obtaining  participants  and  incentive 
concepts 








 Ω Planning  and  management  of  operational  business  for 
 conducting surveys (e.g. obtaining addresses and telephone 
numbers,  invitation  procedures  and  field  inspections, 
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GeDa 2012 2012 – 2013 19,294 18 – 79 +
GeDa 2010 2009 – 2010 22,050 18 – 79 +
GeDa 2009 2008 – 2009 21,262 18 – 79 +
KiGGs Wave 2 2014 – 2016 appr. 23,000   0 – 29 
KiGGs Wave 1 2009 – 2012 12,368   0 – 24 
KiGGs-baseline 2003 – 2006 17,460   0 – 17 
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 Ω Committee  for  Environmental  Medicine,  involvement  in 
environment-related panels              www.rki.de/fg24-en
The results obtained are used for policy advice and to provide 
information  for  actors  in  the  health  system,  the  scientific 
 community and interested members of the public.
The  Federal  Health  Monitoring  follows  a  pluralistic 
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around three-quarters  
of women and men  
in Germany assess their 
health condition as  
good or very good
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Unit 25: Physical Health 
The unit is committed to maintaining and improving  physical 
health  and  functional  resources  in  the   population across  all 
age groups. The unit analyses time trends in the distribution 









aspects  of  physical  health  (e.g.  chronic  pain,  balance,  grip 
strength,  walking  speed  and   cognitive  functioning).  Epide-
miological  and  public  health  analyses  conducted  in  unit  25 
contribute to national health reporting, health policy advising 
and public health research.
Cross-sectional  and  time-trend  analyses  are  based  on  data 
collected as part of the continuous health monitoring system 
in periodically conducted national health interview and exam-
ination  surveys  for  adults  (GEDA,  DEGS)  and  for  children 
and adolescents (KiGGS) in Germany. In addition, data from 
official  health  statistics  and  disease  registers  are  used  for 
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KiGGs-studie – erste folgebefragung (KiGGs Welle 1). bundes-
gesundheitsbl 57: 771–778.
5. steppuhn h, Langen u, Mueters s, Dahm s, Knopf h, Keil t, 
scheidt-nave c (2016) asthma management practices in adults – 
findings from the German health update (GeDa) 2010 and  
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cardiometabolic  risk  factors  (e.g.  blood  pressure,  serum 
cholesterol,  glycosylated  hemoglobin  A1c)  and  functional 
capacities (e.g. grip strength, cognitive functioning) 
 Ω To provide population-based reference values for continu-
ous  risk  factors  and  functional  capacities,  considering 
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 Ω Scientific  lead of  the Robert Koch  Institute public health 
research initiative on Healthy Aging
 Ω Coordinator  of  the  Robert  Koch  Institute  steering  group 
Health of Children and Adolescents.         www.rki.de/fg25-en
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Unit 26: Mental Health 
Unit 26 is responsible for the monitoring of mental health of 
the general population including children, adolescents, adults 
of  working  age  and  the  elderly.  The  unit  primarily  focuses 
on  mental  disorders  with  a  high  burden  of  disease  as  well 
as on health-related quality of life and social participation in 
the   context  of  psychological  distress  and  mental  disorders. 
Examining the change in prevalence of mental distress and dis-
orders over time (trend analysis) is as important in the unit’s 
work  as  monitoring  changes  throughout  people’s  life  span 
(longitudinal analysis). All aspects are considered at the per-
sonal, familial, social and societal level.
The main topics cover the following fields:
 Ω Burden  of  disease:  epidemiology  of  common  mental 
 disorders  with  high  public  health  relevance,  particularly 











 Ω Psychometrics  and  the  further  development  of  methods 
for  the  assessment  of  mental  health  problems  in  large, 
 population-based epidemiological studies. 
www.rki.de/fg26-en
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Publications
1. hapke u, Maske ue, scheidt-nave c, bode L, schlack r, busch Ma. 
(2013) chronischer stress bei erwachsenen in Deutschland:  
ergebnisse der studie zur Gesundheit erwachsener in Deutschland 
(DeGs1). [chronic stress among adults in Germany: results of  
the German health Interview and examination survey for adults 
(DeGs1)] bundesgesundheitsblatt – Gesundheitsforschung –  
Gesund heitsschutz 56(5/6), 749–754.
hölling h, schlack r, Petermann f, ravens-sieberer u, Mauz e, 
KiGGs sG (2014) Psychische auffälligkeiten und psychosoziale 
beeinträchtigungen bei Kindern und Jugendlichen im alter von  
3 bis 17 Jahren in Deutschland – Prävalenz und zeitliche trends  
zu 2 erhebungszeitpunkten (2003–2006 und 2009–2012).  
ergebnisse der KiGGs-studie – erste folgebefragung (KiGGs 
Welle 1). [Psychopathological problems and psychosocial impair-
ment in children and adolescents aged 3–17 years in the German 
popu lation: prevalence and time trends at two measurement 
points (2003–2006 and 2009–2012): results of the KiGGs study:  
first follow-up (KiGGs Wave 1)]. bundesgesundheitsblatt – 
Gesundheitsforschung – Gesundheitsschutz 57, 807–819.
2. Maske ue, buttery aK, beesdo-baum K, riedel-heller s, hapke u, 
busch Ma (2016) Prevalence and correlates of DsM-IV-tr  
major depressive disorder, self-reported diagnosed depression  
and current depressive symptoms among adults in Germany.  
Journal of affective Disorders, 190, 167–177.
12-month mental dis - 
orders are more frequent  
in adults who report high  
levels of chronic stress  
than in adults who report 
below-average to average 
levels chronic stress (based 
on DeGs1-Mh data)
 “No health  
 without mental health.”
  Heike Hölling
3. Maske ue, riedel-heller sG, seiffert I, Jacobi f, hapke u  
(2016) häufigkeit und psychiatrische Komorbiditäten von selbst-
berichtetem diagnostiziertem burnout-syndrom: ergebnisse der 
bevölkerungsrepräsentativen “studie zur Gesundheit erwachsener 
in Deutschland (DeGs1)” [Prevalence and comorbidity of self- 
reported Diagnosis of burnout syndrome in the General Population: 
results of the German health Interview and examination survey 
for adults (DeGs1)]. Psychiatrische Praxis, 43, 18–24.
4. schlack r, Mauz e, hebebrand J, hölling h, KiGGs sG (2014)  
has the prevalence of parent-reported diagnosis of attention deficit 
hyperactivity disorder (aDhD) in Germany increased between 
2003–2006 and 2009–2012? results of the KiGGs-study: first  
follow-up (KiGGs Wave 1). bundesgesundheitsblatt – Gesund-
heitsforschung – Gesundheitsschutz 57, 820–829.
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Unit 27: Health Behaviour
What we eat, how much we move, how much we weigh, and 
if  and  how  much  we  smoke  and  drink  alcoholic   beverages 
has  a  major  impact  on  our  health  and  life  expectancy.  All 
these  factors  contribute  essentially  to  the  development  of 
 non-communicable  diseases.  However,  all  these  factors  are 
modifiable and therefore they are in focus of health promotion 
and disease prevention activities. 
Unit  27  analyses  data  from  the  population-wide  health 
and nutrition surveys of the RKI considering the actual situa-
tion and the development over time. The focus is particularly 
on:  dietary  intake,  physical  activity,  overweight,  tobacco  and 
alcohol consumption as well as health promotion and disease 
prevention  activities.  In  this  context,  the  distribution  in  the 
population, the determinants as well as specific and combined 
associations with health outcomes during all stages of life is 
taken  into  account.  From  the  results  recommendations  for 
public health activities and their evaluation are drawn. 
Publications
1. finger JD, tylleskär t, Lampert t, Mensink GbM (2013) Dietary 
behaviour and socioeconomic Position: the role of Physical  
activity Patterns. PLos one 8: e78390.
2. haftenberger M, Mensink GbM, herzog b et al. (2015) changes in 
body weight and obesity status in German adults – results of seven 
population-based prospective studies. eur J clin nutr: advance 
online publication, http://dx.doi.org/10.1038/ejcn.2015.179.
3. Jordan s, Von Der Lippe e, starker a, hoebel J, franke a (2015)  
einflussfaktoren für die teilnahme an bonusprogrammen der 
gesetzlichen Krankenversicherung. ergebnisse der studie “Gesund- 
heit in Deutschland aktuell”. Gesundheitswesen 77(11) s 861–868.
4. Manz K, schlack r, Poethko-Muller c, Mensink G, finger J, 
Lampert t, & KiGGs study Group (2014) Körperlich-sportliche 
aktivität und nutzung elektronischer Medien im Kindes- und 
Jugendalter. ergebnisse der KiGGs-studie – erste folgebefragung 
(KiGGs Welle 1). bundesgesundheitsbl – Gesundheitsforsch – 
Gesundheitsschutz 57: 840–848.
5. Mensink GbM, fletcher r, Gurinovic M et al. (2013) Mapping low 
intake of micronutrients across europe. br J nutr 110: 755–773.
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 “Making the healthy choice  
 the easy choice –  
the role of surveillance and  
     epidemiology.”













 Ω Development  of  appropriate  assessment  tools  for  health 
behaviour 
 Ω The Prevention and Health Promotion working group based 
in  our  unit  supports  the  department  to  integrate  aspects 
of  disease  prevention,  health  promotion  and   healthcare 
in its research 
 Ω Support  of  the  Health  Reporting  unit  in  the  preparation 
of health reports                www.rki.de/fg27-en
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Unit 28: Social Determinants of Health
This unit analyses the social determinants of health and the 
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sozialforschung (WZb) (eds.) Datenreport 2016. ein sozialbericht 
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politische bildung, s. 259–271.
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health of children and adolescents in single-parent, step-,  
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(KiGGs Wave 1). bundesgesundheitsblatt – Gesundheitsforschung – 
Gesundheitsschutz 57(7): 860–868.
“Understanding the  
societal causes  
 of health and diseases.”










 Ω Examination  of  correlations  between  professional  quali-
fications, occupation, working conditions and health









 Ω Analysis  of  the  effects  of  demographic  change  on  the 
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social differences in self-rated health (“fair”, “poor” or “very poor”),  
diabetes mellitus and depressive symptoms




diseases  in  the  general  population  in  Germany.  Therefore, 
the department supports the German public health service by 
maintaining  a  comprehensive  national  surveillance  system 
and providing a nationwide accessible 24/7 on call duty system 











 Ω Implementation  and  support  of  outbreak  investigations









 Ω Information  of  health  professionals  and  the  scientific 
community
 Ω Exchange  with  other  national  and  international  health 
authorities
 Ω Qualification  and  further  training  in  the  field  of  public 
health with emphasis on infectious disease epidemiology
Surveillance of notifiable  infectious diseases,   complementary 
monitoring  and  surveillance  of  non-notifiable  infectious  dis-
eases,  international  reporting  obligations  within  the  Early 
Warning and Response System (EWRS) of the European Union 
and  the  International  Health  Regulations  (IHR)  are  part  of 
these primary responsibilities of the department. Coordination 
of response to public health emergencies of  infectious origin 

















to  the  yearly  epidemiological  report,  regularly  publish  in 
peer-reviewed journals as well as in the RKI Epidemiological 




ment  are  renowned  experts  visible  through  publications, 
memberships  in  international  advisory  groups,  and  invited 




Training  for  Applied  Epidemiology”  (PAE)  is  based  at  the 







the  first  joint professorship appointment  in  the  remit of  the 
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Public Health Actions 
Data Management 
and Analysis 
 Surveillance activities 
 Protection against 
Infection Act – 
Reporting system 
 Electronic reporting 
system (DEMIS) 




 Applied research 
 Vaccination 
 Antibiotic resistance 
 Health economy 






networking of public health 
service and international 
health authorities 
 Education and training 
 Outbreak investigations 
 Crisis management 
 Political consultancy 






Our aims for the future are divided into three areas of responsibility:
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1. beermann s, allerberger f, Wirtz a, burger r, hamouda h: Public 
health microbiology in Germany: 20 years of national reference 
centres and consultant laboratories. Int J Med Microbiol 2015; 
305(7): 595–600.
2. bernard h. et al: Large multistate outbreak of norovirus gastro-
enteritis associated with frozen strawberries, Germany, 2012. euro 
surveill. 2014 feb 27;19(8): 20719.
3. frentz D. et al: Patterns of transmitted hIV drug resistance in 
europe vary by risk group. PLos one. 2014 apr 10;9(4): e94495.
4. Karo b, Krause G, hollo V, van der Werf MJ, castell s, hamouda o, 
haas W: the impact of hIV infection on treatment outcome of 
tuberculosis: analysis of surveillance data from nine european 
countries, 2010–2012. aIDs. 2016 Jan 8.
5. schmidt D. et al: from pills to patients: an evaluation of data 
sources to determine the number of people living with hIV who 
are receiving antiretroviral therapy in Germany. bMc Public  
health. 2015 Mar 17;15: 252.
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“Research, surveillance and  
recommendations on  
infectious diseases to improve  
 public health.”
 Dr. Osamah Hamouda










For  the  future,  a  tight  link  of  epidemiological  and  lab-
oratory  data  seems  of  high  importance.  The  Department 
of  Infectious  Disease  Epidemiology  already  collaborates 
closely with relevant institutes in Germany as well as with other 
departments of the RKI.                  www.rki.de/abt3-en
head of Department with administrative and scientific staff
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Unit 31: Data Management
The Data Management unit is responsible for the design, devel-
opment and management of IT projects within the Department 































focus  is  the  management  of  applications  and  processes  for 
ongoing projects, the adaption to new software methodologies 
and new technologies. By using modern technologies (Online 









1. survnet3@rKI 0.9.19 http://www.rki.de/De/content/Infekt/IfsG/
software/software_inhalt.html.
2. Velasco e, agheneza t, Denecke K, Kirchner G, eckmanns t  
(2014) social Media and Internet-based Data in Global systems 
for Public health surveillance: a systematic review. Milbank  
Quarterly 92(1): 7–33.
3. fähnrich c, claus h, Kirchner G, et. al. (2016) ebola outbreak 
containment: real-time task and resource coordination with 
sorMas, Journal of biomedical and health Informatics. submitted.
4. haller s, eckmanns t, claus h, et.al. (2014) results from the  
first 12 Months of the national surveillance of healthcare-associ-
ated outbreaks in Germany, 2011/2012; PLos one 9(5).
5. benzler J, Kirchner G, Diercke M, Gilsdorf a (2014)  
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Der hygieneinspektor 16 (2): 20–29.
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“We provide tools  
to transform data into knowledge  
 and insight.”
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Our main goals include:
Development and improvement of surveillance standards
Surveillance methods and possibilities including IT  solutions 
are  changing  in  the  wake  of  new  scientific  discoveries; 
 therefore  an  efficient  surveillance  system  needs  continuous 
revision.  A  vitally  important  modern  electronic  notification 
system will be developed in future for all users of the notifi-
cation  system.  Enabling  the  linking  between  national  and 




Strengthening of public health services
The public health services are responsible  for  the control of 
infectious diseases. The Surveillance unit is the central part- 
ner  for  the  regional  and  local  public  health  services.  This 
coope ration should be extended through closer interaction in 
order to strengthen the public health service capacities. Inter-
national  cooperation  with  public  health  services  in  partner 
countries and with  international public health organisations 
contribute  to  the  global  health  cooperation  and  needs  to  be 
continued and enhanced.
Fostering preparedness planning and crisis management
The Surveillance unit has a long-standing experience with crisis 
management at the RKI and will use this knowledge to advance 
crisis  planning.  Crisis  planning  is  also  an  important  aspect 
covered by the international projects run by the  Sur veillance unit. 
www.rki.de/fg32-en
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Unit 32: Surveillance
Epidemiological  surveillance  is  the  ongoing  systematic 
 collection,  analysis,  evaluation  and  dissemination  of  health 
data  for  the  purpose  of  planning,  implementation  and 
 evaluation of disease control measures.
The  Surveillance  Unit  is  primarily  responsible  for 
the  implementation  of  the  notification  system  within  the 
framework  of  the  German  Protection  against  Infection  Act 
(Infektionsschutzgesetz,  IfSG).  The  Surveillance  Unit  sup-
ports  disease-specific  units  with  their  surveillance  activities 










Notification system within the framework of the IfSG
 Ω Quality  management  and  evaluation  of  surveillance  of 
notifiable biological threats
 Ω Continuous  epidemiological  analysis  of  surveillance  data 
 Ω Early  detection  and  prevention  of  spread  of  infectious 
diseases 




















 Ω Coordination  of  the  Federal  State  working  group  on 
surveillance  of  infectious  diseases  and  the  federal  and 
state reporting procedures
International networks and early warning systems
 Ω Focal  point  for  international  public  health  authorities  of 
the EU and the WHO with emphasis on the early warning 
systems  as  part  of  the  International  Health  Regulations 
(IHR ) (2005) and the European Network “Early Warning 
and Response System (EWRS)”
 Ω National  coordinator  for  Germany’s  cooperation  with  the 
European Centre for Disease Prevention and Control (ECDC)
 Ω International cooperation within the framework of ECDC’s 







 “We collect data for  
knowledge and for action.”
 Dr. Andreas Gilsdorf
Main areas of work of the  
Surveillance Unit
the collection of data on  
infectious disease is important 
allowing timely identification 
and assessment of risks of infec-
tious threats in the po pu lation. 
close collaboration with the 
regional and local public health 
services addi tionally helps to 
strengthen public health and 
enables rKI to translate data  
into action. strong surveillance 
and response struc tures are  
an extremely important com-
ponent of an efficient public 
health system
Publications
1. rexroth u, Diercke M, Peron e, an der heiden M, Gilsdorf a:  
ebola response missions: to go or not to go? cross-sectional study 
on the motivation of european public health experts, December 
2014. euro surveill 2015. 
2. Milde-busch a, Gilsdorf a: the aIrsan project – efficient,  
coherent eu level response to public health threats in air trans-
port. euro surveill 2014. 
3. Diercke M, benzler J, schöneberg I, et al.: falldefinitionen für  
die surveillance meldepflichtiger Infektionskrankheiten in 
Deutschland, ausgabe 2015 [the 2015 edition of case definitions 
for the surveillance of notifiable infectious diseases in Germany]. 
bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 
2014; 57:1107–1110.
4. balabanova Y, Klar s, Delere Y, et al.: serological evidence  
of asymptomatic infections during escherichia coli o104: h4  
outbreak in Germany in 2011. PLos one 2013; 8:e73052.
5. Greutélaers b, Wadl M, nachtnebel M, et al.: Krankenhaus- 
surveillance während großer ausbrüche ambulant erworbener 
erkrankungen [hospital surveillance during major outbreaks  
of community-acquired diseases. Pandemic Influenza hospital 
surveillance (PIKs) 2009/2010 and surveillance of bloody  
Diarrhea (sbD) 2011]. Dtsch Med Wochenschr 2013; 138:632–637.












and crisis management 
Coordination of activities in 
crisis: Federal States, other 
sectors 
International alerts (EWRS, IHR) 
Support  of surveillance activities 
in partner countries 
Support  of outbreak and crisis 














Use of secondary data 
Further development of the 
Protection against Infection Act 
Activities to improve 
collaboration with clinicians 
Support of IHR implementation 
Cooperation with international 
organizations 
Development of a RKI Crisis Plan  
National and international 
projects on infectious diseases 
and transport 
Surveillance Unit: Main areas of work 
Crisis management:  
situation centre 
Cooperation with international 
surveillance systems 
Generic surveillance, mandatory reporting: data for action 
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Unit 33: Immunisation
The  Immunisation  unit  is  responsible  for  a  wide  range 
of  activities  related  to  the  development  and  evaluation  of 
 evidence-based  vaccination  recommendations  in  Germany. 
According  to  the  German  Protection  against  Infection  Act, 
the unit hosts the executive secretariat of the German Stand-
ing  Committee  on  Vaccination  (STIKO),  responsible  for 
developing  national  vaccination  recommendations.  These 









A  standard  operating  procedure  (SOP)  for  the  systematic 
development  of  vaccination  recommendations  was  endorsed 




data  on  the  efficacy  and  safety  of  vaccines  (available  from 
published  literature)  and  country-specific  disease  burden, 









Surveillance, research and evaluation 
The unit monitors the burden of vaccine preventable diseases 
and  vaccination  impact  through  epidemiological  analysis 
of notification data  in Germany  [3].  In  addition,  it  currently 










were  more  than  4.3  million  clicks  on  these  two  webpages. 
In  2015  the  unit  received  also  funding  from  the  Federal 
 Ministry of Health to develop a smartphone app that supports 
physicians in their vaccination activities with up-to-date infor-
mation and  recommendations. A beta  version  is planned  to 
be released and piloted in mid-2016.              www.rki.de/fg33-en
Publications
1. remschmidt c, Wichmann o, harder t (2015) Vaccines for  
the prevention of seasonal influenza in patients with diabetes:  
systematic review and meta-analysis. bMc Med 13: 53.
2. ultsch b, Damm o, beutels P, et al (2015) Methods for health 
economic evaluation of Vaccines and Immunization Decision 
frameworks: a consensus framework from a european Vaccine 
economics community. Pharmacoeconomics 2015: 1–18.
3. takla a, Wichmann o, rieck t, Matysiak-Klose D (2014)  
Measles incidence and reporting trends in Germany, 2007–2011.  
bull World health organ 92: 742–749.
4. Deleré Y, remschmidt c, Leuschner J, et al. (2014) human Papillo-
mavirus prevalence and probable first effects of vaccination in  
20 to 25 year-old women in Germany: a population-based cross-sec-
tional study via home-based self-sampling. bMc Infect Dis 14: 87.
5. bödeker b, remschmidt c, schmich P, Wichmann o (2015) Why 
are older adults and individuals with underlying chronic diseases in 
Germany not vaccinated against flu? a population-based study. 
bMc Public health 15: 618.
scIentIfIc staff ~ PD Dr. ole Wichmann (Head) ~ Dr. anette siedler (Deputy) ~ Dr. Gerhard falkenhorst ~ Dr. thomas harder ~ Dr. Jane hecht  
Dr. Wiebke hellenbrand ~ Dr. Judith Koch ~ Kristin Kocksch ~ alexandra Lang ~ Dr. Dorothea Matysiak-Klose ~ Dr. cornelius remschmidt  
thorsten rieck ~ Kristin tolksdorf ~ Dr. bernard ultsch ~ Dr. felix Weidemann ~ Dr. Miriam Wiese-Posselt
aDMInIstratIVe staff ~ stephanie buck ~ flor Montesinos ocampo ~ eva Wetzel
implemented,  to  enhance/optimize  communication   activities 
and  to enable  the  interpretation of  epidemiological data after 
vaccine  introduction.  One  of  the  tasks  of  the  Immunisation 
unit is to collate, analyze and publish vaccination coverage data 



















States’  Health   Ministers  and  the  German  Federal  Ministry 
of Health in 2015.
Communication
Healthcare  professionals  and  local/state  health  authorities, 
but also media, are the main target groups of the health-com-
munication activities of  the unit, with  the aim of  improving 
knowledge and advising on appropriate procedures  concerning 
vaccinations.  In  recent  years  the  Immunisation  Unit  has 
updated  and  expanded  its  online  information  services, 
 including FAQs  that provide a broad overview on questions 
related  to  immunization  and  vaccines,  also  for  the  general 
 public (www.rki.de/impfen and www.stiko.de). In 2015, there 
“Vaccines are among the most  
powerful public health tools.  
Our aim is to reduce infection-related  
morbidity and mortality in our  
population through vaccination based 
on the best available scientific  
evidence and in collaboration with  
national and international partners.”
PD Dr. Ole Wichmann
Major activities and tasks of 
the Immunisation unit
Adaptation, if necessary	  
Evidence-based Vaccination Recommendations	  
-Executive secretariat of the STIKO	  
-Development or adaptation of recommendations 	  
                                 	  
 	  
Implementation	  
-Monitoring of  
  vaccination  
  coverage 	  
-Assessment of  
 knowledge, attitudes    
 and practices in  
  target groups	  
Vaccine Effects	

-Impact analyses  
 (e.g. before-and-after  
 or time-series analyses)	  
-Assessment of  
indirect effects  
-Estimation of vaccine 	  

















-Internet (e.g. FAQs)	  
-Smartphone App	  
-Telephone hotline	  
-Presentations at  
  scientific meetings	  




-Routine surveillance of  
  notifiable vaccine- 
  preventable diseases	  
-Sentinel surveillance for  
  non-notifiable diseases  
  (herpes zoster, invasive  











Evidence Assessment  
-Systematic reviews 




 methods and decision- 
 making frameworks	

Evaluation of 	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Unit 34: HIV/AIDS, STI and  
Blood-borne Infections
The main task of the unit for HIV/AIDS, STI and Blood-borne 










of  collecting  data  on  blood  donations  and  infections  among 
blood donors. We complement HIV notification data by clinical- 
microbiological  long-term  cohort  studies  (ClinSurv  and  HIV 
seroconverter study). This allows us to gain insight into infec-
tion  dynamics,  resistance  patterns  and  clinical  management 
of HIV infections. In addition, we collect data on gonococcal 
resistance and chlamydia through laboratory sentinel systems. 
We  use  integrated  biological  and  behavioural  surveys  to 





















patient.  The  results  of  the  HIV  incidence  surveillance  help 
us to  further understand the dynamics of the HIV epidemic, 
while  the  clinical  surveillance  provides  clinicians  and  stake-












1. an der heiden M, ritter s, hamouda o, offergeld r: estimating 
the residual risk for hIV, hcV and hbV in different types of platelet 
concentrates in Germany. Vox sang. 2015 feb; 108(2): 123–130.
2. Jansen K, thamm M, bock ct, scheufele r, Kücherer c, 
Muenstermann D, hagedorn hJ, Jessen h, Dupke s, hamouda o, 
Gunsenheimer-bartmeyer b, Meixenberger K, hIV seroconverter 
study Group (2015): high prevalence and high incidence of 
coinfection with hepatitis b, hepatitis c, and syphilis and low rate 
of effective vaccination against hepatitis b in hIV-positive men 
who have sex with men with known date of hIV seroconversion  
in Germany. PLos one 10 (11): e0142515. epub nov 10.
3. Marcus u, ort J, Grenz M, eckstein K, Wirtz K, Wille a: risk factors 
for hIV and stI diagnosis in a community-based hIV/stI testing 
and counselling site for men having sex with men (MsM) in a large 
German city in 2011–2012. bMc Infect Dis 2015; 15: 14.
4. schmidt D, Kollan c, stoll M, et al.: from pills to patients:  
an evaluation of data sources to determine the number of people 
living with hIV who are receiving antiretroviral therapy in Germany. 
bMc Public health 2015; 15: 252.
5. Zimmermann r, Marcus u, schäffer D, Leicht a, Wenz b,  
nielsen s, santos-hövener c, ross rs, stambouli o, ratsch ba, 
bannert n, bock ct, Kücherer c, hamouda o (2014): a multicentre 
serobehavioural survey for hepatitis b and c, hIV and htLV 
among people who inject drugs in Germany, using respondent 
driven sampling. bMc Public health 14 (1): 845. epub aug 14.  
doi: 10.1186/1471-2458-14-845.
Our  large  nation-wide  integrated  biological  and  behavioural 
survey among i.v. drug users (DRUCK study) has demonstrated 
the  need  to  upscale  prevention  measures  such  as  needles 
exchange and hepatitis B vaccination in this group.  Preliminary 
results  of  a  survey  on  sexual  health  among  migrants  from 



















The  results  from  our  surveillance  systems  and  diverse 
studies  put  us  in  a  unique  position  to  guide  policy  makers 
in the development of new strategies for HIV, STI and viral 
hepatitis  in  Germany  and  health  professionals  to  improve 
prevention, counselling, diagnosis and treatment. 
www.rki.de/fg34-en
“Our data puts us in a unique  
position to guide policy makers in   
 developing new strategies.”
Dr. Viviane Bremer
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  Infectious Disease Epidemiology    
 
 
Activities of the unit for HIV/AIDS, STI and Blood-borne Infections 





Hepatitis B, C und D 
Chlamydia laboratory 
sentinel 





Clinical HIV surveillance 
(ClinSurv)  













IVDU** (DRUCK study) 
Sex workers (Outreach) 
Migrants from sub-
Saharan-Africa (MiSSA)  
Use of secondary data 
and health services 
research 
HIV, STI and hepatitis 
diagnosis and treatment 
Situation analysis 
hepatitis B/C (Hep-Epi) 




Research for healthy 
communities 
(PartKommPlus) 
*Men who have sex with men; ** i.v. drug users 
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Unit 35: Gastrointestinal Infections,  
Zoonoses and Tropical Infections
We work on the epidemiology and prevention of a wide range 
of  gastrointestinal  and  zoonotic  pathogens.  The  spectrum 








on  27  different  infectious  disease  agents  in  peer  reviewed 
 journals over the last seven years. 
One major focus is placed on outbreak investigations. We 
have  coordinated  various  large  outbreak  investigations  and 
have  supported  public  health  authorities  in  many  local  and 
regional  outbreaks.  We  closely  collaborate  with  the  federal 
food safety authorities, the local and state health departments, 
and  the  national  reference  laboratories.  In  recent  outbreaks 
the usefulness of the new techniques of isolate typing (whole 
genome  sequencing)  in  combination  with  epidemiological 
data could be demonstrated. 
In  large  multistate  outbreaks  the  unit  usually  coordi-
nates  the  investigations  in  order  to  control  the  outbreak. 
Prime examples are the outbreak of STEC O104:H4 caused 
by sprouted seeds in 2011, the norovirus outbreak with more 
than  10,000  cases  caused  by  frozen  strawberries  in  2012, 
and various Salmonella and Listeria outbreaks. The evidence 
from  our  epidemiological  studies  contributed  to  the  timely 
 identification  of  the  vehicles  of  infection,  the  removal  of 
dangerous  foodstuffs  from  the  market  and  the  prevention 
of further cases of disease.






We  regularly  analyse  surveillance  data  in  order  to  detect 
changing trends or disease clusters. This forms one basis for out-
break detection and for analyses of spatio-temporal trends. Data 
on  imported mosquito-borne diseases  (malaria, dengue  fever, 
chikungunya fever) are constantly monitored and analysed. This 
enables us  to  issue pertinent  information  for  travel medicine 
experts and the public.
Additional research focuses on burden of disease  studies, 
seroepidemiology  and  risk  factor  studies.  We  analysed  the 
 burden of disease of haemolytic uraemic syndrome (HUS) and 
other gastrointestinal  infections. Time series analyses reveal 
temporal  trends,  geographic  and  demographic  distribution 
of  infectious diseases. We have published such analyses  for 
 campylobacteriosis, yersiniosis, norovirus enteritis,  brucellosis 
and  leptospirosis  providing  important  clues  for  prevention 
and  public  health.  Serosurveys  on  markers  of  infection  in 
Publications
1. frank c, Werber D, cramer JP, et al.: epidemic profile of shiga- 
toxin- producing escherichia coli o104:h4 outbreak in Germany.  
n engl J Med 2011; 365: 1771–1780. 
2. rosner bM, stark K, höhle M, Werber D. risk factors for sporadic 
Yersinia enterocolitica infections, Germany 2009–2010. epidemiol 
Infect 2012; 140: 1738–1747.
3. bernard h, faber M, Wilking h, et al.: Large multistate outbreak  
of norovirus gastroenteritis associated with frozen strawberries, 
Germany, 2012. euro surveill 2014; 19: 20719.
4. Wilking h, fingerle V, Klier c, thamm M, stark K. antibodies 
against borrelia burgdorferi sensu lato among adults, Germany, 
2008–2011. emerg Infect Dis 2015; 21: 107–110. 
5. faber M, schink s, Mayer-scholl a, et al.: outbreak of trichinellosis 
due to wild boar meat and evaluation of the effectiveness of  
post exposure prophylaxis, Germany, 2013. clin Infect Dis 2015;  
60: e98-e104. 
 representative population samples (Lyme borreliosis,  hepatitis 




service,  yielding  the  surprising  finding  that  even  in  young 





sporadic  listeriosis  and  for  hepatitis  E  virus  infections  with 
large case-control studies. 
Molecular epidemiology at the cross roads between  classic 
infectious  disease  epidemiology  and  microbiology/virology 
becomes  increasingly  important. Linkage of epidemiological 










In  conjunction  with  our  RKI  laboratory  experts,  we  were 





Overall,  by  investigating  current  trends  and  events  our 
unit’s work is able to directly prevent cases of disease. In our 
scientific studies we obtain evidence for effective and targeted 
public health measures.                   www.rki.de/fg35-en
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“Diversity, complexity, and dynamics 
of zoonotic diseases require  
preparedness, broad expertise and  
 flexible response.”
 Prof. Dr. Klaus Stark
outbreak of hus and stec gastroenteritis caused by stec o104:h4 in Germany,  















notified hantavirus cases by county of infection  
and probable virus type, Germany, 2006–2015
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Unit 36: Respiratory Infections
Robert  Koch,  the  founding  director  of  our  institute,  is  best 
known  for  his  work  on  tuberculosis.  The  unit  for  Respira-
tory Infections within  the Department of  Infectious Disease 
Epidemiology, founded 10 years ago in 2006, carries on this 
tradition  with  its  work  on  the  epidemiology  of  infectious 
 diseases spread by the respiratory route. Today, lower respira-
tory infections are still among the leading causes of death in 
Germany  and  pneumonia  contributes  about  half  a  million 




epidemiological  models  of  respiratory  infections.  Also  new 
emerging  infections,  such  as  SARS,  MERS  coronavirus  or 
avian  influenza, are within the scope of our unit.
Influenza and other respiratory viruses
Our  unit  has  established  and  maintains  several  surveil-






(Arbeitsgemeinschaft  Influenza),  and  a  hospital  sentinel  of 
severe  acute  respiratory  cases  (SARI-Surveillance)  based  on 
ICD-10-Codes.  The  latter  system  is  a  scientific  cooperation 
between the RKI and a large private German hospital network 
(ICOSARI).




circulating  influenza  strains  and  antigens  in  the   influenza 











in  knowledge  regarding  the  burden  of  influenza  (and  other 
acute  respiratory  diseases)  and  the  identification  of  risk 
 factors for severe disease and complications of influenza and 
 community-acquired pneumonia in Germany.
We  collaborate  closely  with  the  World  Health  Organi-





Legionella  spp.  are  important  causative  agents  of  sporadic 
community  acquired  pneumonia  (community  acquired 
Legionnaires’ disease; CALD). LD  is exclusively  transmissible 


















for  the  early  detection  of  LD  clusters/outbreaks  with  inter-
national  implications.  European  guidelines  ensure  proper 
source  management  and  thus  prevention  of  further  cases. 
For  Germany,  the  RKI  reports  since  2012  German  TALD 
cases  to ELDSNet and  informs German health departments 
Publications
1. Karo b, Krause G, hollo V et al. (2016) the impact of hIV infection 
on treatment outcome of tuberculosis: analysis of surveillance data 
from nine european countries, 2010–2012. aIDs (London, england).
2. fiebig L, hauer b, brodhun b, altmann D, haas W (2015)  
tuber culosis in Germany: a declining trend coming to an end?  
the european respiratory Journal. 
3. reuss a, Litterst a, Drosten c et al. (2014) contact investigation 
for imported case of Middle east respiratory syndrome, Germany. 
emerg Infect Dis 20: 620–625.
4. bayer c, remschmidt c, an Der heiden M et al. (2014) Internet- 
based syndromic monitoring of acute respiratory illness in  
the general population of Germany, weeks 35/2011 to 34/2012. 
euro surveill 19: pii: 20684.
5. suess t, remschmidt c, schink sb et al. (2012) the role of  
facemasks and hand hygiene in the prevention of influenza trans-
mission in households: results from a cluster randomised trial; 














integration  of  molecular  typing  and  genome  sequencing 
results  of  the  pathogens.  This  is  to  detect  clusters  of  TB 






completeness  of  TB  surveillance  data,  e.g.  drawing  on 
independent  secondary  data  sources.  This  is  important 
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“Working on prevention and  
control of respiratory infections we  
take on the challenge of monitoring  
and tracing airborne transmis- 
sion of pathogens that can cause  
large outbreaks and rapidly  
spread within the population.”
Prof. Dr. Walter Haas
Mycobacterium tuberculosis. scanning electron microscopy




Surveillance: ARS, AVS 
 
Individual pathogens: German Protection 













Centre for Protection and Prevention of 
Antibiotic Resistance 
Evaluation and further improvement of 
surveillance systems 
Improvement of methods for outbreak 
investigation (NGS, network analysis) and 
Burden of Disease for HAI/AMR, methods-
development 
 
Reduction of  HAIs, AMR pathogen spread 
and unnecessary use of antibiotics in 
order to reduce the burden of disease . 
 
Tailoring of systems and technical updates 
 
Analysis of secondary data 
 
Support national recommendations  with 
evidence 
Development of powerful preventive 
strategies 




• Tasks of the public health authorities 
in HAI/AMR in Germany 
• RKI-based cooperation in the areas of 
HAI/AMR 
• RKI-role in HAI/AMR in Germany  
 
 
Identification of high and low incidence 
regions or facilities to enable 
benchmarking process 
Activities Immediate goals Long-term aspirations 
What we do and why 
Integrated surveillance/One Health 
International cooperation 
Digital Epidemiology/Big Data 
Better understanding of mechanisms 
leading to spread of AMR and HAI 
Timely identification of source and mode 
of transmission 
Unit 37: Healthcare-associated Infections,  
Surveillance of Antimicrobial Resistance  
and Consumption
Healthcare-associated  infections  and  antimicrobial-resistant 
pathogens (HAI/AMR) contribute significantly to the overall 
burden  of  disease  and are  likely  to  increase due  to  contem-
porary changes in demographics as well as ongoing medical 
developments. At the international level, trends for HAI/AMR 
act  more  like  non-communicable  diseases:  even  with  a 
decrease of infectious diseases in general, HAI/AMR can be 
expected to increase. 
Our  unit  has  been  appointed  the  “Centre  for  the 





Infection  Act  (Infektionsschutzgesetz,  IfSG)  as  well  as  the 









data  collection  is  voluntary,  and  direct  responsibility  for 
local surveillance and related activities  is with the respective 
healthcare facilities. 
Surveillance and Outbreak Support
The RKI hosts two dedicated surveillance systems based within 
our unit. ARS (“Antimicrobial Resistance Surveillance”)  is a 
laboratory-based  surveillance  system  of  antimicrobial  resis-
tance (ars.rki.de)  [1], and AVS (“Antimicrobial Consumption 
Surveillance”/project collaboration between RKI and  Charité) 
is  the  surveillance  system  of  antibiotic  consumption  (avs.
rki.de)  [2].  Both  are  voluntary  surveillance  systems,  and  the 
overall objectives of both are to get representative data of the 
 antimicro bial  resistance  situation  in  both  hospital  and  out-
patient care settings, and data about antibiotic consumption 
in  hospitals  for  development  and  implementation  of  public 
health actions in Germany. 
The  data  collected  in  ARS  and  AVS  are  processed  in 












veillance  have  resulted  in  multiple  requests  to  support  local 
health authorities during outbreak investigations for HAI (e.g. [3]).
Findings  from  these  outbreak  investigations  directly 
influence national recommendations, exemplified in the 2012 
“Recommendation  for  the  prevention  of  nosocomial   infec- 
tions for neonatal intensive care newborns with a birth weight 
less  than  1,500 g”.  Improvement  of  methods  for  outbreak 




Further national and international research activities







surveillance  technology and  increasing digitization,  the unit 
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(2015) Incidence of invasive meticillin-resistant staphylococcus 
aureus infections in Germany, 2010 to 2014. eurosurveillance; 20.
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(2014) surveillance of antibiotic consumption in hospitals: tasks  
of the Public health service. bundesgesundheitsblatt – Gesund-
heitsforschung – Gesundheitsschutz; 57: 399–405.
3. haller s, eller c, hermes J, et al. (2015) What caused the out break 
of esbL-producing Klebsiella pneumoniae in a neonatal intensive 
care unit, Germany 2009 to 2012? reconstructing transmission with 
epidemiological analysis and whole-genome sequencing. bMJ 
open; 5.
4. harder t, haller s, Deindl P, et al. (2016) neurological sequelae  
of sepsis in very low birth weight infants: umbrella review  
and evidence-based outcome tree. eurosurveillance (in press).
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for Public health surveillance: a systematic review. Milbank  
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the  management  of  biological  incidents.  This  also  includes 
informing decision-makers and experts on such incidents and 
to advise them on adequate countermeasures.










highly  pathogenic  agents  including  toxins.  Recent  outbreaks 






As  a  reference  institution  for  specific  highly   pathogenic 
 biological agents, ZBS harbours BSL-3 and BSL-4 high contain- 
ment  laboratories  and  conducts  research  activities  necessary 
for the related tasks, e.g. research in diagnostics, epidemiology 
and pathogenesis. Some examples for the particular research 
interests  of  the  centre  are  the  host  range  of  poxviruses, 
 genetics and epidemiology of a newly discovered Bacillus cereus 
biovar  anthracis,  variability  and  functionality  of  selected  bio-
logical toxins, the transmissibility of proteinaceous infectious 
agents  (prions)  and  rapid  and  generic  diagnostics  of  patho-
gens  and  toxins  (e.g.  electron  microscopy,  next  generation 
 sequencing, spectroscopy, mass spectrometry and array-based 
detection  technologies).  In addition,  instruction and  training 
are  offered  regarding  the  secure  handling  of  specific  highly 
pathogenic  biological  agents  and  the  managing  of  unusual 
 biological events. 
Furthermore, in the case of an incident with unusual and 




closely  together  with  infectious  disease  specialists  all  over 
 Germany and has its own communications abilities. In order 
to  ensure  a  quick  exchange  of  information  and  interagency 
coordination,  it  serves  as  a  coordinating  hub  of  the  Perma-
nent Working Group of Competence and Treatment Centres 
in   Germany  (STAKOB)  and  is  interconnected  with  national 
(Federal Criminal Police Office [BKA]), Federal Office of Civil 
Protection  and  Disaster  Assistance  [BBK],  Federal   Centre 
for  Health  Education  [BZgA],  state  health  authorities)  and 
international  institutions  and  networks  (WHO,  EU  and  the 
Global Health Security Initiative [GHSI]).      www.rki.de/zbs-en
ZBS: Centre for Biological Threats and Special Pathogens
Publications
1. special Issue of toxins: “Detection and identification of biological 
toxins in international proficiency tests”, toxins 2015, 7(12).
2. special Issue: “seltene hochkontagiöse und lebensbedrohliche 
erkrankungen”, bundesgesundheitsblatt – Gesundheitsforschung – 
Gesundheitsschutz 2015, 58(7).
3. abIG – außergewöhnliche biologische Gefahren, website for 
mobile use, robert Koch Institute 2014, www.abig.rki.de.             
4. siegmund-schultze n: abwehr biologischer Gefahren: auf der 
spur hochpathogener erreger, Deutsches Ärzteblatt 2012; 109(47): 
a-2352 / b-1917 / c-1879.
5. uhlenhaut c, schaade L, finke eJ (2013): case study – Germany. 
In: hunger I et al. (hrsg), biopreparedness and Public health – 
exploring synergies, nato science for Peace and security series 
a: chemistry and biology. Dordrecht: springer science +business 
Media, s. 107–119. DoI: 10.1007/978-94-007-5273-3_10.
“Preparedness for unusual events  
caused by highly pathogenic agents and  
the response to them are essential  
public health functions. The Centre for  
Biological Threats and Special Pathogens  
at RKI provides unique capabilities  
to support the crises management  
related to highly pathogenic biologicals  
and to avert health consequences from  
 the population.”
 PD Dr. Lars Schaade
heaD of centre ~ PD Dr. Lars schaade (Vice President of RKI)
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Biological sample collection during an  
exercise between operative response teams 
of law enforcement and public health. 
the team was established in response to the 
anthrax letters that claimed several lives in 
the us in 2001. It can support and aid federal 
and local institutions as well as decision- 
makers in situations where release, spill or 
leakage of dangerous biological agents is 
suspected or confirmed. the team is capable 
of conducting environmental sampling in  
hot zones (areas where presence of dangerous 
biological agents is confirmed or most likely). 
further, the team analyzes samples taken  
or supports and advises in safe packaging 
and transportation measures of samples to 
competent laboratories for in-depth analysis. 
Moreover, this team supports federal police 
during state visits with expert advice and aid 
in preventive measures
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IBBS: Federal Information Centre for Biological 
Threats and Special Pathogens 
The  Federal  Information  Centre  for  Biological  Threats  and 
Special  Pathogens  (Informationsstelle  des  Bundes  für  Biolo-
gische Gefahren und Spezielle Pathogene – IBBS) advises on 
how  best  to  protect  public  health  and  reduce  health  conse-
quences following unusual biological incidents and outbreaks 




Koch  Institute  with  the  aim  of  providing  relevant  informa-
tion  for  the  professional  public  on  bioterrorism  relevant 
agents.  Since  then,  IBBS  has  played  a  significant  role  in 
strengthening  German  public  health  preparedness  and 
response  capabilities  to  unusual  biological  incidents  and 
outbreaks involving highly pathogenic agents. 
Over  the  last  years,  IBBS  provided  expert  advice  and 
support to state and local public health authorities and emer-
gency  services  on  different  occasions,  including  suspected 







relevant  authorities  with  appropriate  information  on  the 
highly pathogenic agent involved as well as on preparedness 
and  response  measures.  IBBS  gives  expert  advice  on  the 
 incident-specific  risk  assessment  and  informs  on  matters 




on  infectious  disease  epidemiology,  hygiene  and  laboratory 
analysis among others.
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“Prepare. Respond. Recover.  
We support and advice  
crisis management in all phases  
of unusual biological  
incidents and outbreaks.” 
 Dr. Christian Herzog
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forschung – Gesundheitsschutz. 58(7): 655–656.
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4. robert Koch Institute (lead managed by Ibbs) (2015): framework 
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STAKOB) brings together experts on public health prepared-
ness  and  response,  as  well  as  on  the  clinical  management 
of  patients  with  highly  contagious  and  life-threatening 
diseases.  IBBS  operates  the  STAKOB  office,  supports  the 
coordination  of  the  working  group  and  ensures  around- 
the- clock availability of STAKOB experts for consultation on 
the clinical management of these patients.
To  ensure  optimal  preparedness  for  unusual  biological 
incidents and outbreaks  involving highly pathogenic agents, 
IBBS  identifies  high-priority  biological  agents  and  devel-









IBBS  organizes  regular  courses  on  Advanced  Management 
of  Biological  Threats  (AMBIT),  which  include  table-top 
 exercises  and  practical  training  sessions.  Information  on 
highly pathogenic agents and unusual biological incidents are 
provided  regularly  to  the  professional  public  using  modern 
communication  tools  such  as  webinars,  podcasts  and  short 
video sequences.
IBBS  is  also  engaged  internationally  in  supporting 




















































Overall,  IBBS  supports  state  and  local  authorities  in 
Germany  in  their  preparedness  and  response  activities  to 
biological  incidents of  low probability but high consequence 
for public health.                  www.rki.de/ibbs-en
In  case  of  an  accidental  or  deliberate  release  of  a  highly 
pathogenic  agent  into  the  environment,  initial  sampling 
of  visible  contaminations  will  primarily  be  undertaken  by 
fire  services  in  the  immediate  incident  response.  However, 
strategic  sampling  to  determine  the  extent  of  contamina-
tion requires expert knowledge. A highly qualified biological 
incident  response  team  at  IBBS  is  trained  and  prepared  to 
undertake  strategic  environmental  sampling  in  situations 




genic  agent  is  very  challenging.  The  Permanent  Working 
Group  of  Competence  and  Treatment  Centres  for  Highly 
Contagious, Life-threatening Diseases in Germany (Ständiger 
Arbeitskreis  der  Kompetenz-  und  Behandlungszentren 
für  hochkontagiöse  und  lebensbedrohliche  Erkrankungen  – 
   Centre for Biological Threats and Special Pathogens      
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ZBS 1: Highly Pathogenic Viruses
The unit ZBS 1 addresses questions regarding rare and emerg-
ing viral diseases which are often caused by viruses of high 





and  reliable  diagnostics.  Since  only  a  limited  number  of 















Hence,  ZBS  1  supports  national  and  international  out-




but  also  for  sero-epidemiological  studies  of  rare  diseases. 
Immunofluorescence  tests, ELISAs, neutralization  tests and 
modern  multiplex  techniques  are  established  and  are  being 
steadily improved. To characterize viruses, they can be propa-
gated in cell culture up to level BSL-3.
Because  one  of  the  major  threats  of  bioterrorism  is  the 
deliberate release of Variola virus, the causative agent of the 
eradicated disease smallpox, ZBS 1 has developed a complete 








ZBS  1  is  coordinating  the  German  Laboratory  Network 
for the Diagnostics of Bioterrorism Agents (NaLaDiBa) aim-
ing at the improvement of the molecular pathogen detection 
particularly  in  environmental  samples.  The  strong  focus  on 





establishment  of  diagnostic  laboratories  in  various  African 
partner countries. For example, in 2015 we set up a diagnostic 
laboratory to help control the Ebola outbreak. 
The  second  main  pillar  of  our  work  is  basic  research 
on  mechanisms  that  determine  the  pathogenicity  of  highly 












as  with  modern  proteomics,  genomics  and  transcriptomics. 







Finally,  we  are  pursuing  several  projects  in  the  field  of 
virus discovery using mainly molecular techniques,  including 
NGS,  which  closes  the  circle  to  the  diagnostic  applications 
of molecular diagnostics in ZBS 1.
Publications
1. Doellinger J, schaade L, nitsche a (2015) comparison of the  
cowpox Virus and Vaccinia Virus Mature Virion Proteome: analysis 
of the species- and strain-specific Proteome. PLos one 10 (11): 
e0141527.
2. radonić a, Metzger s, Dabrowski PW, couacy-hymann e,  
schuenadel L, Kurth a, Mätz-rensing K, boesch c, Leendertz fh, 
nitsche a (2014) fatal monkeypox in wild-living sooty mangabey, 
côte d’Ivoire, 2012. emerg Infect Dis 20 (6): 1009 –1011.
3. Dabrowski PW, radonić a, Kurth a, nitsche a (2013) Genome- 
wide comparison of cowpox viruses reveals a new clade related  
to Variola virus. PLos one 8 (12): e79953.
4. bourquain D, nitsche a (2013) cowpox virus but not Vaccinia  
virus induces secretion of cxcL1, IL-8 and IL-6 and chemotaxis  
of monocytes in vitro. Virus res 171 (1): 161–167.
5. Langhammer s, Koban r, Yue c, ellerbrok h (2011) Inhibition  
of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa). 
antiviral res 89 (1): 64–70.
Service units run by ZBS 1
PCR facility
ZBS 1 is responsible for one of the accredited PCR facilities 











The central  sequencing  laboratory of  the RKI offers  various 
variants  of  DNA  sequencing,  such  as  Sanger  sequencing 
(accredited according to ISO 17025) for diagnostic and research 





ultradeep  sequencing  and  further  approaches  on  request. 
We offer advice on questions of sequencing  technologies  in 
 internal and external collaborations.               www.rki.de/zbs1-en
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 “With our work we  
intend to contribute to a better  
understanding and control  
of highly pathogenic viruses.” 
PD Dr. Andreas Nitsche
human cowpox  
infections transmitted  
by domestic animals.  
a: typical lesion,  
b: atypical lesion
 
Phylogenetic analysis  
of 22 new cowpox virus 
genomes reveals a new 
clade of cowpox viruses 
genetically closely related 
to Variola virus
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ZBS 2: Highly Pathogenic Microorganisms
ZBS 2 focuses mainly on bacterial pathogens of risk group 3 
such  as  the  causative  agents  for  anthrax,  tularemia,  plague, 
melioidosis,  glanders,  brucellosis,  and  Q-fever.  For  these 
 pathogens, ZBS 2 provides flexible accredited laboratory diag-
nostics according to DIN EN ISO 15189: 2014 and 17025: 2005 
and  is  running a BSL-3  laboratory  in addition  to BSL-2  lab-
oratories.  Depending  on  the  pathogen,  various  diagnostic 





















The  research  activities  of  ZBS  2  on  questions  of   epide - 
miology and ecology, pathogenesis, and decontamination are 
consequently  mainly  focused  on  the  two  above-mentioned 
zoonotic  bacterial  pathogens.  Besides  classical  B.  anthracis, 
a  cooperative  research  focuses  on  the  investigation  of 






together  with  partners  at  RKI,  in  Africa  and  other  interna-
tional institutes. The pathogen is unusual because it contains 
the two virulence plasmids pXO1 and pXO2 of B. anthracis in 
a  chromosomal  background  of  B. cereus. The  consequences 
of this genetic composition for the pathological mechanisms 





pean   countries  and  Germany.  ZBS  2  was  involved  in  the 
diagnostics,  phylogenetic  typing,  and  management  of  the 




1. Keim P, Grunow r, Vipond r et al.(2015) Whole genome analysis 
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strains  for  both  epidemics  and  a  case  that  occurred  several 
years before. As B. anthracis forms very resistant spores, ZBS 
2  conducted  intensive  research  on  proper  inactivation  and 
decontamination  approaches  for  situations  of  natural  and 
intentional release of these spores.
Tularemia  caused  by  Francisella tularensis  is  a  relatively 
rare  zoonosis  in  Germany,  although  ZBS  2  contributed  in 
 showing  that  it  is  probably  highly  underestimated  in  the 
human  and  wild  animal  population.  Therefore,  the  unit 
 conducts studies on the natural prevalence, possible reservoirs, 
and environmental resistance of this pathogen. Several isolates 
of  this  bacterium  obtained  from  wild  animals  were  studied 





ZBS  2  (working  group  “Cellular  Interactions  of  Bacterial 
Pathogens”)  together  with  national  collaborators  discovered 
a new Francisella species in Germany, underlining the diver-
sity  of  this  pathogen  in  nature.  It  is  of  special  interest  to 
study  the  mechanisms  of  the  pathogen-host  interactions 
and   pathogenicity  of  the  facultative  intracellular  bacterium 




ZBS  2  has  acquired  special  knowledge  in  laboratory 
bio-risk management which is applied for own purposes but 
also  disseminated  on  national  level  and  to  international 
partners in the framework of scientific projects and interna-
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“The natural prevalence of highly 
pathogenic bacteria might be  
relatively low in Germany, but these 
pathogens have always the potential for 
causing severe diseases and even large 
outbreaks. Therefore, we need quality-
assured diagnostics and research for 
better understanding the epidemiology, 
ecology, and pathogenicity of these  
bacteria in order to contribute to the 
health of our society.” 
 Prof. Dr. Roland Grunow
   Centre for Biological Threats and Special Pathogens      
figure 1 (left): circular maps of “B. cereus bv anthracis” chromosome 
(a) and plasmids (b). [Klee sr et al., PLos one. 2010 Jul 9; 5(7); e10986]
figure 2: Detection of antibodies against F. tularensis in wild animals. 
 a: examples of racoon dogs and foxes
 b: Documentation of seroconversion in a hippopotamus by sera from 
2001 (1), 2003 (2), 2004 (3), and 2006 (4). [Kuehn a, schulze c, Kutzer P, 
Probst c, hlinak a, ochs a, Grunow r. tularaemia seroprevalence  
of captured and wild animals in Germany: the fox (Vulpes vulpes) as  
a biological indicator. epidemiol Infect. 2013 apr; 141(4): 833–840.]
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they  are  not  living,  hence  unable  to  reproduce,  propagate  or 
spread from person to person. Therefore, they share many of 
the characteristics of classical chemical agents. However, since 





















 Ω the  detection  of  proteotoxins,  using  modern  immuno-
logical,  functional,  mass  spectrometric  and  molecular 
biological techniques;
 Ω the  prevalence,  variability  as  well  as  epidemiology  of 
 biological toxins, especially toxins produced by C. botulinum 
(Consultant Laboratory for C. botulinum), as well as 





proteotoxins  that  are  now  implemented  in  different  com-
plementary detection approaches and commercial platforms, 
Publications
1. stern D, Pauly D, Zydek M, Müller c, avondet M a, Worbs s, Lisdat f, 
Dorner M b, Dorner b G (2016). simultaneous differentiation  
and quantification of ricin and agglutinin by an antibody-sandwich 
surface plasmon resonance sensor. biosens bioelectron.  
78: 111–117. doi: 10.1016/j.bios.2015.11.020. 
2. rummel a (ed), Dorner b G (ed) (2015). Detection and identification 
of biological toxins in international proficiency tests. special Issue 
of toxins (http://www.mdpi.com/journal/toxins/special_issues/
detect-identi-toxins).
3. Kull s, schulz K M, Weisemann J, Kirchner s, schreiber t, bollen-
bach a, Dabrowski P W, nitsche a, Kalb s r, Dorner M b, barr J r, 
rummel a, Dorner b G (2015). Isolation and functional character-
ization of the novel clostridium botulinum neurotoxin a8 subtype. 
PLos one. 10: e0116381. doi: 10.1371/journal.pone.0116381.
4. Lee K, Zhong x, Gu s, Kruel aM, Dorner Mb, Perry K, rummel a, 
Dong M, Jin r. (2014). Molecular basis for disruption of e-cadherin 
adhesion by botulinum neurotoxin a complex. science. 344(6190): 
1405–1410. doi: 10.1126/science.1253823.
5. Pauly D, Kirchner s, stoermann b, schreiber t, Kaulfuss s, schade r, 
Zbinden r, avondet M a, Dorner M b, Dorner b G (2009).  
simultaneous quantification of five bacterial and plant toxins from 
complex matrices using a multiplexed fluorescent magnetic sus-
pension assay. analyst. 134: 2028–2039. doi: 10.1039/b911525k.
among  them  mobile  array-based  technologies,  suspension 
arrays  and  surface  plasmon  resonance  sensors.  In  order  to 
foster  the  identification  of  best  practices  for  toxin  detec-
tion,  ZBS  3  coordinated  a  large  European  project  called 




toxins  and  their  intricacies  with  respect  to  detection,  identi-
fication and reference materials – topics that are relevant for 
an  efficient  management  of  natural  or  man-made  incidents 
involving   biological  toxins.  By  building  a  network  of  expert 




Consultant Laboratory for Clostridium botulinum
Prevalence, variability and epidemiology
ZBS 3 is involved in national and international outbreak analy-
sis as well as in criminal investigations and provides diagnostic 













scIentIfIc staff ~ Dr. brigitte Dorner (Head) ~ Dr. Martin Dorner (Deputy) ~ Dr. uwe fiebig ~ Dr. bettina Kampa ~ Dr. Martin skiba  
Dr. Daniel stern ~ Dr. sylvia Worbs
technIcaL staff ~ Kathrin Grunow ~ Jacek Millert ~ olena shatohina ~ ewa schlereth
PhD stuDents ~ Laura von berg ~ eva-Maria hansbauer ~ Maren Krüger
“Biological toxins are relevant in  
the health sector as molecules inducing  
severe and recurrent intoxications 
worldwide. In the security sector selected  
biological toxins are known as potential 
agents of bioterrorism. Nevertheless, 
dissecting the toxins’ mechanism of 
function within the body teaches us a lot  
about the physiological process of life.” 
Dr. Brigitte Dorner
sources of highly potent biological  
toxins: Clostridium botulinum (top left), 
Ricinus communis (top right), Abrus  
precatorius (bottom left), Staphylococcus 
aureus (bottom right)
   Centre for Biological Threats and Special Pathogens      
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as a  scouting method and  independent  control  in emergen-
cies,  like  outbreaks  or  patient  cases  of  severe  diseases  with 
unknown cause (Fig. 1). In our role as the consultant  laboratory 
for diagnostic electron microscopy of infectious pathogens we 






who  are  specialists  in  the  various  types  of  microscopy.  The 
basic goal of the microscopy core facility is to provide optimal 
support for all lab-based scientists of the institute.
The  photography  facility  provides  imaging  services  for 






1. Dittmann. c.; han, h.-M.; Grabenbauer, M.; Laue, M. (2015) 
Dormant bacillus spores protect their Dna in crystalline nucleoids 
against environmental stress. J. struct. biol. 191: 156–164.  
doi: 10.1016/j.jsb.2015.06.019.
2. Laue, M.; Möller, L. (2015) the Virusexplorer – a database for  
diagnostic electron microscopy of viruses. http://dx.doi.
org/10.5281/zenodo.34926.
3. Möller, L.; schünadel, L.; nitsche, a.; schwebke, I.; hanisch, M.; 
Laue, M. (2015) evaluation of virus inactivation by formaldehyde  
to enhance biosafety of diagnostic electron microscopy. Viruses 7, 
(2): 666–679. doi: 10.3390/v7020666.
4. schaudinn, c.; stoodley, P.; hall-stoodley, L.; Gorur, a.; remis, J.  
et al. (2014) Death and transfiguration in static staphylococcus  
epidermidis cultures. PLos one 9(6): e100002. doi: 10.1371/ 
journal.pone.0100002.
5. hocke, a.c.; becher, a.; Knepper, J.; Peter, a.; holland, G.;  
tönnies, M.; bauer, t.t.; schneider, P.; neudecker, J.; Muth, D.; 
Wendtner, c.M.; rückert, J.c.; Drosten, c.; Gruber, a.D.; Laue, M.; 
suttorp, n.; hippenstiel, s.; Wolff, t. (2013) emerging human middle 
east respiratory syndrome coronavirus causes widespread infec-
tion and alveolar damage in human lungs. am. J. respir. crit. care 
Med. 188: 882–886. doi: 10.1164/rccm.201305-0954Le.
Research
The research of the group follows two major lines: (1) Improve-
ment  of  diagnostic  electron  microscopy  and  microscopic 
methods  to  study  pathogenic  microorganisms  and  (2)  basic 
and applied research on bacterial endospores and pathogenic 










remarkable  resistance  and  how  these  forms  can  be  treated, 
whenever  they  pose  a  problem  to  public  health,  as  in  the 
 transmission of Clostridia or biofilm in wound infections.
www.rki.de/zbs4-en; www.rki.de/cl-em
scIentIfIc staff ~ Dr. Michael Laue (Head) ~ Dr. christoph schaudinn (Deputy) ~ christin Dittmann ~ Lars Möller
technIcaL staff ~ Gudrun holland ~ Petra Kaiser ~ Dr. Kazimierz Madela ~ Janett Piesker ~ Marc schumann
PhotoGraPhers ~ Günter bredow ~ andrea schnartendorff
stuDent ~ tobias hoffmann
“The reasons for using  
microscopy at the Robert Koch 
Institute have not changed 
much during the last 125 years: 
We visualize microorganisms to 
find the cause of an infectious 
disease and to examine  
how they live and perform.” 
Dr. Michael Laue
figure 1: transmission electron microscopy of Norovirus from a diagnostic 
sample of the large gastroenteritis outbreak in 2012. Diagnostic electron 
microscopy was used as an independent control for the diagnosis based 
on nucleic acid amplification techniques and to exclude other viruses 
involved. Width of a single virus particle is about 30 nm
figure 2: transmission electron microscopy of a cross section through  
a spore of Bacillus anthracis (anthrax) which reveals the different coat layers 
including the hairy exosporium. Width of the spore is about 500 nm
   Centre for Biological Threats and Special Pathogens      
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ZBS 5: Biosafety Level 4-Laboratory 
The  Centre  for  Biological  Threats  and  Special  Pathogens  5 
(ZBS5)  was  established  in  2012.  Situated  within  the  Robert 
Koch  Institute,  ZBS5  was  appointed  to  operate  a  biosafety 
level 4  (BSL-4)  laboratory  to prioritize research of emerging 
and re-emerging viral pathogens, in particular those that cause 
severe  haemorrhagic  fever  in  humans.  The  agents  include 
risk group 4 pathogens such as Ebola virus, Crimean Congo 
 haemorrhagic  fever virus, Lassa virus, and Nipah virus, and 
many  of  these  agents  are  considered  to  be  the  emerging 
 diseases most  likely  to cause major epidemics by  the World 
Health  Organization,  for  which  preventive  or  therapeutic 
 interventions are not available. 
Upon  commission  of  the  BSL-4  laboratory  in  2016  the 
group  will  investigate  viral  persistence  in  biological  and 
environmental  samples,  which  will  lead  to  the  development 
and  establishment  of  diagnostic  methods  for  risk  group  4 
 pathogens. As part of a global call for more detailed research 
into dangerous pathogens, ZBS5 will further develop strategies 
for  the  prevention  and  control  of  highly  pathogenic  viruses 
together  with  the  Federal  Information  Centre  for  Biological 
Threats and Special Pathogens and ZBS1. The research group 
will implement cutting edge technologies to study viral trans-




EU  projects  including  EVIDENT  (Ebola  Virus  Disease  – 
correlates of protection, determinants of outcome, and  clinical 
management)  and  EMLab  (European  Mobile   Laboratory). 
Within  the  latter project, diagnostic  investigations have been 
repeatedly  performed  during  the  Ebola  outbreak  in  West 





1. carroll MW, Matthews Da, hiscox Ja, elmore MJ, Pollakis G,  
rambaut a, hewson r, García-Dorival I, bore Ja, Koundouno r, 
abdellati s, afrough b, aiyepada J, akhilomen P, asogun D,  
atkinson b, badusche M, bah a, bate s, baumann J, becker D, 
becker-Ziaja b, bocquin a, borremans b, bosworth a, boettcher JP, 
cannas a, carletti f, castilletti c, clark s, colavita f, Diederich s, 
Donatus a, Duraffour s, ehichioya D, ellerbrok h, fernandez-Garcia 
MD, fizet a, fleischmann e, Gryseels s, hermelink a, hinzmann J, 
hopf-Guevara u, Ighodalo Y, Jameson L, Kelterbaum a, Kis Z, 
Kloth s, Kohl c, Korva M, Kraus a, Kuisma e, Kurth a, et al. (2015). 
temporal and spatial analysis of the 2014–2015 ebola virus out-
break in West africa. nature 524(7563), 97–101. 
2. Kohl c, brinkmann a, Dabrowski PW, radoniḉ a, nitsche a,  
Kurth (2015). a Protocol for metagenomic virus detection in clinical 
specimens. emerg Infect Dis 21(1), 48–57. 
3. Marklewitz M, Zirkel f, Kurth a, Drosten c, Junglen s (2015).  
evolutionary and phenotypic analysis of live virus isolates  
suggests arthropod origin of a pathogenic rna virus family.  
Proc natl acad sci usa 112(24), 7536–7541. 
4. Kohl c, Kurth a (2014). european bats as carriers of viruses with 
zoonotic potential. Viruses 6(8), 3110 –3128. 
5. Kurth a, Kohl c, brinkmann a, ebinger a, harper Ja,  
Wang Lf, Mühldorfer K, Wibbelt G (2012). novel paramyxoviruses 
in free-ranging european bats. PLos one 7(6).
scIentIfIc staff ~ Dr. andreas Kurth (Head) ~ Kathryn edenborough (PhD)
bIosafetY offIcer ~ frank siejak
technIcaL staff ~ nicole hetzelt ~ Petra Kreher ~ angelika Lander ~ uwe Vogel
PhD stuDent ~ Marcel bokelmann
“One of the few good  
news from the tragic Ebola  
epidemic in West Africa  
is that it stresses the  
wake-up call: we must pre- 
pare for future outbreaks  
of deadly diseases  
that may spread more  
effectively than Ebola.”
Dr. Andreas Kurth
Test operation of the new bio-
safety level 4 (BSL-4) laboratory 
at the Robert Koch Institute.  
the bsL-4 laboratory allows a 
safe handling of pathogens  
of the highest risk group such  
as ebola, Marburg and Lassa 
viruses. the laboratories have 
their own air, power and water 
supply; multi-tiered security  
systems prevent pathogens  
from being released
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of  rapid  diagnostics  of  microbial  pathogens  and  the  patho-
genesis of protein misfolding diseases such as prion  diseases, 






methods  for  the  detection,  differentiation  and  identification 
of pathogenic microorganisms. In particular, Raman and IR 
microspectroscopy are extensively used to identify and classify 





To  identify  pathogenic  microorganisms  we  employ 
also  proteomic  techniques  such  as  matrix-assisted  laser/
desorption ionization time-of-flight mass spectrometry (MAL-
DI-TOF  MS)  or  electrospray-ionisations  mass  spectrometry 
in combination with separation techniques (HPLC, 2D PAGE). 
Specifically MALDI-TOF MS has been widely used as a tool 
for  objective,  simple,  rapid  and  cost-effective  identification 
Publications
1. Dieckmann r, hammerl Ja, hahmann h, Wicke a, Kleta s,  
Dabrowski PW, nitsche a, stämmler M, al Dahouk s, Lasch P 
(2016) rapid characterisation of Klebsiella oxytoca isolates from 
contaminated liquid hand soap using mass spectrometry, ftIr 
and raman spectroscopy. faraday Discuss, advance article.  
DoI: 10.1039/c5fD00165J.
2. beekes M, thomzig a (2016) sterilization techniques:  
counter the risk of alzheimer’s transfer. nature 531(7596): 580. 
DoI: 10.1038/531580a. 
3. Lasch P, Wahab t, Weil s, Pályi b, tomaso h, Zange s, Kiland 
Granerud b, Drevinek M, Kokotovic b, Wittwer M, Pflüger V,  
Di caro a, stämmler M, Grunow r, Jacob D (2015) Identification  
of highly pathogenic microorganisms using MaLDI-tof mass 
spectrometry – results of an inter-laboratory ring trial. J. clin 
Microbiol 53(8): 632-2640.
4. beekes M, thomzig a, schulz-schaeffer WJ, burger r (2014) Is there  
a risk of prion-like disease transmission by alzheimer- or Parkinson- 
associated protein particles? acta neuropathol 128:463–476.
5. Daus ML, Wagenführ K, thomzig a, boerner s, hermann P,  
hermelink a, beekes M, Lasch P (2013) Infrared microspec-
troscopy detects protein misfolding cyclic amplification 
(PMca)-induced conformational alterations in hamster scrapie 
progeny seeds. hYPerLInK “http://www.ncbi.nlm.nih.gov/
pubmed/24163371” J biol chem 288: 35068-80.
to trigger further protein misfolding in a manner reminiscent 
of prion diseases.  Importantly,  the potential  transmissibility 
of AD or PD pathologies may also represent an issue in regard 










the  commonalities  and  discrepancies  of  AD,  PD  and  prion 
diseases in terms of the infectivity, pathogenicity and associa-
tion with heterogeneous disease phenotypes of different A, 
tau, S or PrP conformers.               www.rki.de/zbs6-en 
scIentIfIc staff ~ Dr. Peter Lasch (Head) ~ PD Dr. Michael beekes (Deputy) ~ Dr. Michael baier ~ Dr. Michael burwinkel ~ Dr. Jörg Döllinger 
Dr. achim thomzig
 
technIcaL staff ~ stefanie herfort ~ Marion Joncic ~ Karin Krohn ~ Maren stämmler ~ andy schneider ~ Patrizia reckwald ~ elke Westhäuser
 
stuDent ~ Max Weydmann (BsC)
Principle of protein misfolding cyclic  
amplification (PMca) for the cell-free propa-
gation in vitro of the infectious, pathological 
isoform of the prion protein (PrPsc)
of bacteria. In the past ZBS 6 has developed a MALDI-TOF 
MS compatible inactivation protocol for RG3 pathogens. 
The  scientific  and  technical  staff  of  ZBS  6  combines 
furthermore long-standing expertise and research experience 
in the field of neurodegenerative protein aggregation diseases 








Protein Misfolding Cyclic Amplification (PMCA)
Proteomic equipment available at Zbs 6.  
a: autoflex speed MaLDI-tof mass spectrometer 
(bruker Daltonics). b: easY-nLc Liquid chroma-
tograph (thermo scientific). c: LtQ orbitrap esI mass 
spectrometer (thermo)
“It is necessary to look at the results 
of observation objectively, because 
you, the experimenter, might like one 
result better than another.”
Richard P. Feynman
   Centre for Biological Threats and Special Pathogens      
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Project Groups









An  evaluation  of  the  groups  is  done  regularly  by  the 
 Scientific  Advisory  Board  of  the  RKI,  normally  every  three 
years. Depending on the verdict of the evaluation process the 
project  groups  can  be  prolonged,  changed  in  the  research 
direction, or the staff can be integrated back into the scientific 
departments. 
Currently,  there  are  five  project  groups.  The  research 
 topics range from immune defense mechanisms to virulence 






dedicates  its  efforts  to  the  modelling  of  infectious  diseases. 
  Project Groups    
The following project groups are going  
to be introduced subsequently:
 Ω P 1: Immune Defense Mechanisms
 Ω P 2: Acinetobacter baumannii –  
Biology of a Nosocomial Pathogen
 Ω P 3: Epidemiology of Highly  
Pathogenic Microorganisms
 Ω P 4: Epidemiological Modelling  
of Infectious Diseases











P 1: Immune Defense Mechanisms
In our unit we try to understand how T cells, which constitute 
a  major  part  of  the  memory-bearing  adaptive  immune  sys-
tem,  contribute  to  fighting  infections.  Initially,  we  searched 
for  essential  molecules  initiating  and  driving  activation  of 
T cells in humans. Thus, we originally cloned CD40L and ICOS, 
described  the  function  of  these  T cell-specific  surface  mole-
cules, and identified human diseases associated with their loss 















effector  immune  response  in appropriate models  and could 
identify some central elements in this pivotal decision. 
More  recently,  we  turned  our  attention  to  DC  themselves, 





T cells  (1). Later, we could demonstrate  that  in humans  too, 
XCR1 is uniquely expressed on the corresponding DC  subset (2). 
Extending  previous  work  from  other  groups,  we  then  could 
show that DC can generally be subdivided into two  functional 
types.  The  SIRP+  DC  mainly  take  up  antigens  flowing 
freely  in  the  blood  (e.g.  viral  particles)  and  present  them  to 
CD4+ T cells. The activated CD4+ T cells  then direct B cells 













the  cytotoxic  arm  of  adaptive  immunity,  we  have  developed 
Publications
1. Dorner bG*, Dorner Mb*, Zhou x* et al. (2009) selective  
expression of the chemokine receptor xcr1 on cross-presenting  
dendritic cells determines cooperation with cD8+ t cells.  
Immunity 31: 823–833.
2. bachem a*, Güttler s*, hartung e* et al. (2010) superior  
antigen cross-presentation and xcr1 expression define human 
cD11c+cD141+ cells as homologues of murine cD8+ dendritic 
cells. J exp Med 207: 1273–1281.
3. Gurka s*, hartung e*, becker M*, Kroczek ra (2015) Mouse  
conventional dendritic cells can be universally classified based  
on the mutually exclusive expression of xcr1 and sIrP.  
front Immunol 6: 35.
4. hartung e*, becker M*, bachem a et al. (2015) Induction of  
potent cD8 t cell cytotoxicity by specific targeting of antigen to cross- 
presenting dendritic cells in vivo via murine or human xcr1.  
J Immunol 194: 1069–1079.
5. VuVan D, beier Kc, Pietzke L J et al. (2016) Local t-b cooperation  
in inflamed tissues is supported by t follicular helper-like cells.  
nat commun 7: 10875.
*equal contribution
a system which allows  to  target antigens  into XCR1+ DC  in 
vivo.  To  this  end,  we  utilize  XCL1,  the  natural  small  solu-
ble  ligand  of  the  XCR1  receptor,  as  a  transporter  molecule. 
 Proteins  of  choice  are  recombinantly  attached  to  XCL1  and 
injected in vivo. After binding to XCR1, the proteins are taken 






which  dramatically  amplify  this  initial  cytotoxic  CD8+  T cell 









prophylactic  vaccines  against  infectious  agents  to  which 
currently no protection exists. At  the same time, we hope  to 
establish  therapeutic  vaccines  capable  of  eradicating  various 
types of cancer.
Finally,  in  close  collaboration  with  the  group  of  Dr. 
Andreas Hutloff of the German Rheumatism Centre in  Berlin, 
we  have  in  recent  years  made  some  contributions  to  the 
 understanding  of  the  communication  between  CD4+  T cells 
and B cells in inflamed tissues (5).                      www.rki.de/p1-en
scIentIfIc staff ~ Prof. richard Kroczek, M.D. (Head) ~ hans-Werner Mages, Ph.D. (Deputy) ~ stephanie Gurka, Ph.D. 
technIcaL assIstants ~ Petra Jahn ~ Monika Jaensch ~ Katja ranke
DoctoraL stuDents ~ Laura bauer ~ annette Lahmann ~ nele reeg ~ Yi Yang
“We are attempting to translate basic 
immunological knowledge into  
a novel vaccination system inducing 
cytotoxic CD8+ T cells.”
 Prof. Dr. Richard Kroczek
Division of labour between two different types of dendritic cells. 
soluble antigens (e.g. viral particles) in the blood flow are taken up by sIrP+ dendritic cells and  
presented to cD4+ t cells. this results in the activation of the b cell system and production of protective  
antibodies. In contrast, infected cell material/tumour tissue is taken up by xcr1+ dendritic cells  
and mainly presented to cD8+ t cells. these become activated and differentiate into cytotoxic t cells,  
now capable of eliminating infected/tumour cells all over the body 
  Project Groups    
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P 2: Acinetobacter baumannii –  
Biology of a Nosocomial Pathogen
Objective
To elucidate the biology of the nosocomial pathogen Acineto-
bacter baumannii  in  order  to  contribute  to  prevention  and 
therapy.
Why working on Acinetobacter baumannii?
Nosocomial  infections  caused  by  multi-drug  resistant 
 pathogens  are  among  the  major  public  health  concerns, 
especially  in  the  light of an ageing population.   Acinetobacter 
 baumannii  is  a  Gram-negative  bacterium  which  causes 
 nosocomial  infections worldwide and progressively develops 
antibiotic resistance. A. baumannii and some other Acinetobacter 








ied  today,  fundamental  questions  on  the  biology  of  these 
 species  remain unresolved  the answers  to which could help 
significantly  in  setting  up  better  measures  of  prevention, 
surveillance and therapy.
Where does Acinetobacter baumannii originally come from?
Most  members  of  the  genus  Acinetobacter  are  ubiquitous 
environmental bacteria found in water and soil. By contrast, 
the natural reservoirs of A. baumannii and of other clinically 
relevant  Acinetobacter  species  are  poorly  defined.  Healthy 
humans only rarely carry A. baumannii on their skin, at least 
in  temperate  climates.  In  order  to  understand  the  biology 
of  pathogens,  it  is  however  important  to  study  them  within 





at  considerable  rates.  Whole  genome  sequencing  of  animal 
isolates  in  cooperation  with  unit  13  and  the  junior  research 
group “Microbial Genomics” allows us to assess the relevance 
of these reservoirs for transmission to humans. 
What are the secrets of success of this pathogen?
There is a worldwide spread of a few successful clonal lineages 
of A. baumannii in hospitals but also a perpetual influx of novel 
lineages  from  unknown  reservoirs  into  the  clinical  setting. 
Basically, the clonal lineage isolates show a higher degree of 
antibiotic resistance compared to non-clonal sporadic isolates 
consistent  with  a  more  recent  entry  into  the  hospital  en vi-
ronment of the latter. In general, A. baumannii is considered 
highly  resistant  to  desiccation  stress  and  disinfectants.  Fur-
thermore, an enhanced capability to form biofilms has been 
identified in the most successful clonal lineage. Colonization 
of surface environments  is of  the utmost  importance  in  the 
bacterial world, notably also during  infection. Motility  facili-
tates initial stages of biofilm formation resulting in increased 




colonization  and  infection  of  patients  and/or  persistence  in 
the  hospital  environment.  Therefore,  we  presently  seek  to 
elucidate the molecular basis of motility and biofilm formation 
in  A. baumannii  in  cooperation  with  colleagues  from  ZBS4 
and DFG Research Unit FOR2251. Within biofilms individual 
Acinetobacter  cells communicate  in a complex manner  inclu-
ding physical and chemical  interactions. We are particularly 
interested  in  studying  how  gaseous  signalling  molecules 
contribute to biofilm formation and resistance development.
How does Acinetobacter baumannii acquire resistance genes?
The  development  of  multi-drug  resistance  (MDR)  is  one  of 
the most awesome features of A. baumannii and facilitated by 
horizontal gene transfer (HGT). HGT not only occurs exten-
sively  among  members  of  the  genus  Acinetobacter,  but  also 
in  exchange  with  Pseudomonas  spp.  and  Enterobacteriaceae. 
The global spread of the New Delhi metallo--lactamase gene 
(blaNDM-1)  exemplifies  the  existence  of  “genetic  exchange 
Publications
1. Poppel Mt, skiebe e, Laue M, bergmann h, ebersberger I, Garn t, 
fruth a, baumgardt s, busse hJ, Wilharm G (2015) acinetobacter 
equi sp. nov. isolated from horse faeces. Int. J. syst. evol. Microbiol., 
in press. doi: 10.1099/ijsem.0.000806. 
2. heindorf M, Kadari M, heider c, skiebe e, Wilharm G (2014) 
Impact of acinetobacter baumannii superoxide dismutase on 
motility, virulence, oxidative stress resistance and susceptibility  
to antibiotics. Plos one 2014, 9: e101033.
3. Wilharm G, heider c (2014) Interrelationship between type  
three secretion system and metabolism in pathogenic bacteria.  
frontiers in cellular and infection microbiology 2014, 4: 150.
4. Wilharm G, Piesker J, Laue M, skiebe e (2013) Dna uptake by  
the nosocomial pathogen acinetobacter baumannii occurs during 
movement along wet surfaces. J. bacteriol. 2013, 195: 4146–4153.
5. skiebe e, de berardinis V, Morczinek P, Kerrinnes t, faber f,  
Lepka D, hammer b, Zimmermann o, Ziesing s, Wichelhaus ta,  
hunfeld KP, borgmann s, Gröbner s, higgins PG, seifert h,  
busse hJ, Witte W, Pfeifer Y, Wilharm G (2012) surface-associated  
motility, a common trait of clinical isolates of acinetobacter  
baumannii, depends on 1,3-diaminopropane. Int. J. Med. Microbiol. 
2012, 302: 117–128.













Our  work  is  funded  by  the  German  Research  Foundation 




scIentIfIc staff ~ PD Dr. Gottfried Wilharm (Head)
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a colony of acinetobacter baumannii moving along a wet surface
“To really understand  
Acinetobacter baumannii  
we need to identify  
its natural reservoirs.”
  PD Dr. Gottfried Wilharm
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I. Zoonotic pathogens in tropical wildlife and livestock 
Group lead: Dr. Fabian Leendertz







related  humans.  We  also  investigate  other  wildlife  species, 
especially  those  which  have  adapted  to  human  settlements 
(bats and rodents) as well as livestock as intermediate hosts. 
At  the  same  time,  we  collect  environmental  and  epide-
miological data in the respective regions. This multifactorial 





The  last  decade  witnessed  the  simultaneous  development 
of  powerful  sequencing  and  statistical  methods.  This  was 
particularly  profitable  to  our  understanding  of  the  biology, 
spread  and  recent  evolutionary  history  of  measurably  evolv-
ing viruses,  i.e. RNA viruses,  including influenza and Ebola 
viruses.  The  deep  evolutionary  history  of  many  viruses  was 
also  considerably clarified. It now seems clear that a number 
of viral lineages have been associated to their hosts for much 
longer  than  previously  thought.  However,  such  progresses 




predictions  from  the  study of  the deep evolution of  viruses. 
We do  this by  focusing on African great apes and bats, and 
investigating all conceivable sources of  information on their 
co-evolution  with  viruses  –  from  their  own  genomes  to  the 
genomes of their exogenous viruses, using contemporaneous 















collaborative  effort  between  many  units  at  RKI  and  several 
African partners, our group  focuses on pathogens of animal 





After  identifying  the  pathogens  underlying  the  above 
syndromes, we aim to guide appropriate interventions, such 
as implementing rapid diagnostic tests where appropriate and 
introducing  infection  control  measures  (e.g.  vector   control) 
and  outbreak  management.  Our  hypothesis  is  that  locally 





scIentIfIc staff ~ Dr. fabian Leendertz (Head) ~ Dr. sébastien calvignac-spencer (Deputy) ~ etile anoh ~ ariane Düx 
Kim Grützmacher ~ Jan Gogarten ~ constanze hoffmann ~ Leonce Kouadio ~ Dr. susanne Köhler ~ alexander Lang ~ therese Löhrich 
freda Madinda ~ arséne Mossoun ~ Kathrin nowak ~ Dr. Livia Patrono ~ Dr. Grit schubert ~ fee Zimmermann
aDMInIstratIon ~ Maja Kovacev-Wegener
technIcaL assIstants ~ Kevin Merkel ~ andreas sachse ~ ulla thiesen
stuDent assIstants ~ Verena Keil ~ Markus ullrich
transmission cycles of zoonotic pathogens among wildlife (e.g. non-human primates),  
domestic animals (e.g. dogs) and humans in a rural setting in tropical africa
Publications
1. saéz aM, Weiss s, nowak K, Lapeyre V, Zimmermann f, Düx a, 
Kühl hs, Kaba M, regnaut s, Merkel K, sachse a, thiesen u, 
Villányi L, boesch c, Dabrowski PW, radoniḉ a, nitsche a, 
Leendertz saJ, Petterson s, becker s, Krähling V, couacy-hymann e, 
akoua-Koffi c, Weber n, schaade L, fahr J, borchert M, Gogarten Jf, 
calvignac-spencer s and Leendertz fh (2015). Investigating  
the zoonotic origin of the West african ebola epidemic.  
eMbo Molecular Medicine 7: 17–23.
2. Kouadio L, nowak K, akoua-Koffi c, Weiss s, allali bK, Witkowski Pt, 
Krüger Dh, couacy-hymann e, calvignac-spencer s and Leendertz 
fh (2015). Lassa Virus in Multimammate rats, côte d’Ivoire, 2013. 
emerging infectious diseases 21: 1481.
3. calvignac-spencer s, Leendertz sa, Gillespie tr and Leendertz  
fh (2012). Wild great apes as sentinels and sources of infectious 
disease. clinical Microbiology and Infection 18(6): 521–527.
4. hoppe e, Pauly M, Gillespie tr, akoua-Koffi c, hohmann G,  
fruth b, Karhemere s, Madinda nf, Mugisha L, Muyembe JJ,  
todd a, Petrzelkova KJ, Gray M, robbins M, bergl ra, Wittig rM,  
Zuberbühler K, boesch c, schubert G, Leendertz fh, ehlers b and 
calvignac-spencer s (2015). Multiple cross-species transmission 
events of human adenoviruses (hadV) during hominine evolution. 
Molecular biology and evolution 32(8): 2072–2084.
5. Weiss s, Witkowski P, auste b, nowak K, Weber n, fahr J,  
Mombouli J, Wolfe nD, Drexler Jf, Drosten c, Klempa b, Leendertz 
fh and Krüger Dh (2012). hantavirus in bat, sierra Leone.  
emerging infectious diseases 18: 159–161.
“Understanding mechanisms of  
disease emergence in high  
risk areas is of direct relevance  
for global public health.”
Dr. Fabian Leendertz
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from  physics,  computer  science,  dynamical  systems  theory, 
complex networks theory and complexity science we develop 
computational and theoretical models to improve our under-
standing  of  the  dynamics,  proliferation  and  evolution  of 
infectious diseases. These models are designed to advance our 
understanding of basic mechanism and observed phenomena 





Global mobility and emergent infectious diseases
On one end of the spectrum we develop large-scale computa-
tional models that target global aspects of disease dynamics, 
predominantly  the  geographic  spread  of  diseases  or  how 
relative import risks are globally distributed as a function of 
outbreak locations. For instance, we have developed a class of 





diseases  we  apply  new  techniques  from  network  theory  to 
understand how hidden structural features of global mobility 
networks shape the expected spread or distribution of import 
risks  across  the  globe.  These  quantitative,  early  risk-assess-
ment methods are extremely useful  in the early phase of an 




1. D. K. Wells, Y. chuang, L. M. Knapp, D. brockmann, W. L. Kath,  
J. n. Leonard, spatial and functional heterogeneities shape  
collective behavior of tumor-Immune networks, PLos compu-
tational biology, 11: e1004181 (2015).
2. D. helbing, D. brockmann, t. chadefaux, K. Donnay, u. blanke,  
o. Woolley-Meza, M. Moussaid, a. Johansson, J. Krause,  
s. schutte, M. Perc, saving human Lives: What complexity  
science and Information systems can contribute, Journal of  
statistical Physics, 14: 1–47 (2014).
3. P. Lemey, a. rambaut, t. bedford, n. r. faria, f. bielejec, G. baele, 
c. a. russell, D. J. smith, o. G. Pybus, D. brockmann, M. a. suchard, 
unifying Viral Genetics and human transportation Data to Predict 
the Global transmission Dynamics of human Influenza h3n2, 
PLos Pathogens, 10: e1003932 (2014).
4. D. brockmann and D. helbing, the hidden geometry of complex, 
network-driven contagion phenomena, science, 342: 1337 (2013).
5. V. V. belik, t. Geisel, D. brockmann, natural human mobility  
patterns and spatial spread of infectious diseases.  
Phys. rev. x 1: 011001 (2011). 
Big Data and digital epidemiology
Currently, novel technological developments, trackable items, 
social  media,  personal  health  monitors,  and  smart  devices 
open new possibilities and opportunities for measuring con-






precision  embedded  in  large  scale  natural  experiments,  for 
instance electronic contact tracing using RFID technology in 
hospital settings, has become a powerful technique for under-










networks  in  order  to  improve  predictive  and  complement 
 statistical models usually applied in traditional epidemiology. 
www.rki.de/p4-en
scIentIfIc staff ~ Prof. Dr. Dirk brockmann (Head) ~ Dr. chen Li
PhD stuDents ~ olga baranov ~ benjamin Maier ~ frank schlosser
GraDuate stuDents ~ stephan adler ~ nikolas brunner ~ thea Denell ~ Lars Zerbe
using methods from network science, data on worldwide air-transportation we developed  
a computational interactive tool for computing the most probable spreading routes for ebola  
during the ebola crisis. the node on the bottom represents the conakry airport cKY,  
the lines the most probable import routes to other locations
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P 5: Virulence Factors in Salmonella  
and Campylobacter
Significance of our research
Salmonella  and  Campylobacter  are  pathogens  in  the  highest 
priority  group  when  numbers  of  cases,  severity  of  disease 
and costs  for  the public health system are considered. With 
more  than 69,800 and  13,700 cases  in 2015, Campylobacter 
and   Salmonella  respectively  were  responsible  for  over  85  % 
of all reported  bacterial intestinal infections in Germany. The 
actual  incidences are probably  far higher as mild courses of 
the   diseases  are  not  recorded.  In  most  cases  contaminated 
food is the source of infection since both pathogens are consid-
ered classical zoonoses and livestock in particular constitutes 
























into  the  interaction  between  Salmonella  and  the  intestinal 




Not so breathless bacteria
Bacterial  pathogens  have  to  adapt  in  order  to  survive  and 
 replicate in the challenging environments of the human body. 
Low  oxygen  concentration  (hypoxia)  is  one  of  the  key  envi-
ronmental  signals  to  which  enteric  pathogens  are  exposed 








decrease  in  antimicrobial  activity  of  the  macrophages.  This 








Campylobacter  is  comparable  with  opportunistic  pathogens 
which cause disease only when the host immune system is weak-
ened or colonization resistance is otherwise  disturbed. Here we 
investigate  possible  resistance  mechanisms  of   Campylobacter 
against  host-derived  antimicrobial  peptides.  In  combination 
with  other  factors,  resistance  might  be  one  component  ulti-




scIentIfIc staff ~ Dr. roman G. Gerlach (Head)
technIcaL assIstant ~ christiane schmidt
PhD stuDents ~ stefanie hoffmann ~ steffi Walter
“The unexpected is  
 the most fascinating.”
Dr. Roman G. Gerlach
Publications
1. Jennewein J, Matuszak J, Walter s, et al. (2015) Low-oxygen ten-
sions found in salmonella-infected gut tissue boost salmonella 
replication in macrophages by impairing antimicrobial activity and 
augmenting salmonella virulence. cell Microbiol 17: 1833–1847.
2. bielecki P, Jensen V, schulze W, et al. (2015) cross talk between  
the response regulators Phob and tctD allows for the integration 
of diverse environmental signals in Pseudomonas aeruginosa. 
nucleic acids res 43: 6413–6425.
3. Wille t, Wagner c, Mittelstädt W, et al. (2014) siia and siib are 
novel type I secretion system subunits controlling sPI4-mediated 
adhesion of salmonella enterica. cell Microbiol 16: 161–178.
4. bender JK, Wille t, blank K, Lange a, Gerlach rG (2013) LPs  
structure and PhoQ activity are important for salmonella 
 typhimurium virulence in the Galleria mellonella infection model.  
PLos one 8: e73287. 
5. Wille t, blank K, schmidt c, Vogt V, Gerlach rG (2012) Gaussia 
princeps luciferase as a reporter for transcriptional activity, protein 
secretion, and protein-protein interactions in salmonella enterica 
serovar typhimurium. appl environ Microbiol 78: 250–257.
the hypoxia workstation enables experiments  
under physiological oxygen concentrations
Wildtype salmonella (red) invading an epithelial cell (upper panel)  
and a sPI-4 mutant (blue, lower panel)
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Junior Research Groups
Like the project groups, the junior research groups are a con-
sequence  of  the  report  of  the  German  Council  for   Science 
and  Humanities  in  1997.  Young  and  talented  scientists 
shall have the possibility to conduct high-level research on a 
self-chosen  topic  without  being  obliged  to  contribute  to  the 
daily work of the institute. The field of research should com-












was  a  success  story  for  the  RKI.  A  considerable  number  of 
high quality publications were compiled by the groups which 
helped  to  establish  the  reputation  of  the  RKI  as  a  qualified 




The following junior research groups are going  
to be introduced subsequently:
 Ω Microbial Genomics
 Ω Bioinformatics






we  use  are  genomic  approaches  that  are  combined  with 
phenotypic analyses to understand the virulence, transmission 
and host-interactions of the bacteria. 
An  important  theme  of  our  research  activities  is  the 
understanding  of  anti-microbial  resistance  (AMR)  which  is 
one of the most essential evolutionary forces in the develop-
ment of the bacteria in the presence.
The  group  is  following  two  approaches  to  increase  the 




characterize  the  whole  population  of  a  species  to  identify 
certain evolutionary successful phylogenetic groups or groups 
that  are  characterized  by  an  increase  in  their  pathogenicity 
and/or  an  extended  antimicrobial  resistance  and  try  to  find 
the molecular source for this. We identify orthologous genes, 
present in all members of the population which will be used 
to  compare  the  strains  and  their  shared  molecular  charac-
teristics and genes that are accessory for example responsible 
for interaction with specific hosts, or for specific pathogenic 
mechanisms.  We  often  find  associations  here.  For  example 
in Escherichia  coli  strains of  the phylogenetic group B2 are 





us  to  track  how  resistant  strains  like  extended-spectrum 
beta-lactamases E.coli (ESBL) and methicillin-resistant Staphy-
lococcus  aureus  (MRSA)  are  on  the  rise  and  what  are  the 
mechanisms behind this trend.
On the other hand we also analyze and compare very closely 
related  strains  of  one  species.  Such  comparisons  allow  us 
to  track  the  microevolution  within  evolutionary  successful 
 lineages and ancient origins of a species. For example we are 
able  to  determine  the  genomic  factors  that  are  responsible 


















the  one  hand  the  causing  bacteria  are  evolving  very  quickly 
and on the other hand these bacteria can be resistant to almost 
all antibiotics. This can have fatal consequences, particularly 
in  developing  countries.  Mechanisms  of  adaptations  on  the 
pathogen side as well as on the host side and their  interaction 




the  different  global  lineages  have  clade  specific  distinct 















rithms  for  species  identification  and  a  quantification  of  the 
resistome  and  virulome  in  shotgun  metagenomics  datasets 
and their application in medical and veterinary setups.
www.rki.de/ng1-en
scIentIfIc staff ~ torsten semmler (Head) ~ Dr. ramani baddam
PhD stuDents ~ temesgen Dadi ~ barbara Moriel
stuDent ~ Lennard epping
 “Everything must be  
 made as simple  
 as possible.  
  But not simpler.”
 Albert Einstein (1879 – 1955)
Publications
1. t semmler, e M harrison, a Lübke-becker, r G ulrich, L h Wieler, 
s Guenther, I stamm, a-M hanssen, M a holmes, s Vincze, b 
Walther: a Look into the Melting Pot: the mecc-harboring region 
Is a recombination hot spot in staphylococcus stepanovicii. PLos 
one 01/2016; 11(1): e0147150. DoI: 10.1371/journal.pone.0147150.
2. K schaufler, t semmler, L h Wieler, M Woehrmann, r baddam,  
n ahmed, K Müller, a Kola, a fruth, c ewers, s Guenther:  
clonal spread and interspecies transmission of clinically relevant 
esbL-producing escherichia coli of st410 – another successful 
pandemic clone?. feMs Microbiology ecology 12/2015; 92(1): 
fiv155. DoI: 10.1093/femsec/fiv155.
3. t r connor, c r barker, K s baker, f-x Weill, K a talukder, a M smith, 
s baker, M Gouali, D P thanh, I J azmi, W Dias da silveira, t 
semmler, L h Wieler, c Jenkins, a cravioto, s M faruque, J Parkhill, 
D W Kim, K h Keddy, n r thomson: species-wide whole genome 
sequencing reveals historical global spread and recent local  
persistence in shigella flexneri. eLife sciences 08/2015; 4. DoI: 
10.7554/eLife.07335.
4. a v Mentzer, t r connor, L h Wieler, t semmler, a Iguchi,  
n r thomson, D a rasko, e Joffre, J corander, D Pickard, G Wiklund, 
a-M svennerholm, a sjöling, G Dougan: Identification of entero-
toxigenic escherichia coli (etec) clades with long-term global 
distribution. nature Genetics 11/2014; DoI: 10.1038/ng.3145.
5. c ewers, a bethe, t semmler, s Guenther, L h Wieler: extended- 
spectrum beta-lactamase- (esbL-) and ampc- producing escherichia  
coli from livestock and companion animals and their putative impact 
on public health: a global perspective. clinical Microbiology and 
Infection 03/2012; 18(7): 646-55. DoI: 10.1111/j.1469-0691.2012.03850.x.
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Bioinformatics
Technological  advances  in  high-throughput  processes  are 
allowing previously unimagined insights into biomedical con-
texts. Today, billions of genetic bases can be sequenced and 








Our  work  focuses  on  developing  and  applying  fast 
and  robust  bioinformatics  procedures  for  high-throughput 
experiments,  the main aim being  to clarify  issues  related  to 
diagnosing  and  characterizing  pathogens.  The  scope  of  our 
work  ranges  from  formulating  the  respective  question  in 




therefore,  is  not  so  much  the  actual  collection  of  informa-
tion as data analysis and the automated extraction as well as 
interconnection of relevant information. In view of the huge 
amount of data and  their  structures, we  require  tailor-made 
algorithms to obtain prompt and reliable results.
Our  work  focuses  on  next-generation  sequencing  data 
for analyzing DNA and RNA sequences, as well as on mass 
spectrometry  measurements  for  protein  identification  and 
structure predictions. In this context, we are especially inter-
















gut  or  skin.  Metagenomic  or  metaproteomic  approaches 
allow direct  analyses of  these samples without prior  cultiva-
tion and give a detailed insight into their composition. Here, 





1. f Zickmann, Ms Lindner, bY renard (2014). GIIra – rna-seq 
Driven Gene finding Incorporating ambiguous reads. bioinfor-
matics, 2014, 30(5): 606-613.[10.1093/bioinformatics/btt577] 
[software]. 
2. L aeberhard, s banhart, M fischer, n Jehmlich, L rose,  
s Koch, M Laue, bY renard, f schmidt, D heuer. the Proteome  
of the Isolated chlamydia trachomatis containing Vacuole  
reveals a complex trafficking Platform enriched for retromer 
components. Plos Pathogens, 2015, 11 (6), e1004883.  
[10.1371/journal ppat.1004883]. 
3. Ms Lindner, bY renard (2013). Metagenomic abundance  
estimation and Diagnostic testing on species Level. nucleic acids 
research, 2013, 41(1): e10. [10.1093/nar/gks803] [software]. 
4. a Penzlin, Ms Lindner, J Doellinger, PW Dabrowski, a nitsche,  
bY renard (2014). Pipasic: similarity and expression correction for 
strain-Level Identification and Quantification in Metaproteomics. 
bioinformatics, 2014, 30(12): i149-i156. [10.1093/bioinformatics/
btu267] [software]. 
5. s calvignac-spencer, J schulze, f Zickmann, bY renard.  
clock rooting with rootannotator further Demonstrates that 
Guinea 2014 eboV is a Member of the Zaire Lineage. PLos  
currents: outbreaks, 2014, 6(1), [10.1371/currents.outbreaks.
c0e035c86d721668a6ad7353f7f6fe86] [software].
One  recent  disease  focused  example  of  our  work  is  the 
 analysis of the 2014 Ebola outbreak in West Africa [5]. Here, 













data.  Here,  we  build  computational  infrastructure  for  large-
scale data management and automated computational analyses 






We  expect  constant  growth  of  high-throughput  experi-
ments and resulting data. Thus, we particularly focus on the 
fast  translation  of  data  into  actionable  information  and  the 
integration of knowledge across experimental platforms and 
constantly growing databases.               www.rki.de/ng4-en
scIentIfIc staff ~ PD Dr. bernhard renard (Head) ~ Dr. sandro andreotti ~ Dr. Wojtek Dabrowski ~ Dr. carlus Deneke ~ berit haldemann
Vivi Lieu ~ thilo Muth ~ Dr. robert rentzsch
PhD stuDents ~ Martina fischer ~ christine Jandrasits ~ Mathias Kuhring ~ tobias Loka ~ Vitor Piro ~ Kathrin trappe
stuDents ~ Jonathan baumann ~ christian Knauth ~ enrico seiler ~ Jakob schulze ~ benjamin strauch
“Infectious disease research  
nowadays commonly implies the analysis 
 of big, complex data volumes.”
PD Dr. Bernhard Renard
Figure 1: Growth of genome sequencing capacity at RKI within  
the last decade. It becomes apparent that, even on this logarithmic 
scale, we see strong growth in sequencing capacities requiring 
constant adaption of data management and analysis
figure 2: Probabilistic analysis of the con- 
catenated coding sequences belonging  
to the Zaïre clade for the analysis of the 2014  
ebola outbreak. It becomes apparent that  
the 2014 ebola outbreak strain (shown in  
yellow) falls within the Zaïre clade and is  
thereby highly related to previous outbreaks  
(see [5] for a full analysis and description)
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Sexually Transmitted Bacterial Pathogens
Sexually transmitted infections (STI) are caused by a hetero-
geneous  group  of  bacterial,  viral  and  parasitic  pathogens. 




Pathogens”  focuses  on  the  obligate  intracellular  bacterium 
Chlamydia trachomatis  which  is  among  the  most  frequently 
sexually transmitted bacteria worldwide. About 5 % of young 
adults worldwide have C. trachomatis-based genital infections, 
which  can  potentially  result  in  female  infertility.  Despite 
great efforts vaccines are not available to date. C.  trachomatis is 
sensitive to antibiotics, but these do not prevent  re-infection, 
cannot  fight  asymptomatic  cases.  Thus,  current  control 
 measures  are   inadequate,  and  new  and  more  effective 
approaches  are  required.  The  group  aims  to  understand 
the  mechanisms   Chlamydia  uses  to  infect  and  grow  inside 






of  two  distinct  bacterial  forms,  the  infectious  extracellular 
elementary body  (EB) and  the metabolically active  reticulate 
body  (RB).  After  internalization  of  the  EB,  the  bacteria  are 
found inside the inclusion (Fig. 1), which is segregated from 
the  lysosomal  degradation  pathway.  The  surrounding  inclu-
sion membrane is the interface between the bacteria and the 
host  cell  and  is  modified  by  insertion  of  bacterial  proteins. 
We exploit global and hypothesis-driven approaches to under-












proteomics  revealed  C. trachomatis  inclusions  are  an  intra-
cellular trafficking platform that interact with a multitude of 
different  cellular  transport  routes  and are enriched  for  sort-
ing  nexin  (SNX)  proteins  belonging  the  retromer  complex. 
Detailed  analysis  of  these  SNX  proteins  showed  a  strong 
recruitment to C. trachomatis inclusions at mid-infection time 
points. Interestingly, SNX proteins were also found on fibres 
emanating  from  the  inclusion  (Fig.  2)  and  seem  to  control 
development  of  these  structures.  Current  experiments  are 
being performed to describe the structure of SNX positive fibres 
by  high-resolution  microscopy  and  to  understand  the  role 
of SNX proteins and SNX fibres during Chlamydia infection. 
In addition  to Chlamydia’s  ability  to hijack  cellular pro-
teins,  Chlamydia  also  sequesters  lipids  from  the  host  cell. 
Especially  sphingolipids  play  a  pivotal  role  in  Chlamydia 




sphingolipid  family.  These  lipids  are  building  blocks  of  the 
eukaryotic  cell  membranes  and  evidence  accumulates  that 
they  regulate  different  cellular  processes  that  are  important 
in inflammation and immunity. Interestingly, sphingomyelin 
is  also  found  in  Chlamydia.  We  study  how  sphingomyelin 
is  transported  to  Chlamydia  and  its  function  for  different 
Chlamydia species. We apply and establish techniques inclu-
ding  classical  cell  biological,  microscopy-based  assays  and 
state-of-the-art  sphingolipidomics  approaches  to  understand 
localization,  transport  and  metabolism  of  sphingolipids 
before  and  after  infection  with  different  Chlamydia  species. 




processes  will  shed  light  onto  Chlamydia’s  unique  biology 
and will hopefully pave the way for the development of new 
anti-chlamydial strategies.                 www.rki.de/ng5-en
scIentIfIc staff ~ Dr. Dagmar heuer (Head) ~ Dr. Lukas aeberhard ~ Dr. sebastian banhart
technIcIan ~ andrea Martini
PhD stuDents ~ sophia edelmann (née Koch) ~ Laura rose, M. sc.
stuDent research assIstant ~ sandra oehlmann
figure 1: colored scanning electron micrograph of an epithelial cell  
harboring a c. trachomatis inclusion. heLa cells were infected with c.  
trachomatis L2 (MoI 2), fixed at 24 h post infectionem and further  
processed for scanning electron microscopy. During to the preparation 
process inclusions occasionally break open, allowing a view into the  
inclusion lumen. scale bar, 5 μm
Publications
1. aeberhard L, banhart s, fischer M, Jehmlich n, rose L, Koch s, 
Laue M, renard bY, schmidt f, heuer D. the Proteome of the  
Isolated chlamydia trachomatis containing Vacuole reveals a 
complex trafficking Platform enriched for retromer components. 
PLos Pathog. 2015 Jun 4;11(6): e1004883.
2. Knittler Mr, berndt a, bäcker s, Dutow P, hänel f, heuer D,  
Kägebein D, Klos a, Koch s, Liebler-tenorio e, ostermann c,  
reinhold P, saluz hP, schöfl G, sehnert P, sachse K. chlamydia 
psittaci: new insights into genomic diversity, clinical pathology, 
host-pathogen interaction and anti-bacterial immunity. Int J  
Med Microbiol. 2014 oct;304(7): 877–893. 
3. banhart s, saied eM, Martini a, Koch s, aeberhard L, Madela K, 
arenz c, heuer D. Improved plaque assay identifies a novel anti- 
chlamydia ceramide derivative with altered intracellular localization. 
antimicrob agents chemother. 2014 sep;58(9): 5537–5546. 
4. heymann J, rejman Lipinski a, bauer b, Meyer tf, heuer D.  
chlamydia trachomatis infection prevents front-rear polarity of 
migrating heLa cells. cell Microbiol. 2013 Jul;15(7): 1059–69.56. 
5. heuer D, rejman Lipinski a, Machuy n, Karlas a, Wehrens a,  
siedler f, brinkmann V, Meyer tf. chlamydia causes fragmentation 
of the Golgi compartment to ensure reproduction. nature.  
2009 feb 5;457(7230): 731–735. 
figure 2: snx proteins are recruited to the c. trachomatis inclusion and  
to fibers protruding into the host cell. confocal immunofluorescence 
images showing fibers positive for snx1 and Inca in c. trachomatis L2 
infected heLa cells (MoI 2). cells were fixed at 24 h post infectionem and 
stained with antibodies against snx1 (green) and Inca (red); Dna was 
stained with DaPI (blue). Images show a maximum intensity projection  
of a z-stack, arrows indicate snx1/Inca fibers. scale bar, 10 μm
“Chlamydia trachomatis is among  
the most frequently sexually  
transmitted bac teria worldwide.”
 Dr. Dagmar Heuer
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Trainings and Education










All  aspects  of  the  training  are  aimed  at  identifying  and 
implementing appropriate actions to prevent and control infec-
tious  diseases.  The  programme  provides  valuable  practical 
experience as a large portion of the training period is spent on 
independent work under close expert supervision. The training 
objectives  include  the  analysis  of  infectious  disease  surveil-
lance  data,  the  evaluation  of  surveillance  systems  as  well  as 
the  development  and  implementation  of  research  projects  in 
applied epidemiology. PAE fellows communicate their findings 
at  national  and  international  scientific  public  health  confer-
ences and through scientific publications. Thus, the scientific 
community  and public  health decision-makers  receive  essen-
tial  information for permanently  improving the public health 
 system in Germany and beyond.
Another  key  training  objective  of  the  programme  is  out-
break response. As such, PAE fellows are an essential resource 
for  the German public health service  in  the  investigation and 
control of outbreaks and other infectious disease threats. They 
also take responsibility as duty officers of the RKI 24/7 hotline 
for  national  public  health  emergencies.  As  part  of  RKI’s  epi-















In  2009  a  Master  of  Science  programme  in  Applied 
 Epidemiology  (MSAE)  has  been  established  in  cooperation 
with Charité in Berlin and the Berlin School of Public Health. 
The  two-year  fulltime  course  of  120  ECTS  credit  points  is 























ECDC fellowship training programmes: EPIET and EUPHEM
RKI  is  collaborating  with  the  European  Centre  for   Disease 
 Prevention and Control (ECDC) hosting fellows and coordinators 
for  the  European  Programme  for  Intervention  Epidemiology 
Training (EPIET) and the Public Health Microbiology Training 
(EUPHEM). The EPIET path offers a curriculum that trains public 
health experts  in competencies  for  intervention epidemiology 
and the EUPHEM path provides microbiologists with training in 
competencies for public health microbiology. After the two-year 
Pae/ePIet/euPheM scIentIfIc staff ~ Dr. Katharina alpers (Head) ~ Dr. Irina czogiel (Deputy) ~ Dr. sybille somogy
Dr. niklas Willrich ~ Dr. christian Winter
Pae/ePIet/euPheM aDMInIstratIVe staff ~ Juliette Zunk
Pae feLLoWs ~ Dr. Lena bös ~ Dr. Joana haußig ~ Dr. Gerit Korr ~ Dr. anna Kühne ~ Dr. raskit Lachmann ~ Dr. Viktoria schönfeld 
Juliane seidel ~ Gyde steffen ~ Dr. Lutz ehlkes ~ alexandra hoffmann ~ Dr. nobila ouedraogo
ePIet feLLoWs ~ Dr. emilie Peron ~ Janine thoulass
“We strengthen the public  
health workforce in Germany 
and Europe by training experts 
in communicable disease  
surveillance and response.”
Dr. Katharina Alpers
   Trainings and Education    
the Pae has interfaces with many national 
and international players of the public 
health sector. on the international level it is 
part of both the ePIet and the tePhInet 
network. It offers a joint master degree  
with charité and collaborates with the sub-
national public health sector in Germany  
by supporting the epiKurs@rKI and the 
secondment of fellows to the federal states. 
so far 10 states (shown in darkblue) have 
been a Pae training sites
train people in their home countries. For instance one  project, 






In  the  past,  vocational  training  was  limited  to  the  vocational 
training as office clerk, chemical lab technician or animal keeper. 
Today  a  wide  range  of  apprenticeships  are  offered.  Besides 
the above mentioned professions young people are trained to 






sub-­‐na)onal	   interna)onal	  na)onal	  
Joint	  coordina)on	  of	  	  
programme	  curricula	  
	  
Development	  of	  training	  material	  
	  
Providing	  training	  (lectures,	  case	  
studies)	  
	  
Supervision	  of	  EPIET	  and	  
	  EUPHEM	  fellows	  at	  the	  RKI	  
World-­‐wide	  	  
exchange	  with	  	  
field	  epidemiology	  	  
training	  
programmes	  
Support	  in	  	  
developing	  and	  
providing	  training	  
for	  	  local	  puclic	  
health	  departments	  
Coopera)on	  with	  public	  health	  
agencies	  of	  most	  federal	  states	  
	  
Secondment	  of	  fellows	  	  
to	  the	  state	  public	  health	  
agencies	  	  
	  


































Twinning and training of foreign scientists
In the last years the number of scientific personnel from abroad 
that  comes  to  the  RKI  to  learn  special  skills  has  increased 
 steadily. In some cases specialised funds can be raised for these 
purposes,  like  from  EU  twinning  programmes  or  financial 




1. schielke a, Ibrahim V, czogiel I, faber M, schrader c, et al.:  
hepatitis e virus antibody prevalence in hunters from a district  
in central Germany, 2013: a cross-sectional study providing  
evidence for the benefit of protective gloves during disembowelling 
of wild boars. bMc Infectious Diseases 2015; 15: 440.
2. blümel b, schweiger b, Dehnert M, buda s, reuss a, et al.:  
age-related prevalence of cross-reactive antibodies against influenza 
a(h3n2) variant virus, Germany, 2003 to 2010. euro surveillance 
2015; 20: 32.
3. bernard h, faber M, Wilking h, haller s, höhle M, et al.: Large 
multistate outbreak of norovirus gastroenteritis associated with 
frozen strawberries, Germany, 2012. euro surveillance 2014; 19: 8.
4. haller s, eckmanns t, benzler J, tolksdorf K, claus h, et al.: 
results from the first 12 months of the national surveillance of 
healthcare-associated outbreaks in Germany, 2011/2012. 
PLos one 2014; 9: 5.
5. the Who Mers-coV research Group (benjamin blümel  
for rKI/Pae): state of Knowledge and Data Gaps of Middle east  
respiratory syndromecoronavirus (Mers-coV) in humans.  
PLos currents outbreaks 2013; nov 12: 1. 
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National Reference Centres and Consultant Laboratories 
Public health microbiology  laboratories play a central  role  in 
detecting  infectious  diseases,  monitoring  outbreak  response 





The  general  goal  of  this  network  is  to  improve  the 
 efficiency of  infection  protection  by  advising  the  authorities 




for  three  years.  These  laboratories  are  considered  national 
centres  of  excellence  in  the  field  of  laboratory  science  for 
a  particular pathogen or group of pathogens. Of these, 5 NRCs 





with  accurate  diagnosis,  resistance  testing  and  prevention 









structure,  both  NRCs  and  CLs  are  involved  in  training  and 
in providing expert advice  to national health authorities and 
other laboratories. Moreover, these laboratory scientists work 
closely  together  with  their  epidemiologist  counterparts  at 
the RKI as well as those at federal, state and local levels. The 
NRCs  focus  on  outbreak  detection  and  response,  and  advis 
RKI  in  the  preparation  of  case  definitions  according  to  the 
Protection  against  Infection  Act  (IfSG).  Furthermore,  the 
reference  laboratories  conduct  or  are  involved  in  laboratory 




ducting  epidemiological  studies,  evaluating  implemented 
vaccination recommendations and analyzing the effectiveness 
of the vaccines.
The  high  relevance  of  NRC  and  CL  work  for  the  sur-
veillance of  infectious diseases  is  evident by  the wide  range 
of national and international publications. 
For which pathogen a reference laboratory is to be estab-










each appointment period, an evaluation of  the  laboratories  is 
performed by the RKI in cooperation with the Scientific Advi-
sory Board for Public Health Microbiology, which again consults 





In  general,  public  funding  does  not  and  cannot  cover 


















1. beermann s, allerberger f, Wirtz a, burger r, hamouda h:  
Public health microbiology in Germany: 20 years of national  
reference centres and consultant laboratories. Int J Med Microbiol 
2015; 305(7): 595–600.
2. Vogel u, beermann s, Gerlich W, et al.: twenty years of national 
reference and consultant laboratories for infectious diseases  
in Germany. Int J Med Microbiol. 2015; 305(7): 591–594.
3. Laude G, Kist M, Krause G: referenznetzwerke aus natio - 
nalen referenzzentren mit assoziierten Konsiliarlaboratorien  
in Deutschland. bundesgesundheitsbl 2012; 55: 223–230.
   Public Health Laboratories and Collaborating Centres    









national  cooperation  that  aims  to  support  WHO  and  its 
member states in preparing for and responding to emerging 
infections  and  biological  threats  with  specific  tasks.  These 
supportive activities are structured in four terms of reference:
 Ω Support  WHO  in  its  function  to  prepare  for  alert  and 
response  to  outbreaks  of  international  importance  by 
building laboratory capacities. 




 Ω Support  WHO’s  epidemiology  and  surveillance  activities 
including training in outbreak response, applied research, 
data analysis and modelling, when requested.
 Ω Support  the  implementation  of  the  International  Health 
Regulations  (IHR)  (2005)  regarding  emerging  infections 
and biological threats.
The collaborating centre at RKI is a cooperation between the 




Public Health Laboratories and Collaborating Centres
National Reference Centres at the RKI
 Ω Influenza (unit 17)
 Ω Measles, mumps, rubella (unit 12)
 Ω Poliomyelitis and enteroviruses (unit 15)
 Ω Salmonella and other enteric pathogens (unit 11)
 Ω Staphylococci and enterococci (unit 13)
Consultant Laboratories at the RKI
 Ω Bacillus anthracis (unit ZBS 2)
 Ω Clostridium botulinum (unit ZBS 3)
 Ω Electron microscopic diagnostics in infectious  
diseases (unit ZBS 4)
 Ω Cryptococcosis, Scedosporiosis, and imported  
systemic mycoses (unit 16)
 Ω Listeria (unit 11)
 Ω Noroviruses (unit 15)
 Ω Respiratory syncytial viruses, parainfluenza viruses  
and Metapneumoviruses (unit 17)
 Ω Poxviruses (unit ZBS 1)
 Ω Rotaviruses (unit 15)
 Ω Tularaemia (unit ZBS 2)
WHO/EURO Regional reference laboratories at the RKI 
 Ω Poliomyelitis (unit 15)
 Ω Measles and rubella (unit 12)
110
MeMbers ~ Dr. Volker arndt ~ Prof. Dr. Maria blettner ~ Dr. elke bruns-Philipps ~ Dr. susanne elsner ~ Dr. stefan hentschel ~ Dr. rolf heusser  
Dr. Peter Kaatsch ~ Prof. Dr. alexander Katalinic ~ Dr. Monika Klinkhammer-schalke ~ Prof. Dr. Jörg Michaelis ~ Prof. Dr. Iris Pigeot ~ antje Post   









are  located  at  the  RKI  and  organize  all  aspects  concerning 
the  work  of  the  committees,  convey   recommendations  and 
 implement their resolutions.        www.rki.de/committees
The following committees are going  
to be introduced subsequently:
 Ω Advisory Committee of the German Centre for Cancer  
Registry Data
 Ω Central Ethics Committee for Stem Cell Research
 Ω Commission for Hospital Hygiene and Infection Prevention
 Ω Commission on Anti-Infectives, Resistance and Therapy
 Ω Commission on Genetic Testing
 Ω Committee for Environmental Medicine 
 Ω Committee for Health Reporting and Health Monitoring 
 Ω Competence and Treatment Centres for Highly Contagious 
and Life-threatening Diseases
 Ω Editorial Board of the Bundesgesundheitsblatt
 Ω Expert Advisory Board on Influenza
 Ω National Advisory Committee Blood
 Ω National Certification Committee for Poliomyelitis  
Eradication in Germany
 Ω National Verification Committee for Measles and Rubella 
Elimination in Germany
 Ω Scientific Advisory Board for Public Health Microbiology
 Ω Standing Committee on Vaccination
   Scientific Committees    
Advisory Committee of the German Centre  







and  analysis  of  cancer  registry  data  and  the  collaboration 
between clinical and population-based registries in Germany. 
In  order  to  promote  the  more  intensive  use  of  cancer 
 registry  data  in  epidemiological  research,  the  Centre  for 
 Cancer Registry Data – in accordance with the Federal Cancer 
Registry Data Act (Bundeskrebsregisterdatengesetz – BKRG) – 
provides  the  data  of  the  epidemiological  cancer  registries 
in  Germany  to  third  parties  on  application.  The  Advisory 





and  clinical  cancer  registries,  the  German  childhood  cancer 
registry as well as patient organizations. Further members are 
national and international experts in the fields of oncology and 
epidemiology.  The  constructive  exchange  with  the   Advisory 
Committee is important to the continued success of the ZfKD 
and  ensures  an  ongoing  dialogue  among  stakeholders  in 
 cancer registration.                  www.rki.de/ac-zkfd
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Central Ethics Committee  
for Stem Cell Research







dated  28  June  2002  and  by  the  Regulation   concerning  the 
Central  Ethics  Committee  for  Stem  Cell  Research  and  the 
competent  authority  pursuant  to  the  Stem  Cell  Act  (ZES 
Regulation  –  ZESV)  dated  18  July  2002.  The  commission, 





The  committee’s  remit  is  to  review  and  assess  applica-
tions for the import and use of human embryonic stem cells 
(hESCs).  For  every  application  submitted,  the   committee 
issues  an  opinion  which  is  then  sent  to  the  Robert  Koch 
 Institute  (RKI),  the  competent  authority  under  the  Stem 
Cell  Act.  The  committee  reviews  the  ethical  acceptability  of 
the  applications  according  to  the  requirements  stipulated 
in the Stem Cell Act. An application must demonstrate  in a 
 scientifically substantiated manner (a) that the research project 
bIoLoGY anD MeDIcIne ~ Prof. Dr. anna M. Wobus (Deputy) (Prof. Dr. Maria Wartenberg) ~ Prof. Dr. Marion b. Kiechle (Deputy)  
(Prof. Dr. Ricardo E. Felberbaum) ~ Prof. Dr. Mathias bähr (Prof. Dr. Wolfram-H. Zimmermann) ~ Prof. Dr. hans r. schöler (Prof. Dr. Martin Zenke)  
Prof. Dr. anthony D. ho (Prof. Dr. Ursula Just)
ethIcs anD theoLoGY ~ Prof. Dr. Klaus tanner (Head) (Prof. Dr. Hartmut Kreß) ~ Prof. Dr. Jan beckmann (Prof. Dr. Ralf Stoecker)  
Prof. Dr. Dr. nikolaus Knoepffler (Prof. Dr. Christine Hauskeller) ~ Prof. Dr. Dr. antonio autiero (Prof. Dr. Konrad Hilpert)
pursues objectives of outstanding interest for the advance of 
scientific knowledge, (b) that the scientific issues have already 




















1. annual activity reports (2002/2003 to 2014). the english  
versions of so far 12 annual activity reports of the Zes are accessible 
through the rKI web page: www.rki.de/De/content/Kommissionen/ 
Zes/taetigkeitsberichte/taetigkeitsbericht_node.html.
   Scientific Committees    
Publications
1. Kommision für Krankenhaushygiene und Infektionsprävention 
(2015). Infektionsprävention im rahmen der Pflege und  
behandlung von Patienten mit übertragbaren Krankheiten.  
bundesgesundheitsbl (8): 1151–1170.
2. simon a, christiansen b (2012). Zur fortentwicklung der  
arbeiten bei den empfehlungen der Kommission für Kranken-
haushygiene und Infektionsprävention (KrInKo). bundes - 
gesundheitsbl (55): 1427–1431.
3. empfehlung der Kommission für Krankenhaushygiene und Infek-
tionsprävention (KrInKo) beim robert Koch-Institut (rKI) und  
des bundesinstitutes für arzneimittel und Medizinprodukte (bfarM) 
(2012). anforderungen an die hygiene bei der aufbereitung von 
Medizinprodukten. bundesgesundheitsbl (55): 1244–1310.
4. Kommission für Krankenhaushygiene und Infektionsprävention 
(2010). Die Kategorien der richtlinie für Krankenhaushygiene  
und Infektionsprävention – aktualisierung der Definitionen.  
bundesgesundheitsbl (53): 754–756. 
5. Kommission für Krankenhaushygiene und Infektionsprävention 
(2009). Personelle und organisatorische Voraussetzungen  
zur Prävention nosokomialer Infektionen. bundesgesundheitsbl 
(52): 951–962.
MeMbers ~ Dr. bärbel christiansen (Head) ~ PD Dr. arne simon (Deputy) ~ Prof. Dr. heike von baum ~ heike briesch ~ Prof. Dr. Martin exner
Prof. Dr. Petra Gastmeier ~ Prof. Dr. Martin hansis ~ PD Dr. ursel heudorf ~ PD Dr. heinz-Michael Just ~ Prof. Dr. axel Kramer ~ Prof. Dr. ottmar Leiß
Prof. Dr. Joachim Martius ~ Prof. Dr. Georg Peters ~ Prof. Dr. bernhard ruf ~ Prof. Dr. heidemarie suger-Wiedeck ~ Prof. Dr. Matthias trautmann
anna triphaus ~ Prof. Dr. constanze Wendt
Commission for Hospital Hygiene  
and Infection Prevention
The Commission for Hospital Hygiene and Infection Preven-
tion  (KRINKO) has  the official mandate  to develop national 
 recommendations for the prevention of healthcare- associated 
infections.  A  precursor  of  the  Commission  developed  a 





to  clarify  that  beside  hospitals,  the  recommendations  are 




Thus,  the  commission’s  main  function  is  to  compile 
national recommendations for the prevention of nosocomial 
infections  and  structural  and  organizational  measures  of 
hygiene in hospitals and other healthcare facilities. Basic aims 
of  the  recommendations  are  the  decrease  of  infection  rates 
and number of outbreaks as well as preventing the spread of 
multidrug-resistant   organisms. In order  to fulfil  these aims, 
evidence-based  measures  are  recommended,  which  are 
obliged  to be based on  systematic  risk  analysis,  clinical  and 
 epidemiological studies, as well as on results of microbiologi-
cal  and  experimental  research.  They  are  recommended  by 
mutual consensus and published by the Robert Koch  Institute. 
The  scientific  secretariat  of  the  commission  is  affiliated  to 
the unit for Hospital Hygiene, Infection Prevention and Con-
trol at  the Robert Koch Institute. Commission members are 
appointed by  the Federal Ministry of Health  for  a period of 
three years. The commission is composed of eighteen mem-
bers, who are experts and specialists in different medical fields 















Commission on Anti-Infectives,  
Resistance and Therapy
The increasing importance of resistant pathogens is addressed 
in  the  German  Antimicrobial  Resistance  Strategy  (DART). 
The correct use of  anti-infectives plays an  important  role  in 
 combatting development and spread of resistant pathogens. 
In 2011, the law amending the Protection against  Infection 
Act and other  laws created  the basis  for  the Commission on 
Anti- Infectives, Resistance and Therapy (ART) at the RKI, that 
started  working  in  January  2013.  The  commission  compiles 
up-to-date general recommendations for diagnosis and therapy, 
especially  in  the  case  of  infections  with  resistant  pathogens, 
and, in close collaboration with the Association of the  Scientific 
Medical  Societies  (AWMF),  it  initiates  the  compilation  of 








in  the  unit  “Healthcare-associated  Infections,   Surveillance 
of  Antimicrobial  Resistance  and  Consumption  (unit  37)”. 
It  assists  and  coordinates  all  activities  of  the  commission, 
 especially  the  preparation  of  scientific  content  for  meetings 
and for  consulting the Federal Ministry of Health.
Publications
1. Gendiagnostik-Kommission beim robert Koch-Institut (2016) 
tätigkeitsbericht der Gendiagnostik-Kommission (GeKo) für den 
Zeitraum 01.01.2013 bis 31.12.2015. http://www.rki.de/De/content/
Kommissionen/GendiagnostikKommission/taetigkeitsbericht/ 
taetigkeitsbericht_02.html. Zugegriffen: 28 Januar 2016.
2. Gendiagnostik-Kommission beim robert Koch-Institut (2013) 
richtlinie der Gendiagnostik-Kommission (GeKo) für die 
anforderungen an die Durchführung der vorgeburtlichen risiko-
abklärung sowie an die insoweit erforderlichen Maßnahmen  
zur Qualitätssicherung gemäß § 23 abs. 2 nr. 5 GenDG. bundes-
gesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 56: 
1023–1027.
3. Gendiagnostik-Kommission beim robert Koch-Institut (2013) 
richtlinie der Gendiagnostik-Kommission (GeKo) für die beurtei-
lung genetischer eigenschaften hinsichtlich ihrer bedeutung nach 
§ 15 abs. 1 satz 1 GenDG für eine beeinträchtigung der Gesundheit 
des embryos oder des fötus während der schwangerschaft oder 
nach der Geburt gemäß § 23 abs. 2 nr. 1d GenDG. bundesgesund-
heitsbl – Gesundheitsforsch – Gesundheitsschutz 56: 1028–1029.
4. Gendiagnostik-Kommission beim robert Koch-Institut (2013) 
richtlinie der Gendiagnostik-Kommission (GeKo) für die anfor-
derungen an die Inhalte der aufklärung bei genetischen unter- 
suchungen zu medizinischen Zwecken gemäß § 23 abs. 2 nr. 3 
GenDG. – zuletzt geändert am 16.11.2012.bundesgesundheitsbl – 
Gesundheitsforsch – Gesundheitsschutz 56: 326–331.
5. Gendiagnostik-Kommission beim robert Koch-Institut (2013) 
tätigkeitsbericht der Gendiagnostik-Kommission (GeKo) für den 
Zeitraum 19.11.2009 bis 31.12.2012. http://www.rki.de/De/content/
Kommissionen/GendiagnostikKommission/taetigkeitsbericht/ 
taetigkeitsbericht_01.html. Zugegriffen: 28 Januar 2016.
MeMbers froM MeDIcIne anD bIoLoGY ~ Prof. Dr. Gabriele Gillessen-Kaesbach (Deputy) (Prof. Dr. Reiner Siebert) ~ Prof. Dr. ute felbor  
(Prof. Dr. Bernd Wollnik) ~ Prof. Dr. thomas eggermann (Dr. Simone Heidemann) ~ Prof. Dr. Konstantin Miller (Prof. Dr. Eva Klopocki) 
Prof. Dr. heike bickeböller (Prof. Dr. Konstantin Strauch) ~ Prof. Dr. Michael neumaier (Prof. Dr. Karl Lackner) ~ Prof. Dr. Mariam Klouche  
(Dr. Astrid Petersmann) ~ Prof. Dr. Karl oliver Kagan (Prof. Dr. Rita Schmutzler) ~ Prof. Dr. heymut omran (Dr. Uta Nennstiel-Ratzel MPH) 
Prof. Dr. Julia Mayerle (Prof. Dr. Dr. Ingolf Cascorbi) ~ Prof. Dr. Gabriele Leng (Prof. Dr. Thomas Brüning) ~ Prof. Dr. thomas Kirchner  
(Prof. Dr. Ruth Knüchel-Clarke) ~ Prof. Dr. rüdiger Lessig (Prof. Dr. Peter Schneider)
MeMbers froM LaW anD ethIcs ~ Prof. Dr. henning rosenau (Head) (Dr. Regine Cramer) ~ PD Dr. Dagmar schmitz (PD Dr. Andreas Vieth)
rePresentatIon of PatIent anD consuMer orGanIZatIons anD DIsabILItY orGanIZatIons ~ Dr. Katrin Grüber  
(Prof. Dr. Jeanne Nicklas-Faust) ~ Prof. Dr. regine Kollek (Prof. Dr. Raimund Geene) ~ uta Wagenmann (Dr. Wolfgang Wodarg)
MeMbers ~ Prof. Dr. Dr. Marianne abele-horn (Head) ~ Dr. Dr. Katja de With (Deputy) ~ Prof. Dr. attila altiner ~ Prof. Dr. alexander friedrich 
Dr. anette friedrichs ~ Dr. annegret Krenz-Weinreich ~ Prof. Dr. stephanie Läer ~ Prof. Dr. stefan Maier ~ Dr. elisabeth Meyer ~ Prof. Dr. rainer Müller
Dr. Wiltrud Probst ~ Prof. Dr. barbara schmidt ~ Prof. Dr. horst schroten ~ Prof. Dr. Julia seifert ~ Prof. Dr. esther von stebut-borschitz 
Prof. Dr. Klaus unertl
Publications
1. stebut-borschitz, esther (2015) Infektiologische Leitlinien:  
einige veraltet, neue fehlen, Deutsches Ärzteblatt 112 (50): a–2134.
2. Kommission art (2015) bestandsaufnahme, bedarfsanalyse  
und notwendige Verbesserungen für die entwicklung und Über-




3. Kommission art (2015) Infektionserreger und ihre resistenzen 




4. Kommission art (2014) antiinfektiva und resistenzen:  
Gesundheitsgefahren wirksam begegnen- http://www.rki.de/De/
content/Kommissionen/art/Positionspapier/Positionspapier_
inhalt.html – Zugegriffen 12.01.2016.
5. Kommission art (2014) Grundsätze der antibiotika-therapie. 
http://www.rki.de/De/content/Kommissionen/art/Links/ 
Grundsaetze-der-therapie.html . Zugegriffen 12.01.2016.
Commission on Genetic Testing
The Commission on Genetic Testing (GEKO) is an interdisci-
plinary, independent commission based on the Act on Genetic 
Testing  (Gendiagnostikgesetz;  GenDG).  This  act,  effective 




genetic  examinations  for  medical  purposes,  for  parentage 
and  descent  matters  and  genetic  testing  in  insurance  and 
employment sectors. The act does not cover  tumour genetic 



















information specialist.                  www.rki.de/geko-en
The  commission  ART  consists  of  currently  16  independent 
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MeMbers ~ Prof. Dr. Petra Kolip (Head) ~ Prof. Dr. susanne Wurm (Deputy) ~ Dr. Lutz altenhofen ~ Prof. Dr. eva bitzer ~ Dr. andreas böhm 
Prof. Dr. helmut brand ~ Dr. elke bruns-Philipps ~ Prof. Dr. raimund Geene ~ Dr. Michael hägele ~ Prof. Dr. Wolfgang hoffmann 
Prof. Dr. uwe Koch-Gromus ~ Prof. Dr. adelheid Kuhlmey ~ Dr. Joseph Kuhn ~ Prof. Dr. oliver razum ~ Prof. Dr. steffi riedel-heller 
Dr. sebastian schmidt-Kähler ~ Dr. enno swart ~ Prof. Dr. ute thyen ~ Prof. Dr. Jürgen Windeler
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Publications
1. bergmann Kc, heinrich J, niemann h (2016). current status  
of allergy prevalence in Germany. allergo Journal International, 
25(1), 6–10.
2. Moderne Lichtquellen (2015). empfehlung der Kommission 
umweltmedizin am robert Koch-Institut zu Moderne Lichtquellen. 
amtliche Mitteilung. bundesgesundheitsbl, 58, 1171–1174.  
DoI 10.1007/s00103-015-2215-5.
3. hygienehypothese (2014). stellungnahme der Kommission 





4. Klimawandel und Gesundheit allgemeiner rahmen zu handlungs-
empfehlungen für behörden und weitere akteure in Deutschland 
(2013). online unter: http://www.rki.de/De/content/Kommis-
sionen/umweltKommission/aktuelle_Informationen/Downloads/
klimawandel_gesundheit_handlungsempfehlungen_2013.pdf?__
blob=publicationfile. Zuletzt abgerufen 10.03.2016.
MeMbers ~ Prof. Dr. claudia hornberg (Head) ~ Prof. Dr. annette Peters (Head) ~ Prof. Dr. Karl-christian bergmann  
Prof. Dr. Wolfgang Dott ~ Prof. Dr. thomas eikmann ~ Dr. Joachim heinrich ~ Prof. Dr. caroline herr ~ PD Dr. astrid heutelbeck  
Prof. Dr. barbara hoffmann ~ Prof. Dr. Volker Mersch-sundermann ~ Prof. Dr. Dennis nowak ~ Dr. Matthias otto  
Dr. Michael schümann ~ Prof. Dr. Gerhard andreas Wiesmüller






The  task of  the committee  for Environmental   Medicine, 
appointed by the Federal Ministry of Health (BMG) in 2012, 
is  to advise  the Robert Koch  Institute  (RKI)  and  the Federal 
Environment  Agency  (UBA)  on   environment-related  health 











The  committee  consists  of  15  members  who  are  rec-
ognized experts  in  the area of health  sciences/public health, 
environmental  epidemiology  and  environmental  medicine. 
The committee is appointed for a period of four years. Appoint-
ments for a second term will be conducted in 2016. A central 
office,  associated  with  RKI’s  unit  24,  provides  administrative 
and scientific support to the committee.              www.rki.de/cem




















“Over the past decades,  
the health surveys by Robert Koch  
Institute have been a very  
successful means to improve the  
availability of data for health  
reporting. Federal Health Reports  
are an excellent basis to  
formulate recommen dations  
for action and to monitor public  
 health policy.”
 Prof. Dr. Petra Kolip
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Competence and Treatment Centres for Highly 
Contagious and Life-threatening Diseases
STAKOB  denotes  the  Permanent  Working  Group  of  Com-
petence  and  Treatment  Centres  for  Highly  Infectious  and 
Life-threatening  Diseases.  STAKOB  brings  together  experts 
for  public  health  preparedness  and  response  as  well  as  for 
the  clinical  treatment  of  patients  with  highly  contagious 
and  life-threatening  diseases.  The  STAKOB  office  at  the 
 Robert  Koch Institute supports the work of the working group.
Treatment centres in Germany





InternaL MeMbers (feDeraL InstItutes) ~ Prof. Dr. Werner Knöss, bfarM ~ PD Dr. thomas sudhop, bfarM ~ Dr. Guido nöcker, bZga 
Dr. stefanie Weber, DIMDI ~ Prof. Dr. stefan Viehts, PeI ~ Prof. Dr. eberhard hildt, PeI ~ Dr. anke-christine saß, rKI ~ PD Dr. Lars schaade, rKI
externaL MeMbers ~ Prof. emer. Dr. Manfred P. Dierich ~ Dr. suzan fiack ~ Dr. P. h. Dr. Günter Pfaff ~ Prof. Dr. Dr. uwe Koch-Gromus 
Dr. Joseph Kuhn ~ Prof. Dr. Iris Pigeot ~ Dr. Ingrid schubert ~ Dr. Wolfgang straff ~ Prof. Dr. stefan uhlig ~ Prof. Dr. rüdiger von Kries
Editorial Board of the Bundesgesundheitsblatt 
The public health journal “Bundesgesundheitsblatt – Gesund-
heitsforschung  –  Gesundheitsschutz”  is  published  monthly 




up-to-date  information  on  significant  developments  and  on 
 specific  measures  for  health  protection,  prevention  concepts, 
risk prevention and health promotion. It covers a broad spec-
trum of topics, ranging from infection prevention, epidemiology 









are  being  elected  every  four  years.  In  this  process,  present 
members can be reelected or new members can be appointed. 
The members of the editorial board meet with the  editors 
twice  a  year  to  discuss  key  topics  for  the  following  journal 
issues.  The  editorial  office  of  the  “Bundesgesund heitsblatt” 
is located at the Robert Koch Institute. The  responsible editor 
in chief  is Dr. Heidemarie Rohdewohld, who  is  temporarily 
replaced by Sara Preisetanz. 
Training  is  offered  continuously  both  in  the  use  of  personal 
protective equipment and in technical measures and skills to 
prevent infection. Quality standards are developed to ensure 








consistent  minimum  requirements  on  technical  equipment 
and staff training apply in all centres.           www.rki.de/stakob-en
Competence centres in Germany
The STAKOB competence centres operate within the German 















category  “Top  publications  –  German”.  Moreover,  it  is 
indexed  in  Medline,  Science  Citation  Index  Expanded  and 
Scopus. In 2009, the journal received its first impact factor. 
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treatMent centres (IsoLatIon unIts) ~ charité university hospital berlin ~ Düsseldorf university hospital 
university hospital frankfurt ~ university Medical centre hamburg-eppendorf ~ st. Georg hospital Leipzig ~ Municpal hospital schwabing, Munich
robert bosch hospital stuttgart
coMPetence centres (PubLIc heaLth authorItIes) ~ berlin (state Public health authority) ~ frankfurt (centre of competence for highly  
Pathogenic agents) ~ hamburg (Institute for hygiene and environment) ~ Leipzig (Public health authority) ~ München (bavarian health and 
food safety authority, Munich Public health authority) ~ Münster (nrW centre for health) ~ stuttgart (baden Wuerttemberg state health office)
traInInG centres ~ charité university hospital berlin ~ university Medical centre hamburg-eppendorf ~ st. Georg hospital Leipzig 
Würzburg Medical Mission hospital, Department of tropical Medicine
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influenza,  including  the  update  of  the  scientific  part  of  the 




demic  have  been  incorporated,  such  as  preparing  a  flexible 





health of  the German population  in  a  future pandemic  and 
to  mitigate  the  overall  effects  of  a  pandemic.  The  executive 
 secretariat  of  the  RKI  Expert  Advisory  Board  on  Influenza 
is part of unit 36.                       www.rki.de/eab-influenza
MeMbers ~ Dr. ruth offergeld (Head) ~ Dr. bärbel baumann-baretti ~ Prof. Dr. Gregor bein ~ Prof. Dr. rainer blasczyk
Prof. Dr. Martin bornhäuser ~ PD Dr. Gerald Dietrich ~ Prof. Dr. Jochen erhard ~ angelika Gerber ~ Dr. susan halimeh ~ Prof. Dr. Walter hitzler
Prof. Dr. Jörg hofmann ~ PD Dr. Kristina hölig ~ Dr. Gabriele hutschenreuter ~ Dr. reinhard Kasper ~ PD Dr. Dr. frank Kipp  
Dr. harald Krebs ~ thomas Kreil ~ Matthias Meyer ~ Prof. Dr. thomas Müller ~ Prof. Dr. Johannes oldenburg ~ Prof. Dr. hans-hartmut Peter 
Dr. Karl-heinz Pick ~ Prof. Dr. stefan ross ~ Prof. Dr. rüdiger scharf ~ Dr. Maria scho-backes ~ Dr. Kirsten seidel ~ Prof. Dr. Dr. erhard seifried
Prof. Dr. Michael spannagl ~ Dr. uwe taborski ~ Prof. Dr. Jörg timm ~ Dr. Wolfgang Voerkel ~ Prof. Dr. christian von heymann 
Dr. franz Weinauer ~ Dr. annett Zielosko
National Advisory Committee Blood
The  National  Advisory  Committee  Blood  (AK  Blut)  advises 
the  federal  authorities  and  the  authorities  of  the  Federal 
States  (Länder)  on  the  most  appropriate  ways  to  ensure 
the safety of blood, blood products and cells  for  transfusion 
as laid down in the Transfusion Act. This includes advice on 
microbiological  safety,  emerging  pathogens,  donor  selec-
tion,  and  standards  for  training  in  transfusion  medicine. 
The committee takes into account the need to maintain adequate 
supplies of blood and blood products of appropriate quality. 


























the  RKI-president’s  office.  The  main  task  of  the   secretariat 
is  the preparation and  the documentation of  form and  con-













1. arbeitskreis blut (2015) humanes Immunschwächevirus. bundes-
gesundheitsbl 58: 1351–1370.
2. Pauli G, aepfelbacher M, bauerfeind u et al. (2015) hepatitis e 
Virus transfus Med hemother 42(4): 247–265. 
3. arbeitskreis blut (2015) bewertung von apherese- und Pool- 
thrombo zytenkonzentraten. bundesgesundheitsbl 58: 1126–11128.
4. arbeitskreis blut (2015) hygienebedingungen bei  
spende pro zessen und deren mikrobiologische Überwachung.  
bundes gesundheitsbl 58: 1346–1348.
5. arbeitskreis blut (2015) stellungnahme zur Gewinnung und nutzung 
von rekonvaleszentenplasma (rKP) als therapieoption bei aus-
brüchen schwerer Infektionen. bundesgesundheitsbl 58: 1371–1377.
“We can’t predict  
when the next  
influenza pandemic  
will happen but  
we are planning our  
response based  
on sound scientific  
evidence.”
Prof. Dr. Lothar H. Wieler
 “Safe blood for  
patients in Germany.” 
 Dr. Ruth Offergeldthe scientific part of the national Pandemic Preparedness Plan is also published on the rKI 
website www.rki.de/pandemieplanung
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MeMbers ~ Prof. Dr. Lothar h. Wieler (Head) ~ Dr. bernhard bornhofen ~ PD Dr. roswitha bruns ~ Prof. Dr. Petra Gastmeier  
Prof. Dr. timm harder ~ Prof. Dr. ulrich hartenauer ~ Prof. Dr. eberhard hildt ~ Prof. Dr. hanna Kaduszkiewicz  
Peter Lang ~ regine Lehnert ~ Prof. Dr. thomas Mertens ~ Prof. Dr. Georg Peters ~ Prof. Dr. Mathias Pletz ~ Prof. Dr. tom schaberg  
Prof. Dr. horst schroten ~ Prof. Dr. Peter stäheli
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National Certification Committee for  
Poliomyelitis Eradication in Germany












in  the  area  meet  specified  criteria:  1)  absence  of  indigenous 
wild poliovirus (WPV) transmission for at least three consec-
utive  years  monitored  by  a  sensitive,   certification-standard 
surveillance such as Acute Flaccid Paralysis (AFP) surveillance, 
environmental  surveillance  or  enterovirus  (EV)  surveillance; 
2)  ensure  highest  possible  immunity  levels;  3)  capacity  to 
detect,  report,  and  rapidly  respond  to  any  imported  WPV; 
and  4)  implementation  of  containment  measures  according 
to the global action plan for laboratory containment of WPV. 
The WHO European Region was certified polio-free in 2002. 
The  member  states  have  committed  themselves  to  take  all 
required measures to survey and preserve this status until the 
global eradication will be achieved. Each country has an inde-
pendent  National  Certification  Committee  (NCC)  to  collect, 
verify  and  submit  country  documentation  related  to  polio 
 eradication activities to WHO.
Publications
1. Matysiak-Klose D, razum o: Quo Vadis Germany? the German 
national Verification committee for Measles and rubella.  
bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz  
2013; 9: 1293–1296.
2. naVKo 2015: annual update on Measles and rubella elimination 
status for 2014. online available at: http://www.rki.de/De/ 
content/Kommissionen/naVKo/berichte/bericht_2014_en.
pdf?__blob=publicationfile. accessed on 11.01.2015.
3. naVKo 2014: annual update on Measles and rubella elimination 
status for 2013. online available at: http://www.rki.de/De/ 
content/Kommissionen/naVKo/berichte/bericht_2013_en.
pdf?__blob=publicationfile. accessed on 11.01.2015.
4. naVKo 2013: Methodology of the national Verification commis-
sion (in German). online available at: http://www.rki.de/De/
content/Kommissionen/naVKo/Methodik/Methodik.pdf?__
blob=publicationfile.
5. razum o, Matysiak-Klose D, Kouros b: elimination von  
Masern und röteln: Keine signifikante Verbesserung. Dtsch 
arztebl 2016; 113(14): a-646 / b-543 / c-538. online available at: 
http://www.aerzteblatt.de/archiv/175666.
MeMbers ~ Prof. Dr. oliver razum (Head) ~ Prof. Dr. Dr. sabine Wicker (Deputy) ~ Dr. cornelia betsch ~ Prof. Dr. heidemarie holzmann
Prof. Dr. bijan Kouros ~ Dr. Jürgen rissland ~ Dr. Martin terhardt ~ Prof. Dr. birgitta Weltermann
MeMbers ~ Dr. fabian feil (Head) ~ Dr. Konrad beyrer (Deputy) ~ Dr. alexandra barth ~ Prof. Dr. hans-Iko huppertz ~ Dr. Klaus Jahn  
Dr. Gunhild Kilian-Kornell ~ Prof. Dr. thomas Mertens ~ Prof. Dr. uta Meyding-Lamadé ~ Prof. Dr. ulrike schara ~ Prof. Dr. Peter Wutzler
National Verification Committee for Measles 
and Rubella elimination in Germany
Since 1984 the World Health Organization (WHO) European 
Region pursues the goal to eliminate measles. In 2005, it was 
decided  to  stop  also  endemic  transmission  of  rubella-virus, 















































“Based on several indicators 
and outbreak reports we must 
conclude that measles is  
still a public health problem 
in Germany. Activities  
should be enhanced by  
all stakeholders to attain the 
 goal of elimination.” 
 Prof. Dr. Oliver Razum
and rubella in Germany and data on vaccination coverage and 
the immunity of the German population against measles and 
rubella  in order  to assess  the progress achieved with  regard 
to  elimination  goals.  Furthermore,  the  committee  evaluates 
if the available data are sufficient or contain inconsistencies, 
assesses  the quality of  surveillance,  evaluates  the  success of 
implemented key strategies, and advises on activities related 
to  the verification of  the elimination process  in  the country. 
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“It is a privilege  
as well as an obligation 
for all of us to  
be an active partner  
on the way to a  
 world without polio!”
 Dr. Fabian Feil
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Scientific Advisory Board for Public  
Health Microbiology
For effective control of  infectious diseases  in Germany,  it  is 












account  European  and  international  reference  structures, 
 particularly with regard to demand for certain diagnostic areas, 
nominating  possible  candidate  laboratories  and  conducting 
regular evaluations. 
In making  its  recommendations  the Scientific Advisory 
Board for Public Health Microbiology has an advisory  function 




by  the RKI  for periods of  three years. The members of  this 
advisory  board  are  renowned  experts  in  the  fields  of  micro-
Publications
1. standard operating Procedure of the German standing  
committee on Vaccinations (stIKo) for the systematic development 
of vaccination recommendations. Version 2.0. february 6, 2014. 
online available at: www.stiko.de/en. 
2. Pfleiderer M, Wichmann o (2015) from the licensure of vaccines 
to the recommendation of the standing committee on Vaccination 
in Germany: criteria for the assessment of benefits and risks.  
bundesgesundheitsblatt – Gesundheitsforschung – Gesundheits-
schutz, 58: 263–273.
3. stIKo (2015) Mitteilung der ständigen Impfkommission am  
robert Koch-Institut (rKI). empfehlungen der ständigen Impf-
kommission (stIKo) am robert Koch-Institut/stand: august 2015. 
epidemiologisches bulletin 34. online available at:  
www.stiko.de/en.
4. schaade L, Widders u, stange G, höhl n (2009) Vaccination  
recommendations of the standing committee on Vaccination  
at the robert Koch Institute. Legal basis and significance.  
bundesgesundheitsblatt – Gesundheitsforschung – Gesundheits-
schutz 52: 1006–1010.
MeMbers ~ Dr. Jan Leidel (Head) ~ Prof. Dr.rüdiger von Kries (Deputy) ~ Prof.Dr. hilke bertelsmann ~ Prof. Dr. christian bogdan 
Prof. Dr. edeltraut Garbe ~ Prof. Dr. ulrich heininger ~ Prof. Dr. hartmut hengel ~ Prof. Dr. eva hummers-Pradier ~ Prof. Dr. stefanie J. Klug 
Prof. Dr. thomas Ledig ~ Dr. Martina Littmann ~ Prof. Dr.thomas Mertens ~ Dr. Marianne van der sande ~ Dr. Martin terhardt 
Prof. Dr. thomas Weinke ~ Prof. Dr. sabine Wicker ~ Prof. Dr. fred Zepp
MeMbers ~ Prof. Dr. franz allerberger (Head) ~ Dr. angela Wirtz (Deputy) ~ Prof. Dr. barbara Gärtner ~ Prof. Dr. Petra Gastmeier 
Prof. Dr. Gerhard haase ~ Dr. Dr. christoph Königs ~ Dr. Dr. Günther Pfaff ~ Prof. Dr. theresia Popow-Kraupp ~ Prof. Dr. Gernot rohde 
Prof. Dr. Martin schaller ~ Dr. Gabriele schönian ~ Prof. Dr. barbara spellerberg ~ Prof. Dr. Manfred Wildner ~ Dr. nicoletta Wischnewski
Publications
1. beermann s, allerberger f, Wirtz a, burger r, hamouda h:  
Public health microbiology in Germany: 20 years of national  
reference centres and consultant laboratories. Int J Med Microbiol 
2015; 305 (7): 595–600.
2. Vogel u, beermann s, Gerlich W, et al.: twenty years of national 
reference and consultant laboratories for infectious diseases  
in Germany. Int J Med Microbiol. 2015; 305 (7): 591– 594.
3. Laude G, Kist M, Krause G: referenznetzwerke aus nationalen  
referenzzentren mit assoziierten Konsiliarlaboratorien in 
Deutschland. bundesgesundheitsbl 2012; 55: 223–230.
Standing Committee on Vaccination
The  German  Standing  Committee  on  Vaccination  (STIKO) 
is  an  independent  advisory  group  which  is  responsible  for 
the  development  of  national  vaccination  recommendations. 





microbiology,  virology,  immunology,  epidemiology,  public 
health, and evidence-based medicine.
STIKO holds at least two closed meetings every year. As 
permanent  guests,  representatives  of  the  RKI,  the  Federal 
Ministry  of  Health,  the  Federal  States,  the  national  regula-
tory  authority  (Paul-Ehrlich-Institute),  the  Federal  Centre 
for  Health  Education  (BZgA),  the  Federal  Joint  Committee 
(G-BA),  the  Federal  Foreign  Office,  and  the  Federal  Armed 
Forces participate in the meetings without voting rights.
The  executive  secretariat  of  STIKO  is  located  at  RKI’s 
Immunization unit. The secretariat performs systematic reviews 
and meta-analyses of the scientific evidence, and drafts back-
ground  papers  for  new  STIKO  recommendations  in  close 
collaboration with STIKO’s thematic working groups. The sec-
retariat prepares the meetings in cooperation with the STIKO 
chairperson,  and  responds  to  requests  from  the  medical 
 community and media related to STIKO recommendations. 
Since  2012,  the  STIKO  follows  a  standard  operating 










Department  of  Infectious  Disease  Epidemiology  at  the  RKI. 
It assists and coordinates all activities of the advisory board. The 
scientific office – Dr. Osamah Hamouda, Dr. Markus  Kirchner 
and  Dr.  Sandra  Beermann  –  also  technically  supervises  the 





phenomena,  or  likely  shifts  in  the  age  distribution  of  cases 
acquiring the target disease if a vaccination program is imple-
mented.  In  addition,  STIKO  may  integrate  the  results  of 
economic  evaluations  in  its  decision-making  process  if  the 
studies are applicable to the German healthcare setting [1, 2]. 
STIKO  updates  and  publishes  its  recommendations 
once  per  year  (usually  in  August,  see  latest  version:  [3]). 
 Recommendations  of  STIKO  form  the  basis  for  the  federal 
states’ vaccination guidance and G-BA’s vaccination directive 
[4]. The latter stipulates which vaccinations are covered by the 
health insurance plans.                     www.stiko.de/en
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 “Working to improve  
the efficiency and collaboration  
of public health expert labs.”
Dr. Franz Allerberger
“A systematic and  
evidence- based approach is  
needed when developing  
vaccination recommendations.  
It not only improves the  
quality of the recommendations,  
but it also contributes to  
trans parency and the acceptance  
of the recommendation in  
the professional community  
 and the public.”
 Dr. Jan Leidel
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Central Services
The significance of the unglamorous
When you think of the Robert Koch Institute (RKI), its service 
units  are  certainly  not  among  the  first  that  come  to  mind. 
However,  without  the  unremitting  work  of  more  than  150 
employees in the central administration performing unglam-
orous  tasks,  the  Robert  Koch  Institute  would  simply  not  be 
functional: concluding employment contracts, calculating sala-
ries, placing orders, paying bills, securing third-party funding, 









in  action  to  better  serve  the  public.  For  the  Central  Service 
Department at the Robert Koch Institute, this means providing 
the best possible environment and  the best service available 
for  our  scientific  departments  while  strictly  observing  and 
sometimes implementing rules and regulations.
125 years of central administration: from authority to service
The rich history of the Robert Koch Institute is also reflected 
in its central administration department. The  administration’s 
















procurement;  construction,  physical  plant  &  technology; 
information  technology  (IT)  and  organization,  and  internal 
services – in the following chapters.
Smooth running: the Central Services Department today
Our five units manage and maintain the assets, financial and 












All  rules  and  regulations  of  a  higher  federal  authority 
apply directly to the Robert Koch Institute. They are the foun-




of  our  specialised  departments,  who  wish  to  recruit  new 
 personnel, procure consumables, place orders, raise and use 
external funding, be provided with a good IT-equipment and 
who  wish  to  utilise  state-of-the-art,  smoothly  running  labo-
ratories and  laboratory services as effectively and, of course, 
as soon as possible.
It  is  our  duty  to  strictly  observe  public  services  and 
 collective bargaining  laws,  the  federal budget code, procure-









the personnel of  the entire  institute and provides  the  finan-
cial  budgets  for  the  scientific  departments  according  to  the 



















that  guides  our  daily  actions  and  sets  the  standards  for  our 
management and our executives: we act efficiently and shape 
the change.







 Ω We  are  a  socially  competent  team  and  set  high  value  on 
friendly and courteous demeanour.






of service.                     www.rki.de/zv-en
heaD of DePartMent ~ Dr. anke engelbert
aDMInIstratIVe staff ~ bettina raabe ~ uwe schäfer
heaDs of unIts ~ silvia schuckert ~ Marina Pioch ~ Detlef reichenbacher ~ Dr. Michael Goltz (Deputy Head of Department)  
Ines abramowitsch
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ZV 1: Human Resources 
The Human Resources Unit takes care of all aspects  relating 
to  employment,  from  recruitment  to  retirement.  It  offers 
 competent and comprehensive advice and information about 







Human  Resources  development  continues  to  further  the 
advancement  of  flexible  employment  models.  Contracts 
 providing  flexitime  and  part-time  work,  including  telecom-
muting  and  mobile  computing,  creating  a  corresponding 
framework for meeting the needs of individual employees.




educational,  training  and  qualification  measures.  Training 
needs assessment is carried out annually. The results provide 
the  basis  for  RKI’s  annual  internal  education  and  training 
programmes. Employees are  also encouraged  to  take part  in 
external qualification programmes.
Operational health management 








Demographic change and intergenerational human  
resources’ policy 
The Robert Koch Institute is actively addressing the challenges 









learning  and  takes  into  consideration  that  varied  experiences 
mean  every  generation  learns  in  its  own  way.  As  a  result, 
user-oriented and self-directed education and training are sup-
ported. In short, the institute and our employees are oriented 
towards demographic  change  through a  range of measures, 
projects and events.





MeMbers ~ silvia schuckert (Head) ~ christine steinicke (Deputy) ~ Marianne ehlert ~ Maureen fechner ~ anna-rebecca friedrich  
Jürgen Grunzke ~ heike henkel ~ björn Kersten ~ Kerstin Kunke ~ sabine Liedtke ~ Katrin Löffler ~ Melanie Loppaschewski ~ carsten Maurer 
rosika Moll ~ Katrin otter ~ christiane Plath ~ David rohde ~ susanne schaller ~ Juliane schmelzer ~ susanne schönrock 
christina sorge ~ ralf tischendorf ~ Gesa Woschkeit ~ sylvia Wustmann 
traInees (rKI) ~ sina ackermann ~ Leyla al-sabbagh ~ Julia almonat ~ Duygu Demirel ~ esra firat ~ sarah friedländer ~ Pauline Gau 
Kevin Große ~ Jennifer Gubi ~ Danilo Günzel ~ David haney ~ Maxi heinrich ~ Julian heinze ~ salina heyduk ~ edin hrstic ~ Kevin Jacobi 
hannes Jarmuth ~ Marcella Jung ~ sarah Kallweit ~ Kim-Laureen Kämmer ~ asena Kiani ~ Michelle Kilz ~ florian Klocke ~ andre Kötschau
henning Krüger ~ nikita Kuzjaev ~ ulrike Mathis ~ Julia Mitschke ~ conny Müller ~ Daniel Muth ~ Phuong nguyen ~ Janina Pautsch 
Louisa Pfefferkorn ~ Maximilian Prohl ~ helen reibstirn ~ Petr rotkang ~ Katja schulze ~ Juliette schuster ~ franz stephan ~ Viktoria streib 
sabrina tanz ~ antje thiel ~ Jennifer torge ~ robert trojaner ~ beatrice ueberholz ~ felix Walper ~ florian Welteroth
MeMbers ~ Marina Pioch (Head) ~ Gabriela Merzdorf (Deputy) ~ hüzzam atay ~ franziska bading ~ sven bärwald ~ Dennis behs
Marco breninek ~ sabine busch ~ Gülsüm Deliorman ~ ann-christin fritzsche ~ Marion Gotthardt ~ theresa hille ~ Martina Jaensch
birgit Klitzke ~ floronce Lindner ~ Danica Mende ~ andreas Merzdorf ~ Martina Montag ~ Petra neitzel ~ Katja neumüller ~ Kristin ochmann
Marcus Piotrowski ~ Jessyca Pötter ~ christian retzlaff ~ Joanna schultze ~ christian schumacher ~ fabian strohecker ~ hans-Peter strohecker
axenia treichel ~ Dana Zenke ~ elisabeth Zielinski
ZV 2: Budget and Procurement  
Budget/Procurement
The Budget and Procurement Unit’s main tasks are  budgetary 
planning,  budget  implementation,  accounting  and  the  pro-
curement  of  goods.  In  addition  to  budgetary  resources, 
the  unit  also  administers  third-party  funds  that  have  been 
received by scientists for their research work. Depending on 
third-party  funding  volumes,  the  unit  manages  budgetary 
resources that annually amount to more than EUR 80 million. 




Each  year  the  Accounting  team  processes  thousands  of 





Third-Party Funding Administration 
The  Third-Party  Funding  Administration  team  supports 
 scientists  in  managing  and  accounting  for  research  funds 
that  have  been  received  from  third  parties.  The  team  helps 
to prepare a large number of financial plans and requests for 
amendments  and  prolongations  of  project  periods.  It  also 
provides  actual  cost  reports  documenting  how  third-party 
funding is used. It also documents the conclusion of projects. 
Third-Party  Funding  Administration  processes  incoming 
invoices for goods and services that are procured with third-
party  funds.  It  also  files  outgoing  invoices  and  accounts 
for third-party funding income. 
Procurement/Materials Administration 
The  Procurement/Materials  Administration  team  processes 
around  9,000  orders  annually.  In  addition  to  conventional 
price  enquires,  the  team  prepares  national  or  EU-wide 
 invitations to tender. The affiliated materials administrations 
are  made  up  of  the  central  receiving  areas  for  all  incoming 
goods  at  each  institute  location.  Their  stocks  ensure  that 
 supplies are continually available to both the institute’s offices 
and laboratories.                   www.rki.de/zv2-en 
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Furthermore,  the unit handles  the contractual and   technical 
support  of  the  cafeteria  and  its  leaseholders.  It  also  is 
responsible  for  the  coordination  and  processing  of  property 
management  and  occasionally  works  in  cooperation  wi th 
Germany’s Federal Real Estate Authority,  the Bundesanstalt 
für Immobilienaufgaben (BImA). Printing is another  special 
service,  as  is  carrying  out  the  administrative   processing  of 
applications  in  accordance  with  Germany’s  genetic  tech-
nology  laws  (Gentechnikgesetz  (GenTG))  and  biological 
materials   regulations (Biostoffverordnung (BioStV)). Among 
other  services offered are: 




















MeMbers ~ Detlef reichenbacher (Head) ~ Karl-heinz rothe (Deputy) ~ Madeleine antoniak ~ andré aulich ~ Karsten bergtich ~ Julia braune
Wolfgang brüchert ~ sven eggert ~ Mario exner ~ arne fix ~ Mario fritsche ~ Wolfgang Gajewski ~ rené Gürtler ~ ulrich haskamp ~ salina heyduk
Philippe Jardin ~ hannes Kamin ~ sascha Klatt ~ Karola Klein-Mehling ~ olaf Köppe ~ florian Loncle ~ Detlef neumann ~ Wolfgang niehof
harald niemietz ~ olaf rogge ~ uwe sack ~ Marko schmidt ~ thomas schramm ~ andrea schuckert ~ udo schulze ~ Gerd tielke
tom Wandslebe ~ tobias Witing ~ alexander Wolff
MeMbers ~ Dr. Michael Goltz (Head) ~ Wolfgang Weigelt (Deputy) ~ christian baars ~ Dr. Karen bade ~ anja bartelt ~ cornelia bartz 
sven bergholz ~ stefan biere ~ olaf bindszus ~ robert Denker ~ Wolfgang erlemeyer ~ Matthias fiedler ~ saskia fuhrmann ~ Gunter Gebhardi
anke Giesemann ~ Detlef Groth ~ benjamin häringer ~ Matthias heyn ~ thomas Jänicke ~ florian Kientz ~ ralf Kirsch ~ reinhard Klingenberg
Vivi Lieu ~ Matthias Loose ~ andrea Meister ~ Doreen Michaelis ~ christian nitsche ~ ada nitze ~ roabi saman ~ christiane saynisch
Martin schwark ~ Marco sieslack ~ Petros stathakis ~ Pascal steinberg ~ tobias strunz ~ tim Vargas ~ Dr. Michael Voigt ~ robert Vonderwolke
Dr. thomas Wiebach
ZV 4: Information Technology, Organisation 
and Controlling
Information Technology (IT)
The  unit  for  Information  Technology  (IT)  takes  care  of  the 
essential  information  and  communication  technology  (ICT) 
infrastructure required to process tasks relevant for the insti-
tute’s  work.  Continually  furthering  the  development  of  this 
infrastructure  within  the  scope  of  the  institute’s  changing 
demands,  keeping  pace  with  technological  innovations  and 






Among  the  constant  challenges  faced  by  the  unit  is 
guaranteeing  IT  security  while  simultaneously  fulfilling 
the  scientific  need  to  transfer  data  and  information  within 
 Germany and abroad. 
The  unit  also  equips  workstations  with  stationary  and 
mobile PC systems, supplies software for them all and manages 
them  centrally.  Among  the  available  software  are  the  classic 
office applications as well as special applications, e.g. for labo-






and  meeting  high  demands  on  availability.  Various  virtualis-
ation technologies are also being applied. 
All the RKI’s locations are linked together via the institute’s 
central  IT  system  network.  For  both  data  and  voice  commu-




The  unit’s  administrative  responsibilities  also  include 
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ZV 5: Internal Services 
Internal  Services  administers  the  institute’s  real  estate  in 
Berlin and Wernigerode.  Its responsibilities  include, among 
other things: maintenance of exteriors and gardens by build-
ing  superintendents  and  groundskeepers,  management  of 





In  addition,  Internal  Services  manages  five  guest  apart-
ments and ensures the security of infrastructure on all properties. 




Real  Estate  Authority  the  (Bundesanstalt  für  Immobilien-




































Press, Public Relations, Library
One focus of this unit is media relations. The unit also coor-








Strengthening Global Health and Biosecurity
In order  to  fulfil political  commitments  the German govern-




work  of  the   German  Partnership  Programme  for  Excellence 
in Biological  and Health Security. For  further  informationen 
see page 135.











Administrative Office of the Commission on Genetic Testing
The  Administrative  Office  supports  members  and  deputy 
members in the outline, finalization and publication process 
of guidelines and written opinions based on the Act on Genetic 
Testing  (Gendiagnostikgesetz,  GenDG).  The  Administrative 
Office  organizes  the  Commission’s  general  and  working 













authority.  For  further  information  see  chapter  on  scientific 
committees (page 112).
MeMbers ~ Ines abramowitsch (Head) ~ Daniel robertson (Deputy) ~ Valentina aleksic ~ angelika altmann-hannig ~ Karoline aydin 
Petra baer ~ holger bindig ~ ulrich brandt ~ Monika bulik ~ Günter chruscz ~ Jasmine Dietrich ~ Irfan Djemaili ~ sabine eißrich 
habibe ersöz ~ burgitta ewert ~ Gerhard fuchs ~ Jovana Gabisch ~ Kornelia Gericke ~ Gabriela Gewert ~ andreas Golisch ~ helmut Görtz 
Lutz Grünheid ~ andré Guttzeit ~ birgit Guttzeit ~ steffen helmecke ~ Klaus hoffmann ~ Dagmar hornig ~ eveline hosse ~ andrea Jensen 
nurcan Kalayli-Kanat ~ Jolanta Kandziora ~ sabrina Kemp ~ claudia Kieselhorst ~ andreas Klinke ~ Janine Kohlschmidt ~ Mandy Kreienbring 
sabine Kretzschmar ~ Kristof Kronberg ~ christina Kropp ~ claudia Krüger ~ Martina Kuhr ~ nicolas Lehmann ~ Petra Leist ~ andreas Lorenz 
Manuela Lübcke ~ Phun Lullies ~ ronny Maciejewski ~ Jutta Masopust ~ Josef Matuschek ~ ulrike McLernon ~ uwe Meinhardt
renate Melisch-Gierok ~ christina Metzdorf ~ Marion Mielke ~ Katrin naschitzki ~ Michael niecke ~ annette niessen ~ figen onur
hardy Pietsch-Pofahl ~ norbert Pitscheck ~ Melina rathjen ~ sabina reichert ~ Gudrun riemenschneider ~ alexander riess ~ annett ruch 
Gerold ruf ~ stefanie schadow ~ sönke schipmann ~ Iris schlegel ~ nadja schlegel ~ christian schmidt ~ heike schulze 
antje schwappach ~ ruth stölzer ~ emine temür ~ nathalie tollard ~ Marija Vukadin ~ ute Weiss ~ Marina Wildner ~ Monika Wolf  
andrea Woolard ~ simone Zumkowski
   Central Services      
administrative office  
of the commission  
on Genetic testing, one  
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An example for GGBS’s joint activities was the organization 
of  a  ten-day  full-scale  simulation  exercise  in  2014  together 






response  force  is being established  to assist  in  the manage-
ment of  international  large scale public health   emergencies. 
The  teams  will  be  able  to  mobilize  the   capabilities  urgently 
needed on a modular approach – adapted to specific situations. 
Within  this  concept,  GGBS  is  assigned   to  coordinate  the 
 contributions from inside RKI.
GGBS  contributes  to  the  transformation  of  decisions 
from highest political levels to local action.  www.rki.de/gbs-en
MeMbers ~ Dr. Walter biederbick (Head) ~ sophie brödel ~ Dr. Luam Ghebreghiorghis ~ Dr. stefan Kloth ~ ramona-Maria Krnjaic  
Dr. olena Kysil ~ Judith Laske ~ Dr. Jana Wolf
Strengthening Global Health and Biosecurity
The governments of the G 8 countries agreed on their  summit 
in  Deauville  (2011)  to  bundle  their  activities  in  the  Global 
 Partnership  against  the  Spread  of  Weapons  and  Materials 
of  Mass  Destruction.  At  the  summit  in  Elmau  (2015),  the 
 countries  committed  themselves  to  offer  their  assistance  to 
countries implementing the International Health Regulations. 
In  order  to  fulfill  those  political  commitments  the  German 
 government  decided  to  assign  several  international  projects 
to  the  RKI.   RKI  established  Global  Health  and  Biosecurity 
(GGBS) to  implement related projects.
GGBS  is  coordinating  projects  funded  by  the  Foreign 
Office  within  the  framework  of  the  German  Partnership 










At  the  same  time,  GGBS  is  continuously  represented 
at  the  German  Federal  Foreign  Office’s  branch  for  WMD 
 disarmament  and  non-proliferation:  Besides  running  the 
program  office,  GGBS  staff  is  representing  the  programme 
towards partner- countries and external stakeholders but also 
providing scientific advice to the Federal Foreign Office.
Research Coordination /  
International Affairs
The  unit  Research  Coordination /International  Affairs  is 
directly assigned to the president of the Robert Koch  Institute. 
Primarily,  the unit supports  the management of  the   institute 
 by  taking  care  of  a  number  of  tasks  related  to  research,  be 
it   inquiries  from  the  Federal  Ministry  of  Health  or  other 
 institutions  or  the  implementation  of  quality  control  of  the 
 scientific work.
Research  Coordination  takes  care  that  the  schedule  of 






The  unit  also  serves  as  the  scientific  secretariat  for  the 
external   Scientific  Advisory  Committee  and  the  internal 
Research  Board.  The  formulation  of  the  research  agenda 






Board,  Research  Coordination  administers  the  grants  and 
supervises  the  projects.  The  yearly  granting  of  positions  for 
PhD students is also conducted by the unit.
Regular  evaluations  of  the  scientific  departments,  the 
 project  groups  and  the  junior  research  groups  are  organized 
by Research Coordination in order to maintain high scientific 
quality standards. Pivotal to these evaluations is a strong engage-




This  includes  detailed  advice  on  the  application  conditions, 
arranging the legal review of contracts, as well as examining 
and  approving  the  budgets  of  the  research   projects.  Close 
cooperation  within  a  cross-functional  support  team  for  the 




After  approval  all  international  third-funded  projects 
are  financially  administered  and  logistically  supported  by 
the unit. This comprises particularly  the supervision of  the 
financial resources of the research projects, the preparation 
of  financial  reports  and  the  conduct  of  internal  and 
external audits.
Besides  the  above-mentioned  activities  the  unit  is  the 
contact  point  for  international  collaborations  and  serves  as 
an  interface  between  institutions  abroad  and  the  internal 
 scientific coordinators.                       www.rki.de/fo-en
MeMbers ~ Dr. heinrich Maidhof (Head) ~ Dr. sigward von Laue (Deputy) ~ birgit arnold ~ Dr. nils Kirsch ~ Gülay Kizilkaya Güneser 
nadiya Özcelik ~ claudia stettnisch
 “From global  
politics to local  
   action.” 
  Dr. Walter Biederbick
 “We are proud that we can  
help our colleagues to  
conduct research work on the  
 highest possible level.”
 Dr. Heinrich Maidhof
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Press, Public Relations, Library
One focus of this unit is media relations. Effective media com-
munication is a key responsibility of public health  professionals. 
“Communicate  well  and  one  can  reach  more  people  with  a 
clear and credible public health message”, as the World Health 
Organization  puts  it.  The  press  office   provides   information 
about  public  health  emergencies,   scientific  findings,  impor-







information  about  its  tasks,  projects  and  research  to  the 
 scientific and general public on the internet. The press office 
coordinates  the  institute’s  internet  activities  and  edits  the 
German  and  English  websites.  The  information  is  updated 




The  unit  supervises  and  coordinates   publications  and 
 information  brochures  and  takes  care  of  the  institute’s 
 corporate design. The Robert Koch Institute (RKI) publishes 
two  journals  on  a  regular  basis  whose  editorial  offices  are 
 embedded in this unit: the monthly  “Bundesgesundheitsblatt”, 
a  journal  for   public  health,  health  research  and  health  pro-
tection,  and  the  weekly  “Epidemiologisches  Bulletin”  which 
ensures  a  rapid  information  exchange  between  different 
stakeholders such as doctors in surgeries, clinics, laboratories, 






















MeMbers ~ claudia Lerch (Head) ~ Dr. helmut fouquet ~ bettina hanke ~ sabine hofmann ~ Dr. antonia Mehlitz
MeMbers ~ susanne Glasmacher (Head) ~ Günther Dettweiler (Deputy) ~ Marieke Degen ~ Jens erling ~ sarah friedländer ~ heidrun Golisch 
Katharina heldt ~ regina Klinke ~ Kathrin Meyer ~ claudia Paape ~ Judith Petschelt ~ sara Preisetanz (Dr. Heidi Rohdewohld) ~ Jessica riedel
alexander roy ~ Petra schön ~ Dr. Jamela seedat ~ henriette senst ~ francesca smolinski ~ heide tröllmich ~  Dieter umlauf ~ nadin Watzke
Fundamental and Legal Issues
To  give  legal  advice  is  an  important  task  with  regard  to 







scientific  treatment  and  by  coordinating  contributions  from 
the scientific departments.
Legal advice is also often required for carrying out research 
activities  in  the  public  health  field.  Since  these  research 
 activities  are  often  related  to  sensitive  personal  data,  issues 
belonging to the complex legal field of data protection become 
crucial for the design of many projects.
Networking  between  scientific  projects,  working  groups 
and scientific institutions at the national, European and global 
level  and  integration  into  more  and  more  complex  funding 
structures  has  been  becoming  increasingly  important  for 
the  RKI  in  recent  years  and  decades.  This  reflects  to  some 
extent a general trend in the scientific field but even more the 











procedures  e.  g.  in  the  field  of  freedom  of  information  and 
 proceedings of internal legal appeal. 





   Staff Units      





(RKI)  is  one of  the  federal  authorities  in Germany  involved 





The  implementation  of  Regulation  (EC)  No  1829/2003 





The  main  focus  of  safety  assessment  by  RKI  relates  to 




recipient  organism,  genetic  modification  and  its  functional 
consequences,  compositional  characteristics  of  genetically 
modified plants and derived food and feed, potential toxicity 
and allergenicity of gene products (proteins,  metabolites) and 
the  whole  genetically  modified  food  and  feed.  Studies  have 
to  be  performed  according  to  internationally  accepted 
guidelines.  The  main  task  of  risk  assessors  is  to   evaluate 
completeness, validity and reliability of the data focusing on 
a   case-by-case  and  step-by-step  approach.  As  a  result,  RKI 
 forwards a  scientific opinion to the Federal Office of Consumer 
 Protection  and  Food  Safety  (BVL)  which  is  the  competent 
authority in the field of genetic engineering in Germany.
Furthermore,  the  unit  Genetic  Engineering  provides 
advice to the German Federal Ministry of Health in the area 
of   protection  of  human  health  on  natural  science  aspects 
with respect to a broad spectrum of biotechnological subjects. 
 The  unit   cooperates  with  national  federal  authorities  such 




assessment of GMO.  In  the RKI’s  internal organization  the 
unit is assigned to Management Staff.              www.rki.de/l2-en
MeMbers ~ simone Jung, PhD (Head), right ~ helga fender, PhD, left
“All our efforts for ensuring a 
high level of protection of  
human and animal health in 
relation to genetically modified  
  food and feed.”
 Dr. Simone Jung
MeMbers ~ Peter Löser, PhD (Head) ~ anke Guhr ~ sabine Kobold
Additional tasks of the authorization office include the  advising 
of applicants, the monitoring of the scientific  literature for novel 
developments  in  stem  cell  research,  eventually   participation 
 in  task-specific  national  and  international  committees  as 
well  as  the  preparation  of  the  stem  cell  reports  which  have 
to  be   provided  regularly  by  the  Federal  Government  to 
the   Bundestag.  As  a  result  of  the  continuous  survey  of  the 
 scientific  literature  in  the  stem  cell  field  several  large  data-
bases  were  generated  that  contain  a  magnitude  of  data  on 
 globally  available hESC lines and scientific papers published 





Regulatory Authority for the Import and Use  
of Human Embryonic Stem Cells
The  ability  of  human  embryonic  stem  cells  (hESCs)  to 
 reproduce  almost  limitlessly  and  to  differentiate  into  many, 
if  not  all,  cell  types  of  the  human  body  has  generated  an 
enormous amount of scientific  interest. These unique capa-
bilities provide a means  to explore many promising  lines of 
research,  which  are  likely  to  reveal  a  deeper  understanding 
of  human  cellular  biology  and  which  may  lead  to  potential 
cures  for  many  diseases.  Currently,  16  clinical  trials  based 
on hESCs are being performed worldwide. Since hESCs are 
derived from early human embryos  (which are generated  in 
the  course  of  an  in  vitro  fertilization  procedure  but  are  not 




for  research.  It  defines  the  conditions  under  which  hESCs 
can be imported to Germany and used for research. RKI is the 
 competent authority for the implementation of the Stem Cell Act.
The  central  task  of  the  authorization  office  is  the  orga-
nization of the authorization procedure for research involving 
hESCs.  This  predominantly  includes  a  scientific  review  of 
the respective proposals, the decision on whether a research 
project and the hESC lines to be imported and used meet the 
requirements  of  the  Stem  Cell  Act  and  the  granting  of  the 
 corresponding authorizations. The authorization office is also 
in charge of the national registry on hESC research, presenting 
information  on  approved  research  projects  and  on  essential 
reasons for the approval to the public. This registry provides  a 
globally unique degree of transparency on hESC research. The 




1. Kobold s, Guhr a, Kurtz a, Löser P (2015) human embryonic and 
Induced Pluripotent stem cell research trends: complementation 
and Diversification of the field. stem cell rep 4: 914–925.
2. schuldt bM, Guhr a, Lenz M, Kobold s, Macarthur bD, schuppert a, 
Löser P, Müller fJ (2013) Power-laws and the use of pluripotent 
stem cell lines. PLos one 8: e52068.
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stem cell rev 8: 1048–1055.
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Board  composed of  external  experts  from different  scientific 
fields gives advice to the Institute on the general objectives of 
the scientific work. It also makes recommendations  concerning 
the  structure  of  the  institute  and  how  to  generally  improve 
research.
Secondly, the internal Research Council is more  specific 
concerned  with  the  organization  of  the  research  work  and 
decides  on  funds  and  additional  support  for  successful 





sioner,  the  Occupational  Health  and  Safety  unit,  the  Social 
Consulting unit, The Youth and Trainee Representative Coun-
cil  and  the  Severey  Handicapped  Empolyee  Representative. 
They cooperate in many ways to support the staff and to find 
solutions  for  personal  problems  and  any  problem  related  to 
work. Particular attention is drawn to the compatibility of work 
and family obligations.
MeMbers ~ Prof. Dr. Georg Peters (Head) ~ Prof. Dr. angelika Vallbracht (Deputy) ~ Prof. Dr. stephan becker ~ Prof. Dr. regine hakenbeck
Prof. Dr. Jörg hacker ~ Dr. anja hauri ~ Prof. Dr. franz xaver heinz ~ Prof. Dr. Petra Kolip ~ Prof. Dr. Daniela Männel ~ Prof. Dr. Michael Manns
Prof. Dr. Jacqueline Müller-nordhorn ~ Prof. Dr. Mathias Pletz ~ Dr. Matthias Pulz ~ Dr. claudia stein ~ Prof. Dr. sebastian suerbaum
Scientific Advisory Board
The  Scientific  Advisory  Board  (“Wissenschaftlicher   Beirat”) 




four years  term (ending 2017) by  the   president of RKI after 
 consultation with the German Federal Ministry of Health. 
These  members  are  outstanding  scientists  covering  the 
 relevant disciplines of infectious diseases, public health research 
and  epidemiology  of  communicable  and  non- transmittable 




The  current  chairperson  is   Prof. Georg Peters  (see picture), 
Institute  of  Medical  Microbiology  of  University  of  Münster, 
 deputy-chairperson  is  Prof.   emeritus  Angelika  Vallbracht, 
Institute of Virology, University of  Bremen. 
The  Scientific  Advisory  Board  shall  give  guidance  and 
advice for RKI to conduct its scientific activities on an interna-
tional and highly competitive level. Accordingly, the main tasks 

















The following bodies are going to be introduced subsequently:
 Ω Scientific Advisory Board
 Ω Research Council
 Ω Data Protection Officer
 Ω Equal Opportunity Commissioner
 Ω Occupational Safety
 Ω Social Consulting
 Ω Quality Management
 Ω Staff Council
 Ω Youth and Trainee Representative Council 
 Ω Severely Handicapped Employee Representative
“The RKI has developed  
substantially over the last  
decades towards the  
science-based national Public
 Health Institute.” 
 Prof. Dr. Georg Peters











sibility of  the Research Council  to  safeguard good   scientific 
practice.  In  case  of  suspicion  of  scientific  misconduct  the 
Research Council investigates the incident in an unprejudiced 
manner and gives advice on how to proceed further. 
MeMbers ~ Prof. Lothar h. Wieler (President of RKI, Head) ~ PD Dr. Lars schaade (Vicepresident and Head of ZBS) ~ Prof. Dr. Martin Mielke 
(Head of Department 1 Infectious Diseases) ~ Dr. bärbel Maria Kurth (Head of Department 2 Epidemiology and Health Monitoring)  
Dr. osamah hamouda (Head of Department Infectious Disease Epidemiology) ~ Dr. heinrich Maidhof (Head of Research Coordination)  
Dr. anke engelbert (Head of Adminstration) ~ PD. Dr. Michael beekes (Ombudsman for Good Scientific Practice) ~ torsten semmler  
(Speaker of Junior Research Groups) ~ Prof. Dr. Dirk brockmann (Speaker of Project Groups) ~ Dr. heinzfried ellerbrok (elected representative of laboratory 
scientists) ~ Dr. Viviane bremer (elected representative of epidemiologists) ~ sabrina neumann (elected representative of technical staff )  


























objectives  arising  from  compliance  with  laws  and  regula-
tions as well as the requirements arising from the work and 
fields of  activity of  the Robert Koch  Institute with  regard  to 
the institute’s data and IT systems. An Information Security 





proper way and  therefore  that  IT  security  is guaranteed both 
internally  and  externally.  Although  the  management  bears 
















security  management  team  act  in  strong  cooperation  with 
 the  Information  Technology  Unit.  They  are  involved  in  all 
IT   projects  and  advise  scientists,  project  leaders  and  all 
 interested persons in secure implementation of information 










Usually  the Research Council meets  four  to six  times a 
year. The unit Research Coordination acts as the committee’s 
office and takes care of the preparation of the meetings, the 
elaboration  of  meeting  documents  and  the  implementation 
of the decisions of the Research Council.
MeMbers ~ Dr. Jörg Lekschas (Data Protection Officer, Chief Information Security Officer), right ~ Mandy herbst ~ sebastian Kärsten
“Data protection  
and information security  
are tasks for all.”
 Dr. Jörg Lekschas
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Occupational Safety

















Our duties comprise advice and support especially  






and psychosocial strains   for  the employees. We chair  the 
health  and  safety   committee   meetings  (ASA),  which  are 
conducted regularly at the Robert Koch Institute.
 Ω Preparing and shaping of processes  that  are  safe, healthy, 
suitable,  and  humane.  This  particularly  requires  the 













































  π  keep  the  occupational  medical  file  of  the  employees 







 Ω We  work  towards  all  employees  behaving  in  accordance 
with the requirements of occupational safety and accident 





with  all  our  know-how  and  energy,  striving  for  a  symbiosis 
between legal requirements and the ability to work, focusing 
on  a  steady  improvement  of  safety  and  protection  of  health 
of our employees.






The duties of the Equal Opportunity Commissioner  
include in particular:
 Ω support  the  institute  to  achieve  and  implement  the  aim 
of the laws
 Ω increasing  the  proportion  of  women  in  management 
 positions, decision-making bodies and committees
 Ω to  ensure  the  equal  treatment  of  women  and  men  and 
the  prevention  of  discrimination  regarding  employment, 
 training, education
 Ω to ensure an adequate work-life balance
“Closing the gender gap –  
  act now.” 
  OECD, 2012
MeMbers ~ Jutta Masopust (Equal Opportunity Commissioner), right ~ simone Jung, PhD (Deputy), left
   Bodies    




 Ω initiation  of  seminars,  lectures  and  information  sessions 












personnel  guidance,  provided  with  strategies  for   addressing 
employee  problems,  along  with  optional  onsite  training 
and consultation for lab working groups or teams who need 
 assistance as well.























There  are  many  situations  or  problems  that  can  affect 
ones efficiency, motivation or creativity at work. For the various 
issues and problems we offer a very broad range of support for 






the  same  day  of  their  call.  We  offer  brief,  solution-focused 
 counseling to help employees immediately.





Quality  policy,  approved  by  the  management,   fosters  the 
constantly  improving  quality   management  system.  In  close 









laboratories  at  RKI  has  been  performed  by  the  national 
 accreditation body of Germany (DakkS). Thirteen  laboratories 


















A central  issue of quality  assurance at  the   Robert Koch 
Institute  is  the  detection  of  pathogens.  This  includes  the 
validation  of  the  examination  procedures  and  continuous 
performance of verification and documentation of all quality 




inated  as  Quality  Management  Officer.  She  coordinates   the 
 activities of the quality management division and  supervises 
the   standard  conformity  of  all  activities  within  the  quality 
MeMbers ~ Katharina holschbach-bussian (Head) ~ andré schier
“Our defined goals are  
to encourage personal health and 
performance of the  
workforce and keep their  
productivity high.” 
Astrid Weber and Yvonne Janczak
   Bodies    
MeMbers ~ astrid Weber, left ~ Yvonne Janczak




The  staff  representation  rights  apply  not  only  to  the 
 working conditions of employees and workers, but also covers 
working conditions of public officials. Each group is basically 














 Ω to  cooperate  with  the  severely  handicapped  employee 
 representatives, the Youth Council, the Equal Opportunities 
Commissioner and the representation of foreign workers 
MeMbers ~ Michael seibold (Head) ~ uwe schäfer (Deputy) ~ Kerstin schönerstedt-Zastrau (Deputy) ~ birgit arnold ~ andreas bergholz 
hans butschalowsky ~ arne fix ~ stefanie herfort ~ Dr. nils-holger Kirsch ~ ute obst ~ Dr. Julia sasse ~ christina sorge ~ Marco sieslack
Youth and Trainee Representative Council 
In  agencies  with  staff  committees,  which  usually  employ  at 
least five workers who have not attained the age of 18 (young 




A  JAV  represents  those  young  employees  and   trainees 
by  whom  it  is  elected.  It  advises  on  all  matters  relating  to 




















For  the  future,  it  is  important  to  keep  on  training  and 
 promoting dedicated young talents.














in  relation  to  the  RKI’s  management.  The  Staff  Council  is 
the representative of all employees. It follows the task to real-
ize participation of  employees  in  the  scheme of  service  and 
 remuneration  and  working  conditions  and  to  represent  the 
interests of employees.
The  Staff  Council  and  the  agency  management  files 




maxim.  Each  Staff  Council  regulates  the   performance  of  its 
duties independently and autonomously, without being subject 
to legal supervision or instructions of agency management.
Unterkapitel      Kapitel   150 151
Severely Handicapped Employee Representative






provides  opportunities  to  talk,  gather  their   knowledge  and 
experiences and will call  in  to manage   difficulties. The SBV 









at  the  departments  and  the  possibilities  for  people  with 
 disabilities. Disability occurs when a health damage leads  to 
functional limitations.











who  is  severely  disabled,  even  with  a  degree  of  disability  of 
100 %, is able to perform as expected in his/her profession, if 




ments  of  the  working  place  someone  severely  disabled  is 
able  to  provide  the  same  performance  as  someone  without 
 dis abilities. 










DIsabLeD staff rePresentatIVe ~ christiane bug
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The 125th anniversary of  the  foundation of  the   Robert Koch 




 published  on  the  occasion  of  the  75th  anniversary  of  the 
 institute,  covered  all  scientific  papers  from  RKI  until  then, 




This  bibliography  contains  exclusively  literature  about 
the institute and individuals who worked at the institute. The 







of  SurvStat).  Regular  recommendations  by  commissions  at 
the  RKI,  scientific  meetings,  advanced  trainings  as  well  as 
information from the press were not taken into account. 
Apart  from  the  “Bibliography  of  papers  from  the 
Robert Koch Institute”, we reviewed all volumes of the “Bundes-
gesundheitsblatt” (a journal for public health, health research 
and  health  protection,  see  page  119)  since  the  beginning  of 












of the Robert Koch Institute  
from 1881 to 2015
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Publications
For many years, the RKI has been providing information about 






a  regular  basis,  the  monthly  “Bundesgesundheitsblatt”  and 




articles  and  reviews  in  scientific   journals. Furthermore  RKI 




Cases of notifiable diseases / SurvStat
The  Robert  Koch  Institute  maintains  a  database  of  cases  of 
notifiable  diseases  and  confirmation  of  pathogens,  reported 










at  the  Robert  Koch  Institute  in  Berlin.  It  is   responsible  for 
pooling  and  quality-checking  the  data  it  receives  from  the 









Information System of the Federal Health Monitoring
RKI’s  publications  are  complemented  by  the  Information 
System of the Federal Health Monitoring (Informations system 
der  GBE,  IS-GBE).  It  is  an  online  database  which  provides 
information on all GBE topics and is maintained by the Federal 
Statistical Office. The database systematically pools information 









tions  (in  German  only).  The  data  records  can  be  requested 
upon  application  from  the  Epidemiological  Data  Centre 
 (Robert Koch Institute, unit 21). Additional data may  be made 








counselling  centres  and  facilities  of  public  health  service  as 
well as medical societies, national reference centres and sites of 
teaching and research.                 www.rki.de/epidbull
Bundesgesundheitsblatt – Journal for Public Health,  
Health Research and Health Protection 
The  journal  for  public  health,  health  research  and  health 
protection (“Bundesgesundheitsblatt – Gesundheitsforschung – 
Gesundheitsschutz”)  is  published  monthly  by  the  federal 
institutes within the portfolio of the Federal Ministry of Health. 
The journal addresses medical and scientific  questions, which 
are  relevant  for  the  public  health  system  and  the  govern-
mental healthcare policies. The  aim  is  to provide up-to-date 
 information  on  significant  developments  and  on  specific 




Journal of Health Monitoring





topic  is   presented  and  illustrated  by  current  data.  Topics 
are  for example, how many people  in Germany suffer  from 
 diabetes  mellitus  or  how  population  ageing  develops  and 
what   implications  this  has  for  healthcare.  The  articles  are 
written by scientists of the Robert Koch Institute. This  journal 
targets  a  broad  audience  and  is  published  once  a  quarter. 
It is only available as PDF document.    www.rki.de/EN
UMID: Environment and Human Health – Information Service
The “UMID: Environment and Human Health – Information 
Service” (German: “UMID: Umwelt und Mensch – Informa-
tionsdienst”)  is  published  annually  in  two  issues  under 
the  Action  Programme  Environment  and  Health  (APUG) 
and  is  available  free  of  charge.  It  provides  information  to 
public  authorities  and  institutions  working  in  the  areas  of 
environment and health, as well as for environmental health 
professionals  and  interested  members  of  the  public.  The 
abstracts are available in English.           www.rki.de/umid
Epidemiological Yearbook of Notifiable Infectious Diseases
In accordance with the German Protection against Infection Act 
(Infektionsschutzgesetz,  IfSG),  the  RKI  records   and   analyses 
data  on  the  occurrence  of  numerous  infectious   diseases 
in  Germany.  Each  year,  the  results  are  published  in  the 
 Epidemiological  Yearbook  of  Notifiable  Infectious  Diseases. 




Fact sheets for physicians 
The  publication  of  fact  sheets  for  physicians  (RKI- Ratgeber 
für  Ärzte)  is  done  on  the  basis  of  §  4  Protection  against 
Infection  Act  (Infektionschutzgesetz,  IfSG).  They  provide 
practical  important  and  current  information  and  guidance 
on major infectious diseases. The info sheets are worked out 
in   collaboration  with  national  reference  centres  and  other 








Reports on Different Diseases




Report on the Epidemiology of Influenza in Germany 
The Report on the Epidemiology of Influenza in Germany is 
published yearly. An executive summary in English provides 
an  overview  of  the  noteworthy  developments  and  events  in 
influenza  epidemiology of  the  season before. Results  of  the 
influenza  surveillance  of  the  Robert  Koch  Institute  are  pri-







Report on the Epidemiology of Tuberculosis in Germany 
An  executive  summary  in  English  provides  an  overview  of 
the  noteworthy  developments  and  events  in  tuberculosis 
 epidemiology of the year before. The summary contains case 
numbers and the number of deaths, analyses of demographic 
data,  citizenship,  country  of  birth,  tuberculosis  in  children, 
site   of   disease,  drug  resistance,  treatment  outcome  and  a 
 short conclusion.               www.rki.de/tuberkulosebericht
Cancer in Germany 
The German Centre for Cancer Registry Data (ZfKD) is located 
within  the Robert Koch  Institute  in Berlin.  It  is  responsible 
for pooling and quality-checking the data it receives from the 
 population-based  cancer  registries  in  each  German  federal 
state. After pooling and quality-checking,  the ZfKD analyses 
and evaluates the data and publishes its findings on a  regular 
basis.  An  important  publication  is  “Cancer  in  Germany”, 
which  is  released  every  two  years.  In  an  online  database 
one  can  find  current  cancer  statistics  available  through  an 
 interactive query (see above).      www.krebsdaten.de
Recommendations by Committees
Fifteen  scientific  committees  have  their  scientific  office  at 
the  Robert  Koch  Institute,  e.g.  the  Standing  Committee  on 
Vaccination  or  the  National  Advisory  Committee  Blood. 
Their  recommendations,  reports  or  statements  are  either 
published  in  the  Epidemiological  Bulletin,  in  the  Journal 
 for  Public  Health,  Health  Research  and  Health  Protection 
 (Bundesgesundheitsblatt) or on the RKI website. 
Standing Committee on Vaccination
The  national  immunisation  schedule  is  developed  by  the 
Standing Committee on Vaccination (STIKO), and an updated 
version  is usually published once a year  (usually  in August) 
in  the  Epidemiological  Bulletin  of  the  Robert  Koch  Insti-
tute.  Besides  the  routine  immunisation  schedule,  STIKO 
also recommends vaccinations for specific indications or  target 
groups.  The  current  vaccination  recommendations  are  also 
available in English.                         www.rki.de/stiko-en
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Recommendations of the Commission for Hospital Hygiene 





Hospital  Hygiene  and  Infection   Prevention  (KRINKO).This 
commission has been set up at the RKI  according to § 23 of  the 
German  Protection  against  Infection  Act  (Infektionsschutz- 
gesetz).  By now, the KRINKO  recommendations refer to several 
aspects  of  medicine  such  as  prevention  of  HAI,  hygiene 
management  in  special  fields  such  as  dialysis  or  endoscopy, 
reprocessing  medical equipment,  disinfection and sterilization 
and   surveillance  of  HAI.  They  are   recommended  by  mutual 
consensus  of  the   commission  and  are  published  in  Bundes-
gesundheitsblatt and on the website of RKI.
www.rki.de/krankenhaushygiene
Reports of the Central Ethics Committee for Stem Cell Research 
The Central Ethics Committee for Stem Cell Research  (Zentrale 
Ethik-Kommission  für  Stammzellenforschung,  ZES)  was 
established in 2002 as part of the German Stem Cell Act. The 
committee is an independent and interdisciplinary expert body 
whose  activities  are governed by  this  law,  the  ‘Act   ensuring 
the  protection  of  embryos  in  conjunction  with  the  import 
and  use  of  human  embryonic  stem  cells’  (Stem  Cell  Act  – 
StZG) dated 28 June 2002 and by the ‘Regulation  concerning 
the  Central  Ethics  Committee  for  Stem  Cell  Research 
and  the competent authority pursuant  to  the Stem Cell Act’ 
(ZES Regulation – ZESV) dated 18 July 2002. Annual reports 
are  submitted  to  the Federal Ministry of Health and can be 
accessed via the websites of the ministry and the RKI.
www.rki.de/zes-reports
Reports of the Commission on Genetic Testing (GEKO)
Triannual reports describe the past activities of the  commission. 
These  reports  also  include  the  evaluation  of  current  and 
 prospective  developments  in  genetic  diagnostics.  Besides,  it 
processes  requests  for general  interpretation and application 
of  the  guidelines,  maintains  the  GEKO  website  at  www.rki.
de/geko and participates in national and international fora on 
issues of genetic diagnostics.              www.rki.de/geko-bericht
Federal Health Reporting (GBE)
Federal Health Reporting (Gesundheitsberichterstattung des 
Bundes,  GBE)  continuously  supplies  data  and  information 
on the German population’s state of health and the  country’s 
healthcare  services.  It  covers  a  broad  spectrum  of  topics, 
 ranging from diseases, symptoms and risk factors to  subjective 




as  RKI’s  booklets,  GBE  kompakt,  Contributions  on  Federal 
Health Reporting and the reports Health in Germany. GBE’s 
types of publication differ with respect to breadth and depth 








in  2015  in  11  chapters.  It  is  the  third  comprehensive  report 
of  this  kind  in  Federal  Health  Reporting.  A  broad  database 
was included in order to represent the disease  spectrum, the 
distribution of risk factors, the use of prevention and health-
care.  Overall,  it  can  be  observed  that  there  are  two  major 
 developments  which  are  essentially  determining  the  health 
and  care  developments  in  Germany:  demographic  changes 
and  the  strong  influence  of  the  social  situation  on  health. 
The  impact of  the demographic development on health and 













public an opportunity  to  learn about health  issues. The data 
and information in the booklets is presented in a scientifically 
well-founded,  action-oriented  and  clear  way.  One  can  either 
download these booklets as PDF files (German version only) 
or receive a printed copy by post. Executive summaries are also 
available in English.               www.rki.de/health-reporting
Contributions to Federal Health Reporting
Supplementing  the  series of publications by Federal Health 
Reporting,  the  Robert  Koch  Institute  releases  the  series 
“Contributions  to  Federal  Health  Reporting”.   Appearing 
sporadically,  the publications offer the reader additional and 
 in-depth information on important aspects of health  reporting, 
for  example  on  the  health  of  men.  You  can  download  the 















Technical dictionary “Infection Prevention  
and Infectious Disease Epidemiolgy”
In  this  technical  dictionary,  numerous  terms  relating  to 
infection  control  and  prevention  and  infectious  disease 
 epidemiology  are  explained.  The  dictionary  is  in  German, 
with  English  translations  for  all  terms.  (“Infektionsschutz 
und  Infektionsepidemiologie:  Fachwörter  –  Definitionen  – 
 Interpretationen”).                 www.rki.de/fachwoerterbuch
Case definitions and criteria for transmission 
In  accordance  with  the  German  Protection  against  Infection 
Act, RKI develops and publishes case definitions and criteria 
for transmission and evaluation of cases. The case definitions 
offer  uniform  criteria  for  the  control  of  infectious  diseases. 
www.rki.de/falldefinitionen
Fact sheets on rare and imported infectious diseases




CDC surveillance definitions of healthcare-associated  infections




Reference  Centre  for  Surveillance  of  Nosocomial   Infections 
uses  the  same  definitions  as  the  Centres  for  Disease 
Control  and  Prevention  (CDC)  in  the  USA.  Together  with 
the  RKI,   the  National  Reference  Centre  publishes  the  CDC 
 definitions  in German.           www.rki.de/cdc-definitionen
List of disinfectants
Proof  of  disinfectant  activity  is  a  basic  condition  that  must 
be  met  for  successful  and  appropriate  use  of  disinfectants. 
The  RKI  publishes  a  list  of  approved  disinfectants  and 
 disinfection  procedures  as  tested  and  approved  by  the  RKI, 







Statement of the Virucide Working Group on the RKI 
The  Virucide  Working  Group  publishes  the  state  of  the 
art  for  testing  and  labeling  of  disinfectants  against  viruses 
and defines of different virus activity spectra. 
www.rki.de/virucide
Publications about the Robert Koch Institute




 necessarily  have  specialised  medical  knowledge.  The  first 
chapter  describes  the  most  important  tasks  of  the  institute: 
protection from infectious diseases and analysis of the health 
situation in Germany. The second chapter gives an overview 
of  the  institute’s  history  since  its  establishment  in  1891. 
The remaining chapters go on to provide an introduction and 
overview of  the various areas of activity at  the  institute. The 
brochure is also available in English.    www.rki.de/rki-brochure





Flyer “The Robert Koch Institute: A Historical Retrospective”
The Robert Koch Institute was opened  in 1891, with Robert 
Koch as  its  first director. The flyer  informs about  the  life of 
Robert  Koch  and  the  institute.  It  is  available  in  German 
and in English.                         www.rki.de/history
Flyer “Robert Koch in Berlin”
The flyer informs about the places of life and work of Robert 
Koch in Berlin. It is available in German only.  www.rki.de/history
Reports from the field: RKI staff responds to the  
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164 165   Facts and Figures    
1,102 number of employees
461 number of scientists
4 number of sites. the rKI has its headquarters and two additional locations in berlin  as well as a branch in Wernigerode, a university town in the harz region
48 number of trainees
74 number of graduate students
90 number of professional groups 
50 number of different types of degrees held by rKI members
87,800,000 federal budget in euros  Includes € 12.9 million for infrastructure, mainly for construction of laboratories
9,075 total area in square metres of laboratories operating under biosafety level 2 conditions
13,030,000 amount of external project funding in euros, mostly from the european union,  federal ministries and the German research foundation
417,695 cases of notifiable diseases reported to rKI for 2015
5,651 outbreaks of notifiable diseases reported to rKI for 2015
438 number of publications in peer-reviewed journals in 2015 (376 in 2014, 422 in 2013)
100,000 number of books and journals in the rKI library
3,809 number of online journals subscribed to by the rKI library
62,204 number of the journals that rKI scientists have access to online
14,184 citations of articles by rKI scientists in 2015
100,076 Participants in the health Monitoring studies
15 number of scientific committees that have their scientific offices at rKI
15 number of national reference centres and consultant laboratories at rKI
18,000 number of documents on the rKI website www.rki.de and its sub-sites
40,000,000 number of internet page requests in 2015 (38 million in 2014, 41 million in 2013)
3,610 number of twitter followers in May 2016 (2.938 in 2015, 1670 in 2014, 503 in 2013)rKI has been tweeting since July 2013
1,825 number of press inquiries from May 21 to July 26 concerning the ehec outbreak 2011
4,100 number of e-mails sent to the central rKI info mail box info@rki.de every year
575 number of reports sent to the federal Ministry of health in response to official requests  in 2015 (225 in 2014, 300 in 2013)
130 number of unsolicited reports sent to the federal Ministry of health in 2015  (100 in 2014, 100 in 2013)
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Originally founded as the Royal Prussian Institute of Infectious Diseases on July 1st 1891 
with Robert Koch as its director, the Robert Koch Institute has since experienced dra-
matic changes to achieve its present standing as the German National Public Health 
Institute. Today the institute is part of an international network for public health research 
and development. Its two major areas of responsibility lie in combatting infectious 
diseases and analysing health trends in the population but it also focuses on developing 
methods and drawing up scientific standards. Moreover, the RKI is very active in the  
field of qualifying scientists, including doctoral dissertations and trainee programmes.
The RKI depends on the excellence of its scientists. Without their fundamental and 
measure-related research activities the institute would be unable to file recommendations 
for improving public health. The institute is run by the efforts of its more than 1,100  
dedicated employees who, with their over ninety different professions, transform the 
institute’s vision to protect health and explore risks into reality, an excellent basis  
for providing sound recommendations to political decision-makers. This booklet gives 






























   
  
